<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>Subtitle 47 ALCOHOL AND DRUG ABUSE ADMINISTRATION | Library of Maryland Regulations</title>
    <link rel="shortcut icon" href="/us/md/exec/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/md/exec/comar/10.47/index.full.html" data-document="href"/>
    <meta itemprop="toc-json" content="/us/md/exec/comar/10.47/index.json" data-document="href"/>
    <meta itemprop="parent-doc-url" content="/us/md/exec/comar" data-document="href"/>
    <meta itemprop="order" content="|10|47|"/>
    <meta itemprop="doc-type" content="container" data-document=""/>
    <meta itemprop="ref-doc" content="Code of Maryland Regulations" data-document=""/>
    <meta itemprop="ref-path" content="10|47" data-document=""/>
    <!--OpenGraph-->
    <meta property="og:url" content="/us/md/exec/comar/10.47"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content="Subtitle 47 ALCOHOL AND DRUG ABUSE ADMINISTRATION | Library of Maryland Regulations"/>
    <meta property="og:image" content="/us/md/exec/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#0078EF"/>
    <meta name="apple-mobile-web-app-title" content="Library of Maryland Regulations"/>
    <meta name="theme-color" content="#0078EF"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/md/exec/_document/v2/images/favicons/safari-pinned-tab.svg" color="#0078EF"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/md/exec/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/md/exec/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/md/exec/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/md/exec/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/public-sans/public-sans.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/merriweather/merriweather.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/roboto-mono/roboto-mono.css" type="text/css" rel="stylesheet" data-document=""/>
    <!--Document CSS-->
    <link href="/us/md/exec/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print" data-document=""/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js" data-document=""> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/md/exec/comar/10.47/index.full.html" as="fetch"/>
    <link rel="prefetch" href="/index.json" as="fetch"/>
    <link rel="prefetch" href="/us/md/exec/comar/10.47/index.json" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message"> </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__maryland-dsd">
      <header id="section__header" class="ns__document__maryland-dsd">
        <div id="section__header__inner" class="ns__document__maryland-dsd">
          <div id="area__logo" class="ns__document__maryland-dsd">
            <a href="/" class="logo" aria-label="Logo - Return to library home page">
              <img src="/us/md/exec/_document/v2/images/logo/logo.png" srcset="/us/md/exec/_document/v2/images/logo/logo.png 1x, /us/md/exec/_document/v2/images/logo/logo@2x.png 2x, /us/md/exec/_document/v2/images/logo/logo@3x.png 3x" alt="Library of Maryland Regulations logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__maryland-dsd">
            <div class="h__library-logotype"><span class="line1">Library of</span> <span class="line2">Maryland Regulations</span></div>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__maryland-dsd">
        <div id="section__content__inner" class="ns__document__maryland-dsd">
          <section id="area__breadcrumbs" class="ns__document__maryland-dsd" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="Library of Maryland Regulations">Library of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/md/exec/comar" title="Code of Maryland Regulations">Code of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10" data-search-heading="">
                  <a href="/us/md/exec/comar/10" title="Title 10 MARYLAND DEPARTMENT OF HEALTH">Title 10 MARYLAND DEPARTMENT OF HEALTH</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|47" data-search-heading="">
                  <span title="Subtitle 47 ALCOHOL AND DRUG ABUSE ADMINISTRATION">Subtitle 47 ALCOHOL AND DRUG ABUSE ADMINISTRATION</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__maryland-dsd">
            <div class="h__document-title">Code of Maryland Regulations</div>
            <article class="content" role="document" data-ref-path="10|47">
              <div class="tuf-authenticate">
                <h1 class="h__toc" id="/us/md/exec/comar/10.47">Subtitle 47 ALCOHOL AND DRUG ABUSE ADMINISTRATION</h1>
                <h2 id="/us/md/exec/comar/10.47.01" data-order="|10|47|01|" data-ref-path="10|47|01" class="h__chapter">Chapter 01 Requirements</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: April 8, 1985 (12:7 Md. R. 703)</p>
                  <p>Regulations .26H, .30L, and .31K amended effective June 17, 1985 (12:12 Md. R. 1165)</p>
                  <p>——————</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.01" title=".01 Scope.">.01</a>—.33, Certification of Alcoholism and Alcohol Abuse Facilities, repealed and new Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.01" title=".01 Scope.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.09" title=".09 Referral Agreements and Program Cooperation.">.09</a>, Requirements, adopted effective June 10, 2002 (29:11 Md. R. 882)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.02#B" title="">Regulation .02B</a> amended as an emergency provision effective April 1, 2008 (35:9 Md. R. 894); amended permanently effective May 5, 2008 (35:9 Md. R. 898)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.03" title=".03 Governance.">Regulation .03</a> amended as an emergency provision effective April 1, 2008 (35:9 Md. R. 894); amended permanently effective May 5, 2008 (35:9 Md. R. 898)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.03" title=".03 Governance.">Regulation .03</a> amended effective December 12, 2013 (40:24 Md. R. 2017)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">Regulation .04</a> amended as an emergency provision effective April 1, 2008 (35:9 Md. R. 894); amended permanently effective May 5, 2008 (35:9 Md. R. 898)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.05#A" title="">Regulation .05A</a> amended as an emergency provision effective April 1, 2008 (35:9 Md. R. 894); amended permanently effective May 5, 2008 (35:9 Md. R. 898)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.06#A" title="">Regulation .06A</a>, D amended as an emergency provision effective April 1, 2008 (35:9 Md. R. 894); amended permanently effective May 5, 2008 (35:9 Md. R. 898)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.07#A" title="">Regulation .07A</a> amended as an emergency provision effective April 1, 2008 (35:9 Md. R. 894); amended permanently effective May 5, 2008 (35:9 Md. R. 898)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.08" title=".08 Records.">Regulation .08</a> amended as an emergency provision effective April 1, 2008 (35:9 Md. R. 894); amended permanently effective May 5, 2008 (35:9 Md. R. 898)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.08" title=".08 Records.">Regulation .08</a>-1 adopted effective December 12, 2013 (40:24 Md. R. 2017)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §§8-401 — 8-405 and 19-308, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.47.01.01" data-order="|10|47|01|.01|" data-ref-path="10|47|01|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter sets forth the requirements for certification of drug and alcohol treatment programs.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.01.02" data-order="|10|47|01|.02|" data-ref-path="10|47|01|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#A">A.</span> In this subtitle, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(1)">(1)</span> "Addiction Severity Index" means a standardized method for the assessment of adults regarding addictions severity and patient need.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(2)">(2)</span> "Administration" means the Alcohol and Drug Abuse Administration within the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(3)">(3)</span> "Administrator" means the program director of an alcohol or drug abuse facility or a health care facility.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(4)">(4)</span> "Admission" means the documented acceptance of an applicant into a program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(5)">(5)</span> "Adolescent" means an individual 12 — 17 years old.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(6)">(6)</span> "Alcohol abuse" means a disease that is characterized by a pattern of pathological use of alcohol with repeated attempts to control its use, and with significant negative consequences in at least one of the following areas of life: medical, legal, financial, or psychosocial.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(7)">(7)</span> "Alcohol dependence" means a disease characterized by:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(7)(a)">(a)</span> Alcohol abuse; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(7)(b)">(b)</span> Physical symptoms of withdrawal or tolerance.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(8)">(8)</span> "American Society of Addiction Medicine Patient Placement Criteria" means an instrument designed to indicate patient placement guidelines for admission, continued stay, and discharge.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(9)">(9)</span> "Assessment" means the process of ascertaining the treatment needs of the patient regarding addiction and other social issues.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(10)">(10)</span> "Caseload" means the number of patients for whom a drug and alcohol counselor has the responsibility for providing clinical services and case management.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(11)">(11)</span> "Case management" means the process of coordinating and monitoring the services provided to a patient both within the program and in conjunction with other providers.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(12)">(12)</span> "Certification" means the approval issued to a program by the Administration to provide services under this subtitle.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(13)">(13)</span> "Child" means an individual younger than 12 years old.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(14)">(14)</span> "Clinical director" means the individual who is responsible for the therapeutic and rehabilitative aspects and direction of a program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(15)">(15)</span> "Clinical staff" means the individuals employed by or associated with a program who provide treatment, care, or rehabilitation to program patients or patients' families.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(16)">(16)</span> "Clinical supervisor" means the individual responsible for providing supervision to alcohol and drug clinical staff as clinically appropriate.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(17)">(17)</span> "Continuous quality review" means objective and systematic monitoring and evaluation of the quality and appropriateness of patient care, the purpose of which is the improvement of that care, prevention of problems, and resolution of problems.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(18)">(18)</span> "Controlled dangerous substance" means any drug, substance, or immediate precursor in Schedules I — V under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gcr/gcr.pdf" title="">Criminal Law Article, Title 5, Subtitle 4, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(19)">(19)</span> Correctional Facility.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(19)(a)">(a)</span> "Correctional facility" means an institution overseen by the State or one of the 24 subdivisions where individuals are incarcerated.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(19)(b)">(b)</span> "Correctional facility" includes a jail, detention center, prison, or correctional halfway house.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(20)">(20)</span> "Credentialing" means a process of review to determine the professional level at which an employee may practice.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(21)">(21)</span> "Crisis intervention training" means training of staff to respond adequately to emergency situations, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(21)(a)">(a)</span> Medical emergencies;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(21)(b)">(b)</span> Emotional and psychological crises; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(21)(c)">(c)</span> Emergencies arising from environmental circumstances such as fires, floods, terrorism, and other disasters.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(22)">(22)</span> Critical Incident.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(22)(a)">(a)</span> "Critical incident" means a life, safety, or health threat involving the staff or patients participating in a program.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(22)(b)">(b)</span> "Critical incident" includes, but is not limited to, death or physical or sexual assault.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(23)">(23)</span> "Critical incident report" means the documentation of a critical incident.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(24)">(24)</span> "Department" means the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(25)">(25)</span> "Detoxification" means the process of withdrawing addictive psychoactive substances from the body in a safe and effective manner.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(26)">(26)</span> "Director" means the Director of the Administration.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(27)">(27)</span> "Discharge plan" means a written description of specific goals and objectives to assist the patient upon leaving treatment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(28)">(28)</span> Dispense.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(28)(a)">(a)</span> "Dispense" means to deliver a controlled dangerous substance or other drug to the ultimate user by a practitioner pursuant to a lawful order of the practitioner.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(28)(b)">(b)</span> "Dispense" includes prescribing, administering, packaging, labeling or compounding necessary to prepare the substance for delivery.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(29)">(29)</span> "Documentation" means written or recorded information that is dated.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(30)">(30)</span> "Drug" means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(30)(a)">(a)</span> A controlled dangerous substance that is regulated under the Maryland Controlled Dangerous Substances Act;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(30)(b)">(b)</span> A prescription medication; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(30)(c)">(c)</span> A chemical substance when used for unintended and harmful purposes.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(31)">(31)</span> "Drug abuse" means a disease which is characterized by a pattern of pathological use of a drug with repeated attempts to control its use, and with significant negative consequences in at least one of the following areas of life: medical, legal, financial, or psychosocial.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(32)">(32)</span> "Drug dependence" means a disease characterized by:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(32)(a)">(a)</span> Drug abuse; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(32)(b)">(b)</span> Physical symptoms of withdrawal or tolerance.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(33)">(33)</span> "Family" means an individual's immediate relatives or significant others.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(34)">(34)</span> "Family counseling" means a distinct discipline that utilizes accepted family system theories and intervention techniques.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(35)">(35)</span> "Governing body" means the organizational structure that is responsible for establishing policy, maintaining quality care, and providing management and planning for the program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(36)">(36)</span> "Individualized treatment plan" means a written plan of action that is developed and modified to address a patient's specific service needs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(37)">(37)</span> "Intermediate care facility" means a facility that provides a planned regimen of 24-hour professionally directed evaluation, observation, medical monitoring, and addiction treatment in an inpatient setting.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(38)">(38)</span> "Maintenance" means medically supervised continuation of the administration of methadone, LAAM, or other drugs approved by the Administration.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(39)">(39)</span> "Medical director" means a physician who oversees the medical practice of a program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(40)">(40)</span> "Methadone" means a synthetic opioid.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(41)">(41)</span> "Nurse" means an individual who is licensed by the State Board of Nursing to practice registered nursing or licensed practical nursing as defined in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=8-101" title="">Health Occupations Article, §8-101, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(42)">(42)</span> "Nurse practitioner" means a registered nurse who is certified as a nurse practitioner as defined in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=8-508" title="">Health Occupations Article, §8-508, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(43)">(43)</span> "Office of Health Care Quality" means the office under the Department that oversees certification and inspection of programs for the Administration.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(44)">(44)</span> "Patient" means an individual who is admitted into a program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(45)">(45)</span> "Physician" means any person authorized by law to practice medicine in this State under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=14-101" title="">Health Occupations Article, §14-101, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(46)">(46)</span> "Physician assistant" means an individual licensed to act as an assistant to a licensed physician in Maryland, as defined in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=15-101" title="">Health Occupations Article, §15-101, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(47)">(47)</span> "Possess" means the exercise of actual or constructive dominion or control over a controlled dangerous substance.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(48)">(48)</span> "Prevention program" means the Early Intervention Level 0.5 level of treatment as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.02.03" title=".03 Early Intervention Level 0.5.">COMAR 10.47.02.03</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(49)">(49)</span> "Privileging" means the process of review to determine the duties a volunteer or employee may perform.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(50)">(50)</span> "Problem Oriented Screening Instrument for Teenagers" means a standardized method of screening to determine whether or not an adolescent may have alcohol or other drug abuse or dependence or both and will need further evaluation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(51)">(51)</span> Program.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(51)(a)">(a)</span> "Program" means any organization or individual that provides treatment, care, or rehabilitation for individuals who show the effects of drug abuse or alcohol abuse, and represents or advertises itself as an alcohol or other drug abuse treatment program.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(51)(b)">(b)</span> "Program" includes a:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(51)(b)(i)">(i)</span> Program or facility that is owned or operated by the State or any of its political subdivisions; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(51)(b)(ii)">(ii)</span> Detoxification facility as defined in Health-General Article, §8-101(g), Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(52)">(52)</span> "Progress note" means an objective documentation of the patient's progress in relation to specific treatment goals and objectives.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(53)">(53)</span> "Screening" means the utilization of a valid tool or instrument approved by the Administration to determine whether or not an individual may have alcohol or other drug abuse or dependence or both and will need further evaluation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(54)">(54)</span> "Secretary" means the Secretary of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(55)">(55)</span> "Self-help group" means a voluntary fellowship or group that supports patients in recovery from alcohol and other drug abuse or dependence.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(56)">(56)</span> "Therapeutic agent" means an intervention that is used to effect positive change.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(57)">(57)</span> "Treatment plan goal" means an intended resolution of a patient's clinical condition or problem that is completed within a specific amount of time and will contribute to the completion of treatment in a program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(58)">(58)</span> "Treatment plan objective" means a behaviorally measurable symptom or social, legal, or family change that results in a stepwise achievement of a treatment goal.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(59)">(59)</span> "Utilization review" means a systematic assessment of the appropriateness of patient admissions, continuation in treatment, and referral to specific treatment services within a program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(60)">(60)</span> "Variance" means an alternate method of meeting the intent of a regulation under this subtitle.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(61)">(61)</span> "Waiting list" means a list of individuals who are appropriate for services from a program but for whom a treatment slot is not available for 4 or more weeks for outpatient programs, or 2 or more weeks for residential programs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.02#B(62)">(62)</span> "Waiver" means the exemption from compliance with a regulation under this subtitle.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.01.03" data-order="|10|47|01|.03|" data-ref-path="10|47|01|.03" class="h__section">.03 Governance.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A">A.</span> The program shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(1)">(1)</span> Have a governing body legally responsible for overseeing the management and operation of the program and for ensuring compliance with applicable laws and regulations by:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(1)(a)">(a)</span> Approving the program's:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(1)(a)(i)">(i)</span> Mission;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(1)(a)(ii)">(ii)</span> Goals;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(1)(a)(iii)">(iii)</span> Policies and procedures;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(1)(a)(iv)">(iv)</span> Budget; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(1)(a)(v)">(v)</span> Program service plan;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(1)(b)">(b)</span> Adopting written bylaws;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(1)(c)">(c)</span> Overseeing the operation of the program, according to the stated purposes of the program;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(1)(d)">(d)</span> Ensuring proper management of the program by developing a job description for the administrator, and hiring, supervising, and providing for periodic performance evaluation of the administrator; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(1)(e)">(e)</span> Ensuring sound fiscal operation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(2)">(2)</span> Implement fiscal policies and procedure which include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(2)(a)">(a)</span> The maintenance of fiscal records according to generally accepted accounting principles in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=19&amp;section=28A" title="">Article 19, §28A, Annotated Code of Maryland</a>, and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.02.01" title="Chapter 01 Charges for Services Provided Through the Maryland Department of Health">COMAR 10.02.01</a> and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.04.04" title="Chapter 04 Human Services Agreements Manual">10.04.04</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(2)(b)">(b)</span> Appropriate fire, casualty, liability, unemployment, and workers' compensation insurance;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(2)(c)">(c)</span> In the event of fiscal instability, immediately notifying the Office of Health Care Quality;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(2)(d)">(d)</span> Maintaining and posting a list of services and associated charges; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(2)(e)">(e)</span> Maintaining an annual program budget reflecting anticipated expenditures and sources of income;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(3)">(3)</span> Implement personnel policies and procedures that include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(3)(a)">(a)</span> Personnel policies and procedures that promote the objectives of the program;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(3)(b)">(b)</span> Personnel policies that include:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(3)(b)(i)">(i)</span> The qualifications required for each position;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(3)(b)(ii)">(ii)</span> An employee assistance policy and procedure;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(3)(b)(iii)">(iii)</span> A policy to prevent discrimination prohibited by <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/49B/49B.pdf" title="">Article 49B, Annotated Code of Maryland</a>, and federal law;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(3)(b)(iv)">(iv)</span> A policy designed to prevent sexual harassment of staff and patients and appropriately manage complaints of sexual harassment;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(3)(b)(v)">(v)</span> A staff grievance procedure;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(3)(b)(vi)">(vi)</span> A mechanism for assuring annual employee tuberculosis testing;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(3)(b)(vii)">(vii)</span> Before employment, applying for national and State criminal history records checks;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(3)(b)(viii)">(viii)</span> As part of the employment or volunteer application process, requiring the applicant to complete and sign a sworn statement or written affirmation disclosing the existence of a criminal conviction, probation before judgment disposition, not criminally responsible disposition, or pending charges without a final disposition;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(3)(b)(ix)">(ix)</span> Requiring the employee to comply with <a class="internal-link " href="/us/md/exec/comar/10.47.01.03#A(3)(b)(viii)" title="">§A(3)(b)(viii) of this regulation</a> annually; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(3)(b)(x)">(x)</span> Providing information to the employee so the employee may determine whether he or she needs testing or vaccination or both for hepatitis;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(3)(c)">(c)</span> Maintaining a personnel file, in accordance with State and federal confidentiality requirements, for each employee, contractual staff, intern, or volunteer, that includes the individual’s:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(3)(c)(i)">(i)</span> Written application or resume including, name, home address, current telephone number, educational and training background, and employment history;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(3)(c)(ii)">(ii)</span> Emergency contact information;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(3)(c)(iii)">(iii)</span> Copies of required credentials;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(3)(c)(iv)">(iv)</span> Current job title and description;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(3)(c)(v)">(v)</span> Current wage and salary information;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(3)(c)(vi)">(vi)</span> Annual performance evaluation;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(3)(c)(vii)">(vii)</span> Contracts, if applicable;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(3)(c)(viii)">(viii)</span> Results of a criminal background check;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(3)(c)(ix)">(ix)</span> Results of tuberculosis tests; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(3)(c)(x)">(x)</span> Documentation of attendance at continuing education courses or other training; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(3)(d)">(d)</span> Not permitting any individual with a documented history of physical, mental, or sexual abuse or neglect of adolescents or children to work with children and adolescents;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(4)">(4)</span> Manage the program by:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(4)(a)">(a)</span> Implementing a policy and procedure manual that contains:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(4)(a)(i)">(i)</span> An all hazards emergency protocol plan, approved by the Administration and updated at the time of recertification, that includes the name of the contact person for access to medical and clinical records, the written agreement or agreements with another facility to provide services in case of an emergency, notification procedures for the State Methadone Authority, program staff, and patients, a policy regarding patient access to emergency mental health services necessitated by a hazardous event, and a policy assuring that correctional levels of care comply with the institution’s all hazards emergency plan;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(4)(a)(ii)">(ii)</span> The program's mission and goals;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(4)(a)(iii)">(iii)</span> A description of the organizational structure of the program;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(4)(a)(iv)">(iv)</span> Identification of the duties of the administrator and, if applicable, the medical director or clinical director;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(4)(a)(v)">(v)</span> Admission, transition, discharge, and termination procedures;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(4)(a)(vi)">(vi)</span> Procedures governing patient rights and grievances;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(4)(a)(vii)">(vii)</span> If applicable, a procedure for storing, handling, prescribing, dispensing, administering, and disposing of medications;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(4)(a)(viii)">(viii)</span> Procedures for assisting program enrollees with access to entitlements, insurance benefits, and reimbursements for which the individual is eligible, if the program provides case management services; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(4)(a)(ix)">(ix)</span> Procedures for staff orientation, supervision, training, and education that include, but are not limited to, ethics and State and federal laws regarding confidentiality including, but not limited to, Health-General Article, Title 4, Subtitle 3, Annotated Code of Maryland, 42 CFR Part 2, The Health Insurance Portability Assurance and Accountability Act (HIPAA), and 45 CFR Parts 160 and 164; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(4)(b)">(b)</span> Implementing a program service plan, approved by the Administration, that is based on the levels of treatment to be provided as defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.02.03" title=".03 Early Intervention Level 0.5.">COMAR 10.47.02.03</a> — .11 and describes how the program shall comply with the regulatory requirements, is updated annually, and includes:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(4)(b)(i)">(i)</span> A description of medical staff, if required by the level of treatment;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(4)(b)(ii)">(ii)</span> A description of the program's scope that includes target populations and other program characteristics;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(4)(b)(iii)">(iii)</span> Staff positions, their job descriptions, and educational and clinical training requirements, including an organizational chart detailing lines of authority and responsibility;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(4)(b)(iv)">(iv)</span> A list of services to be delivered, including the types of medication and controlled dangerous substances to be prescribed, the types of group sessions, including education, the types of individual sessions and a complete family services plan;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(4)(b)(v)">(v)</span> Names of clinical supervisors and the number of alcohol and drug counselors supervised;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(4)(b)(vi)">(vi)</span> Types of services that are available by referral; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(4)(b)(vii)">(vii)</span> Planning protocol for transfer or discharge of patients;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(5)">(5)</span> Implement a continuous quality review process that includes:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(5)(a)">(a)</span> Designated teams responsible for implementation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(5)(b)">(b)</span> An ongoing procedure for utilization review;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(5)(c)">(c)</span> A plan to identify problems and initiate actions to correct deviations from the program’s established standards, which includes:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(5)(c)(i)">(i)</span> Data collection;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(5)(c)(ii)">(ii)</span> Current information regarding efficient and effective service delivery;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(5)(c)(iii)">(iii)</span> Indicators relevant to the needs of the population served; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(5)(c)(iv)">(iv)</span> Ongoing internal review of the program, including monitoring for effectiveness of changes incorporated; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(5)(d)">(d)</span> An opportunity for all staff to participate on the teams described in §E of this regulation; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(6)">(6)</span> Report critical incidents to the Administration within 5 business days of the incident;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(7)">(7)</span> Limit an individual’s role on the governing body to being a nonvoting member if the individual has an immediate family member who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(7)(a)">(a)</span> Is employed by the program;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(7)(b)">(b)</span> Consults on behalf of the program;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(7)(c)">(c)</span> Owns the program; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(7)(d)">(d)</span> Sits on an advisory committee for the program; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#A(8)">(8)</span> Refuse to allow an individual to serve on the program’s governing body if the individual receives any monetary benefit from the program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#B">B.</span> The program may not allow:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#B(1)">(1)</span> An immediate family member of an employee of an organization to serve as a voting member of the governing body, board of directors, or advisory committee; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.03#B(2)">(2)</span> An individual who is compensated for providing goods or services to the program to serve on the governing body, board of directors, or advisory committee.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.01.04" data-order="|10|47|01|.04|" data-ref-path="10|47|01|.04" class="h__section">.04 Clinical Requirements.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#A">A.</span> Admission. The program:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#A(1)">(1)</span> Shall upon request for admission:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#A(1)(a)">(a)</span> Establish an interview date that falls within 10 working days of the individual's initial contact;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#A(1)(b)">(b)</span> Refer or recommend another program to the individual; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#A(1)(c)">(c)</span> Place the individual on a waiting list;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#A(2)">(2)</span> Shall have a detailed description of patient placement criteria for admission to the program, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#A(2)(a)">(a)</span> Eligibility criteria, using guidelines such as the American Society of Addiction Medicine Patient Placement Criteria or other guidelines approved by the Administration; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#A(2)(b)">(b)</span> Procedures for admission;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#A(3)">(3)</span> Shall include in its admission procedures:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#A(3)(a)">(a)</span> An intake process;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#A(3)(b)">(b)</span> An emergency intake process, including a procedure to refer individuals who are not suitable for its program to a more suitable program;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#A(3)(c)">(c)</span> A procedure for developing and maintaining a waiting list; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#A(3)(d)">(d)</span> A fee schedule; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#A(4)">(4)</span> May not admit a patient unless the individual meets the admission criteria of the American Society of Addiction Medicine Patient Placement Criteria or other guidelines approved by the Administration.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#B">B.</span> Assessment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#B(1)">(1)</span> A program shall prepare a comprehensive assessment for each patient, unless the patient is being readmitted to the same program or admitted to a different program within 30 days of the patient's last discharge, or has received an assessment by a licensed or certified clinician or program within 30 days, in which case the program may update the prior assessment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#B(2)">(2)</span> The comprehensive assessment shall assess the following areas:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#B(2)(a)">(a)</span> Physical health;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#B(2)(b)">(b)</span> Employment or financial support;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#B(2)(c)">(c)</span> Drug and alcohol;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#B(2)(d)">(d)</span> Treatment history;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#B(2)(e)">(e)</span> Legal;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#B(2)(f)">(f)</span> Family and social;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#B(2)(g)">(g)</span> Educational; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#B(2)(h)">(h)</span> Mental health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#B(3)">(3)</span> Programs shall use the Addiction Severity Index as the standardized assessment instrument for adults, or an equivalent assessment instrument chosen by the Administration.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#B(4)">(4)</span> Programs shall use the Problem Oriented Screening Instrument for Teenagers as the standardized screening instrument for adolescents, or an equivalent screening instrument chosen by the Administration.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#B(5)">(5)</span> The initial physical health assessment shall meet the requirements of the appropriate level of treatment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#C">C.</span> Treatment Plans.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#C(1)">(1)</span> A program shall develop a written treatment plan, with the participation of the patient, based on the comprehensive assessment and patient placement criteria, that shall set forth:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#C(1)(a)">(a)</span> The patient's individualized needs, including:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#C(1)(a)(i)">(i)</span> Socialization;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#C(1)(a)(ii)">(ii)</span> Alcohol and drug abuse or dependence;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#C(1)(a)(iii)">(iii)</span> Psychological;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#C(1)(a)(iv)">(iv)</span> Vocational;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#C(1)(a)(v)">(v)</span> Educational;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#C(1)(a)(vi)">(vi)</span> Physical health;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#C(1)(a)(vii)">(vii)</span> Legal; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#C(1)(a)(viii)">(viii)</span> Family; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#C(1)(b)">(b)</span> Individualized interventions, including:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#C(1)(b)(i)">(i)</span> Long-range and short-range treatment plan goals and objectives;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#C(1)(b)(ii)">(ii)</span> Strategy for implementation of treatment plan goals and objectives;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#C(1)(b)(iii)">(iii)</span> Target dates for completion of treatment plan goals and objectives;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#C(1)(b)(iv)">(iv)</span> A schedule of clinical services including individual, group, and, if appropriate, family counseling;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#C(1)(b)(v)">(v)</span> Criteria for successful completion of treatment;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#C(1)(b)(vi)">(vi)</span> Referrals to ancillary services, if needed; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#C(1)(b)(vii)">(vii)</span> Referrals to self-help groups, if recommended.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#C(2)">(2)</span> If the alcohol and other drug counselor is unable to develop a treatment plan within the required time, the clinical director or the clinical supervisor shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#C(2)(a)">(a)</span> Determine the reason for a delay in development of a treatment plan;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#C(2)(b)">(b)</span> Document the reason in the patient's record; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#C(2)(c)">(c)</span> Direct an appropriate clinical staff person to develop a treatment plan within 7 working days of the clinical director's or clinical supervisor's documentation of the delay.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#C(3)">(3)</span> The length of stay in the program shall be based on the patient's level of illness severity and response to treatment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#D">D.</span> Infectious Disease Education. Within the first 30 days of treatment, a program shall ensure and document in the patient record that human immunodeficiency virus, hepatitis, sexually transmitted diseases, and tuberculosis education was completed, including:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#D(1)">(1)</span> Risk assessment;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#D(2)">(2)</span> Risk reduction; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#D(3)">(3)</span> If appropriate, referral for counseling and testing.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#E">E.</span> Family Involvement and Utilization of Self-Help Groups.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#E(1)">(1)</span> A program may provide education and support services to a patient's family directly or through referrals to appropriate community agencies.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#E(2)">(2)</span> A program shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#E(2)(a)">(a)</span> Develop procedures for obtaining an assessment of the treatment needs of the patient's family;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#E(2)(b)">(b)</span> Provide access or referral to family counseling;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#E(2)(c)">(c)</span> Describe how family members are involved in the patient's recovery process; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#E(2)(d)">(d)</span> Develop procedures to encourage ongoing active participation by the patient and the patient's family in self-help groups and support activities.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#F">F.</span> Referrals. Referral documentation shall include the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#F(1)">(1)</span> Reason for referral;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#F(2)">(2)</span> Name of the individual;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#F(3)">(3)</span> Referring program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#F(4)">(4)</span> Receiving program; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#F(5)">(5)</span> Final disposition of referral.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#G">G.</span> Discharge.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#G(1)">(1)</span> A program shall complete a written discharge summary.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#G(2)">(2)</span> The discharge summary shall include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#G(2)(a)">(a)</span> The reason for admission;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#G(2)(b)">(b)</span> The reason for discharge;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#G(2)(c)">(c)</span> The individual's address;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#G(2)(d)">(d)</span> A summary of services delivered, including frequency and duration of services, and progress made;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#G(2)(e)">(e)</span> If appropriate, the diagnosis and prognosis at the time of discharge;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#G(2)(f)">(f)</span> Current medications, if applicable;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#G(2)(g)">(g)</span> Continuing service recommendations and summary of transition process; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#G(2)(h)">(h)</span> The extent of the individual's involvement in the discharge plan.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#G(3)">(3)</span> The discharge summary shall be completed within 30 days of the patient's discharge from the program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#G(4)">(4)</span> In the event of a patient's transfer from the program to another program, the discharging program shall complete a written transfer summary.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#G(5)">(5)</span> The transfer summary shall include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#G(5)(a)">(a)</span> The reason for admission;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#G(5)(b)">(b)</span> The reason for discharge;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#G(5)(c)">(c)</span> The individual's address;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#G(5)(d)">(d)</span> The diagnosis and prognosis at the time of discharge; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#G(5)(e)">(e)</span> Current medications, if applicable.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#G(6)">(6)</span> The transfer summary shall be completed at the time of the patient's discharge from the program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#H">H.</span> Child and Adolescent Services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#H(1)">(1)</span> A parent or guardian of a child or adolescent, with the child or adolescent's consent, may apply on behalf of the child or adolescent for admission to a certified program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#H(2)">(2)</span> A program exclusively for children and adolescents shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#H(2)(a)">(a)</span> Maintain written treatment protocols providing for the needs of adolescents and children, emphasizing the use of family interventions;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#H(2)(b)">(b)</span> Provide for the educational needs of adolescents in compliance with local, State, and federal laws and regulations;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#H(2)(c)">(c)</span> Comply with criminal background requirements for all staff; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#H(2)(d)">(d)</span> Meet any other requirements requested by the Administration.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#H(3)">(3)</span> A program that admits children and adolescents:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#H(3)(a)">(a)</span> May not admit a child or adolescent into treatment unless the treatment plan indicates that the program is appropriate for the child or adolescent;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#H(3)(b)">(b)</span> Shall provide separate social, residential, dietary, and recreational activities for the child or adolescent, if appropriate;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#H(3)(c)">(c)</span> Shall obtain informed consent from the child or adolescent, or the parents or guardians for the child or adolescent, to be admitted to the program;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#H(3)(d)">(d)</span> Shall comply with criminal background requirements for all staff; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#H(3)(e)">(e)</span> Shall meet any other requirements requested by the Administration.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#H(4)">(4)</span> A program that does not admit children and adolescents shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#H(4)(a)">(a)</span> Identify in its program service plan the elements of the program that make treatment, care, and rehabilitation for children or adolescents contraindicated; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#H(4)(b)">(b)</span> Meet any other requirements requested by the Administration.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#H(5)">(5)</span> Programs that provide services to adults and permit the adult's children or adolescents to be present at the program shall verify that the children and adolescents:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#H(5)(a)">(a)</span> Receive proper supervision;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#H(5)(b)">(b)</span> Are appropriately enrolled in education services; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#H(5)(c)">(c)</span> Have access to appropriate health care.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#I">I.</span> Medication Control and Staff Requirements.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#I(1)">(1)</span> A program shall develop and implement a written policy and procedure governing the use of controlled dangerous substances and other drugs used by the program. The policies shall include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#I(1)(a)">(a)</span> A list of controlled dangerous substances and other drugs administered, dispensed, or stored at the program;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#I(1)(b)">(b)</span> Procedures to account for and secure the drugs from time of order until dispensing;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#I(1)(c)">(c)</span> Computer security and accountability, if applicable;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#I(1)(d)">(d)</span> Other policy and procedures required by the Administration; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#I(1)(e)">(e)</span> Procedures for all Level III programs to hold securely all take-home opioid therapy medication for patients who are on opioid maintenance therapy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#I(2)">(2)</span> A program shall dispense medications to the patient according to the instructions, supervision, and directions of the licensed physician.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#I(3)">(3)</span> If staff observes an adverse reaction to medication, the program immediately shall contact a licensed physician or emergency medical service to ensure the patient receives treatment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#I(4)">(4)</span> Medication Errors.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#I(4)(a)">(a)</span> For a medication error regarding administration, dispensing, documentation, inventory, or storage, an appropriate clinical staff person shall complete a report at the time of the incident.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#I(4)(b)">(b)</span> The report shall be filed and brought to the immediate attention of the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#I(4)(b)(i)">(i)</span> Administrator; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#I(4)(b)(ii)">(ii)</span> Medical director, if a medical director is employed by the program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.04#I(5)">(5)</span> Programs shall report the diversion of any controlled substance to the Administration as soon as the diversion is discovered.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.01.05" data-order="|10|47|01|.05|" data-ref-path="10|47|01|.05" class="h__section">.05 Environmental Requirements.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#A">A.</span> Life Safety Requirements. A program shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#A(1)">(1)</span> Have a facility free from fire hazards and have:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#A(1)(a)">(a)</span> Adequate smoke detectors;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#A(1)(b)">(b)</span> Working and updated fire extinguishers;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#A(1)(c)">(c)</span> A written fire evacuation plan; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#A(1)(d)">(d)</span> A current fire inspection certification;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#A(2)">(2)</span> Comply with applicable federal, State, and local sanitation, building, fire codes, and zoning requirements;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#A(3)">(3)</span> Maintain documentation of legally required periodic evacuation drills, if applicable; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#A(4)">(4)</span> Within the first 30 days of employment, provide staff training in emergency evacuation procedures.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#B">B.</span> Special Accommodations. A program shall have protocols, which may include referral agreements with other programs, that provide for admission and treatment of individuals with:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#B(1)">(1)</span> Limited English proficiency or hearing and speaking disabilities; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#B(2)">(2)</span> Physical and mental disabilities.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#C">C.</span> Residential Treatment Programs. A program shall have:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#C(1)">(1)</span> Nurses' stations, if appropriate;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#C(2)">(2)</span> A dining room;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#C(3)">(3)</span> Bathrooms;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#C(4)">(4)</span> Telephones;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#C(5)">(5)</span> A living room;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#C(6)">(6)</span> Space for privacy for visits;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#C(7)">(7)</span> Space for leisure time activities;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#C(8)">(8)</span> Offices for both administrative and counseling personnel; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#C(9)">(9)</span> Sleeping quarters that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#C(9)(a)">(a)</span> Do not allow for more than six patients to share the sleeping quarters, except for therapeutic communities that use dormitory style sleeping areas;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#C(9)(b)">(b)</span> Provide adolescents and adults with separate sleeping quarters;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#C(9)(c)">(c)</span> Provide privacy for patients;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#C(9)(d)">(d)</span> Provide beds that:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#C(9)(d)(i)">(i)</span> Are at least 3 feet apart;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#C(9)(d)(ii)">(ii)</span> Are located more than 18 inches away from radiators and registers;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#C(9)(d)(iii)">(iii)</span> Are at least 36 inches wide, and not rollaway-type beds, cots, or folding beds;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#C(9)(d)(iv)">(iv)</span> Have mattresses that are clean, in good repair, and the same size as the bed frame; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#C(9)(d)(v)">(v)</span> Have at least two sets of sheets;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#C(9)(e)">(e)</span> Have at least two dresser drawers and an enclosed space for hanging clothes; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#C(9)(f)">(f)</span> Have a mirror and window coverings in good repair;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#C(10)">(10)</span> A method for safely storing a patient's valuables; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#C(11)">(11)</span> A written plan for providing temporary shelter for patients if a facility becomes uninhabitable.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#D">D.</span> Dietary Services. If meals are provided, a program shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#D(1)">(1)</span> Comply with applicable local, State, and federal laws;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#D(2)">(2)</span> Have a written plan describing the organization and delivery of dietary services; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#D(3)">(3)</span> Require a dietitian licensed under the <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=5-101" title="">Health Occupations Article, §5-101, Annotated Code of Maryland</a>, to develop and implement the dietary service plan.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.05#E">E.</span> Infection Control — Universal Precautions. A program shall observe universal precautions as required under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.07.02.21" title=".21 Dietetic Services.">COMAR 10.07.02.21</a>-1.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.01.06" data-order="|10|47|01|.06|" data-ref-path="10|47|01|.06" class="h__section">.06 Staff Requirements.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.06#A">A.</span> Administrator.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.06#A(1)">(1)</span> A program shall have an administrator.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.06#A(2)">(2)</span> Qualifications. The administrator shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.06#A(2)(a)">(a)</span> Possess a working knowledge of all applicable State and federal laws;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.06#A(2)(b)">(b)</span> Possess a working knowledge of program management skills;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.06#A(2)(c)">(c)</span> Be employed as an administrator before October 1, 2002; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.06#A(2)(d)">(d)</span> Have at a minimum:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.06#A(2)(d)(i)">(i)</span> A bachelor's degree from an accredited educational institution; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.06#A(2)(d)(ii)">(ii)</span> At least 5 years of documented experience in human services, 2 years of which include providing administrative or clinical supervision.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.06#A(3)">(3)</span> Duties. The administrator shall ensure that the program complies with all applicable State and federal laws.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.06#B">B.</span> Clinical Director.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.06#B(1)">(1)</span> A program may have a clinical director.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.06#B(2)">(2)</span> The clinical director functions under the administrative supervision of the administrator.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.06#B(3)">(3)</span> Qualifications. The clinical director shall have at a minimum:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.06#B(3)(a)">(a)</span> A master's degree in counseling or a related discipline regulated under the <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Annotated Code of Maryland</a>, and certification or licensure as an alcohol and drug counselor by the Board of Professional Counselors and Therapists; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.06#B(3)(b)">(b)</span> Approval to supervise by the Board of Professional Counselors and Therapists.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.06#C">C.</span> Clinical Supervisor.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.06#C(1)">(1)</span> A program shall have a clinical supervisor.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.06#C(2)">(2)</span> Qualifications. The clinical supervisor shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.06#C(2)(a)">(a)</span> Be employed as a clinical supervisor before October 1, 2002; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.06#C(2)(b)">(b)</span> Have at a minimum:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.06#C(2)(b)(i)">(i)</span> A master's degree in counseling or a related discipline regulated under the <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Annotated Code of Maryland</a>, and certification or licensure as an alcohol and drug counselor by the Board of Professional Counselors and Therapists; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.06#C(2)(b)(ii)">(ii)</span> Approval to supervise by the Board of Professional Counselors and Therapists.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.06#C(3)">(3)</span> Duties. A clinical supervisor may carry a caseload at the discretion of the administrator.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.06#D">D.</span> Clinical Staff.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.06#D(1)">(1)</span> Qualifications. All staff employed as alcohol and drug counselors shall, at a minimum be:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.06#D(1)(a)">(a)</span> Licensed or certified as an alcohol and drug counselors by the Board of Professional Counselors and Therapists;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.06#D(1)(b)">(b)</span> Approved by the Board of Professional Counselors and Therapists; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.06#D(1)(c)">(c)</span> Licensed, certified, or permitted under the <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Annotated Code of Maryland</a> to provide substance abuse treatment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.06#D(2)">(2)</span> Credentials. The administrator shall ensure that program staff, including students, interns, and volunteers, are credentialed and appropriately privileged.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.06#D(3)">(3)</span> Policies and Procedures. All clinical staff, including the administrator, clinical director, and clinical supervisor, shall review the program's policies and procedures and shall sign a statement saying that they reviewed and understood the policies and procedures.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.01.07" data-order="|10|47|01|.07|" data-ref-path="10|47|01|.07" class="h__section">.07 Patient Rights and Grievance Procedures.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.07#A">A.</span> Patient Rights.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.07#A(1)">(1)</span> A program shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.07#A(1)(a)">(a)</span> Treat each patient with consideration, respect, and full recognition of the patient's human dignity and individuality;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.07#A(1)(b)">(b)</span> Provide treatment, care, and services that are adequate, appropriate, and in compliance with relevant State, local, and federal laws and regulations;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.07#A(1)(c)">(c)</span> Prevent physical or mental abuse by the program staff;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.07#A(1)(d)">(d)</span> Provide an atmosphere free from discrimination;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.07#A(1)(e)">(e)</span> Not allow use of any physical restraints;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.07#A(1)(f)">(f)</span> Ensure privacy and confidentiality; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.07#A(1)(g)">(g)</span> Allow the patient the right to refuse participation in any experimental research unless the research complies with 45 CFR Part 46.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.07#A(2)">(2)</span> A program shall post in a conspicuous area and provide to each patient a statement of patients' rights.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.07#B">B.</span> Grievance Procedures. A program shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.07#B(1)">(1)</span> Have a grievance procedure approved by the Administration;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.07#B(2)">(2)</span> Provide the patient upon admission a description of grievance policy and procedure that includes the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.07#B(2)(a)">(a)</span> Patient's right to grieve program decisions including but not limited to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.07#B(2)(a)(i)">(i)</span> Discharge; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.07#B(2)(a)(ii)">(ii)</span> Change in status;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.07#B(2)(b)">(b)</span> Steps of the grievance process; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.07#B(2)(c)">(c)</span> Levels to which the grievance may be taken;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.07#B(3)">(3)</span> Take no retaliation against a patient who presents a grievance; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.07#B(4)">(4)</span> Inform each patient if revisions are made to the grievance policy and the nature and extent of the revisions.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.07#C">C.</span> Nondiscrimination. A program may not discriminate in the provision of services on the basis of race, creed, color, age, gender, sexual orientation, national origin, marital status, disabilities, and any other classification prohibited under State or federal law including:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.07#C(1)">(1)</span> Americans with Disabilities Act, 28 CFR 35; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.07#C(2)">(2)</span> Fair Housing Act, 42 U.S.C. §3604.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.01.08" data-order="|10|47|01|.08|" data-ref-path="10|47|01|.08" class="h__section">.08 Records.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08#A">A.</span> Program Records.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08#A(1)">(1)</span> A program shall either manually or electronically maintain a record for each patient that includes, but is not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08#A(1)(a)">(a)</span> A patient identifier, which may be a name, number, or an identifying code;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08#A(1)(b)">(b)</span> Intake information, including the patient's name, date of admission, summary of medical examinations, allergies to medication, and laboratory reports;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08#A(1)(c)">(c)</span> Assessments, individualized treatment plans, progress notes, and consent to disclose information if needed;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08#A(1)(d)">(d)</span> Documentation of each program contact with the patient;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08#A(1)(e)">(e)</span> Critical incident reports documented on the day of the incident; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08#A(1)(f)">(f)</span> A discharge summary.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08#A(2)">(2)</span> A program shall maintain Medicaid patient records for at least 6 years following discharge, and all other patient records for at least 3 years as required by Health-General Article, §4-403, Annotated Code of Maryland, and shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08#A(2)(a)">(a)</span> Maintain, transfer, and destroy all records in a manner consistent with the medical records confidentiality and disclosure requirements of:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08#A(2)(a)(i)">(i)</span> Health-General Article, Title 4, Subtitle 3, Annotated Code of Maryland;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08#A(2)(a)(ii)">(ii)</span> Health-General Article, §4-403, Annotated Code of Maryland;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08#A(2)(a)(iii)">(iii)</span> 42 CFR Part 2;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08#A(2)(a)(iv)">(iv)</span> The Health Insurance Portability and Accountability Act (HIPAA); and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08#A(2)(a)(v)">(v)</span> 45 CFR Parts 160 and 164;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08#A(2)(b)">(b)</span> Locate all records so that they are convenient and available to designated staff; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08#A(2)(c)">(c)</span> Provide a designated staff member responsible for appropriate records control, including storage, security, and indexing records.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08#B">B.</span> Management Information System. The program shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08#B(1)">(1)</span> Participate in the Administration's management information system;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08#B(2)">(2)</span> Comply with reporting requirements as required by the Department; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08#B(3)">(3)</span> Complete and submit the driving while intoxicated data collection form chosen by the Administration for those arrested for driving while intoxicated or driving under the influence.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08#C">C.</span> Electronic Records.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08#C(1)">(1)</span> Electronic records shall be maintained according to requirements set forth in this regulation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08#C(2)">(2)</span> A companion hard copy file shall be maintained at the program and shall contain the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08#C(2)(a)">(a)</span> Informed consent to treatment signed by the patient;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08#C(2)(b)">(b)</span> Any requests for or releases of information shared with other entities signed by the patient;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08#C(2)(c)">(c)</span> Any treatment plan or treatment plan update signed by the patient; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08#C(2)(d)">(d)</span> Any program agreements or patient/counselor behavioral contracts signed by the patient.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.01.08-1" data-order="|10|47|01|.08-1|" data-ref-path="10|47|01|.08-1" class="h__section">.08-1 Outcome Evaluation.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08-1#A">A.</span> The Administration shall annually evaluate all publicly funded substance abuse treatment programs certified under this subtitle, using federal outcomes measures or other subsequently adopted federal standards, to determine the extent that individuals who have received treatment under these programs have:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08-1#A(1)">(1)</span> Been successfully retained in the treatment program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08-1#A(2)">(2)</span> Been successfully discharged from the treatment program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08-1#A(3)">(3)</span> Reduced their substance use;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08-1#A(4)">(4)</span> Successfully attained, maintained, or increased their employment;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08-1#A(5)">(5)</span> Demonstrated a decrease in engaging in criminal activity; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08-1#A(6)">(6)</span> Successfully established or maintained stable living arrangements.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.08-1#B">B.</span> All publicly funded programs shall fully comply with the Administration’s reporting requirements completing all data fields required within the Administration’s management information system as directed.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.01.09" data-order="|10|47|01|.09|" data-ref-path="10|47|01|.09" class="h__section">.09 Referral Agreements and Program Cooperation.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.09#A">A.</span> A program shall coordinate patient care with other community service providers to ensure that the widest range of appropriate services are available to patients.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.01.09#B">B.</span> Referral Agreements.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.09#B(1)">(1)</span> A program shall establish referral agreements with other human service agencies as required by <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.02" title="Chapter 02 Specific Program Requirements">COMAR 10.47.02</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.09#B(2)">(2)</span> The program shall make the referral agreements available to the Administration for review.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.01.09#B(3)">(3)</span> A program shall have referral agreements with other programs for individuals with disabilities whom the program may be unable to accommodate.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.47.02" data-order="|10|47|02|" data-ref-path="10|47|02" class="h__chapter">Chapter 02 Specific Program Requirements</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: November 4, 1985 (12:22 Md. R. 2107)</p>
                  <p>——————</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.02.01" title=".01 Scope.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.02.11" title=".11 Opioid Maintenance Therapy.">.11</a>, DWI Program Protocols, repealed and new Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.02.01" title=".01 Scope.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.02.11" title=".11 Opioid Maintenance Therapy.">.11</a>, Specific Program Requirements, adopted effective June 10, 2002 (29:11 Md. R. 882)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.02.03" title=".03 Early Intervention Level 0.5.">Regulation .03</a> amended as an emergency provision effective April 1, 2008 (35:9 Md. R. 894); amended permanently effective May 5, 2008 (35:9 Md. R. 898)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.02.04" title=".04 Outpatient Services Level I.">Regulation .04</a> amended as an emergency provision effective April 1, 2008 (35:9 Md. R. 894); amended permanently effective May 5, 2008 (35:9 Md. R. 898)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.02.05" title=".05 Intensive Outpatient Services Level II.1 and Partial Hospitalization Services Level II.5.">Regulation .05</a> amended as an emergency provision effective April 1, 2008 (35:9 Md. R. 894); amended permanently effective May 5, 2008 (35:9 Md. R. 898)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.02.06" title=".06 Residential Service — Clinically Managed Low Intensity Treatment Level III.1.">Regulation .06</a> amended as an emergency provision effective April 1, 2008 (35:9 Md. R. 894); amended permanently effective May 5, 2008 (35:9 Md. R. 898)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.02.07" title=".07 Residential Services — Clinically Managed Medium Intensity Treatment Level III.3.">Regulation .07</a> amended as an emergency provision effective April 1, 2008 (35:9 Md. R. 894); amended permanently effective May 5, 2008 (35:9 Md. R. 898)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.02.08" title=".08 Residential Services — Clinically Managed High Intensity Treatment Level III.5.">Regulation .08</a> amended as an emergency provision effective April 1, 2008 (35:9 Md. R. 894); amended permanently effective May 5, 2008 (35:9 Md. R. 898)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.02.09" title=".09 Residential Services — Medically Monitored Intensive Inpatient Treatment Level III.7.">Regulation .09</a> amended as an emergency provision effective April 1, 2008 (35:9 Md. R. 894); amended permanently effective May 5, 2008 (35:9 Md. R. 898)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.02.10" title=".10 Detoxification Services.">Regulation .10</a> amended as an emergency provision effective April 1, 2008 (35:9 Md. R. 894); amended permanently effective May 5, 2008 (35:9 Md. R. 898)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.02.11" title=".11 Opioid Maintenance Therapy.">Regulation .11</a> amended as an emergency provision effective April 1, 2008 (35:9 Md. R. 894); amended permanently effective May 5, 2008 (35:9 Md. R. 898)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.02.11#D" title="">Regulation .11D</a> amended effective December 12, 2013 (40:24 Md. R. 2017)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §§8-401 — 8-405 and 19-308, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.47.02.01" data-order="|10|47|02|.01|" data-ref-path="10|47|02|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter sets forth additional requirements that a program shall meet to be certified to offer a particular level of treatment. The program shall meet the requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01" title="Chapter 01 Requirements">COMAR 10.47.01</a> and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.03" title="Chapter 03 Specific Program Requirements for Correctional Levels of Care">10.47.03</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.02.02" data-order="|10|47|02|.02|" data-ref-path="10|47|02|.02" class="h__section">.02 Definitions.</h3>
                <p>In this chapter, terms have the meanings stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.02" title=".02 Definitions.">COMAR 10.47.01.02</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.02.03" data-order="|10|47|02|.03|" data-ref-path="10|47|02|.03" class="h__section">.03 Early Intervention Level 0.5.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.03#A">A.</span> Prevention Program Description. The prevention program shall treat patients who are, for a known reason, at risk for developing alcohol or other drug abuse or dependence but for whom there is not yet sufficient information to document alcohol or other drug abuse or dependence.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.03#B">B.</span> Patients who are appropriate for this level of treatment shall meet the current edition of the American Society of Addiction Medicine Patient Placement Criteria for Level 0.5, or its equivalent as approved by the Administration.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.03#C">C.</span> Staffing. Services shall be provided by appropriately credentialed staff as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.06" title=".06 Staff Requirements.">COMAR 10.47.01.06</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.03#D">D.</span> Program services include:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.03#D(1)">(1)</span> Assessments as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a> within 2 weeks of admission;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.03#D(2)">(2)</span> An individualized treatment plan as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a>, completed and signed by the alcohol and drug counselor and patient within 7 working days of the comprehensive assessment and updated every 90 days;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.03#D(3)">(3)</span> Group or individual counseling, or both, as clinically indicated;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.03#D(4)">(4)</span> Family counseling, as clinically indicated;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.03#D(5)">(5)</span> Alcohol and drug education; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.03#D(6)">(6)</span> Referral for further assessment or to another level of treatment, as clinically indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.03#E">E.</span> Documentation. The clinical staff providing the service shall write a patient progress note after each counseling session and shall place the note in the patient's record.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.03#F">F.</span> Referral Services. The prevention program shall offer the following services or maintain a listing of agency referral agreements for the following services:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.03#F(1)">(1)</span> Mental health services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.03#F(2)">(2)</span> Social services; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.03#F(3)">(3)</span> Substance abuse treatment programs.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.02.04" data-order="|10|47|02|.04|" data-ref-path="10|47|02|.04" class="h__section">.04 Outpatient Services Level I.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.04#A">A.</span> Program Description. The program shall provide outpatient evaluation and treatment to patients who require services for less than 9 hours weekly for adults and 6 hours weekly for adolescents.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.04#B">B.</span> Patients who are appropriate for this level of treatment shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.04#B(1)">(1)</span> Meet the current edition of the American Society of Addiction Medicine Patient Placement Criteria for Level I, or its equivalent as approved by the Administration; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.04#B(2)">(2)</span> Have a physical and emotional status that allows them to function in their usual environment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.04#C">C.</span> Staffing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.04#C(1)">(1)</span> Services shall be provided by appropriately credentialed staff as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.06" title=".06 Staff Requirements.">COMAR 10.47.01.06</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.04#C(2)">(2)</span> The adult patient to alcohol and drug counselor ratio may not exceed 30 adult patients weekly to one full-time alcohol and drug counselor.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.04#C(3)">(3)</span> The child and adolescent patient to alcohol and drug counselor ratio may not exceed 25 adolescent patients weekly to one full-time alcohol and drug counselor.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.04#D">D.</span> Program Services. A program shall provide the following services:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.04#D(1)">(1)</span> An assessment as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a> within 2 weeks of admission;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.04#D(2)">(2)</span> An individualized treatment plan as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a> completed and signed by the alcohol and drug counselor and patient within 7 working days of the comprehensive assessment and updated every 90 days;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.04#D(3)">(3)</span> Case management services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.04#D(4)">(4)</span> Group or individual counseling sessions;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.04#D(5)">(5)</span> Family services that shall include an assessment for family treatment needs and, as clinically appropriate:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.04#D(5)(a)">(a)</span> Alcohol and drug education; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.04#D(5)(b)">(b)</span> Family counseling.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.04#E">E.</span> Documentation. The clinical staff providing the service shall write a patient progress note after each counseling session and shall place the note in the patient's record.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.04#F">F.</span> Referral Services. The program shall offer the following services or maintain a listing of agency referral agreements for the following services:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.04#F(1)">(1)</span> Medical examinations;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.04#F(2)">(2)</span> Services through the Division of Rehabilitation Services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.04#F(3)">(3)</span> Vocational assistance;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.04#F(4)">(4)</span> Mental health services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.04#F(5)">(5)</span> Substance abuse treatment programs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.04#F(6)">(6)</span> Legal assistance; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.04#F(7)">(7)</span> Social services.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.02.05" data-order="|10|47|02|.05|" data-ref-path="10|47|02|.05" class="h__section">.05 Intensive Outpatient Services Level II.1 and Partial Hospitalization Services Level II.5.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#A">A.</span> Program Description. A program shall provide structured outpatient evaluation and treatment to patients who require programming:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#A(1)">(1)</span> From 9 to 20 hours weekly for adult intensive outpatient services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#A(2)">(2)</span> From 6 to 20 hours weekly for adolescent intensive outpatient services, based on the adolescents' developmental and clinical needs; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#A(3)">(3)</span> From 20 to 35 hours weekly for adult and adolescent partial hospitalization services.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#B">B.</span> Patients who are appropriate for this level of treatment shall meet the current edition of the American Society of Addiction Medicine Patient Placement Criteria for either Level II.1 or Level II.5, or its equivalent as approved by the Administration.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#C">C.</span> Staffing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#C(1)">(1)</span> Services shall be provided by appropriately credentialed staff as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.06" title=".06 Staff Requirements.">COMAR 10.47.01.06</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#C(2)">(2)</span> The patient to alcohol and drug counselor ratio may not exceed 15 patients to one full-time alcohol and drug counselor.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#D">D.</span> Program Services. A program shall provide the following services:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#D(1)">(1)</span> An assessment as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a> within 1 week of admission;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#D(2)">(2)</span> An individualized treatment plan as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a> completed and signed by the alcohol and drug counselor and patient within 5 working days of the comprehensive assessment and updated every 30 days;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#D(3)">(3)</span> Case management services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#D(4)">(4)</span> At least one group counseling session a week;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#D(5)">(5)</span> At least one individual session every 2 weeks;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#D(6)">(6)</span> Family services, which may include an assessment for family needs and, as clinically appropriate:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#D(6)(a)">(a)</span> Alcohol and drug education; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#D(6)(b)">(b)</span> Family counseling.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#E">E.</span> Documentation. A designated clinical staff person shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#E(1)">(1)</span> Write a patient progress note at the end of each week that services are provided; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#E(2)">(2)</span> Place the progress note in the patient's record.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#F">F.</span> Referral Services. The program shall offer the following services or maintain a listing of agency referral agreements for the following services:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#F(1)">(1)</span> Medical services with medical consultations available:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#F(1)(a)">(a)</span> Within 24 hours of a request for service by telephone for intensive outpatient services;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#F(1)(b)">(b)</span> Within 72 hours of a request for service in person for intensive outpatient services;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#F(1)(c)">(c)</span> Within 8 hours of a request for service by telephone for partial hospitalization services; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#F(1)(d)">(d)</span> Within 48 hours of a request for service in person for partial hospitalization services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#F(2)">(2)</span> Services through the Division of Rehabilitation Services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#F(3)">(3)</span> Vocational assistance;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#F(4)">(4)</span> Mental health services with psychiatric consultations available:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#F(4)(a)">(a)</span> Within 24 hours of a request for service by telephone for intensive outpatient services;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#F(4)(b)">(b)</span> Within 72 hours of a request for service in person for intensive outpatient services;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#F(4)(c)">(c)</span> Within 8 hours of a request for service by telephone for partial hospitalization services; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#F(4)(d)">(d)</span> Within 48 hours of a request for service in person for partial hospitalization services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#F(5)">(5)</span> Substance abuse treatment programs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#F(6)">(6)</span> Legal assistance; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.05#F(7)">(7)</span> Social services.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.02.06" data-order="|10|47|02|.06|" data-ref-path="10|47|02|.06" class="h__section">.06 Residential Service — Clinically Managed Low Intensity Treatment Level III.1.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#A">A.</span> Program Description. Clinically managed low intensity treatment programs shall offer treatment services at least 5 hours a week directed toward preventing relapse, applying recovery skills, promoting personal responsibility, and reintegration.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#B">B.</span> Patients who are appropriate for this level of treatment shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#B(1)">(1)</span> Meet the current edition of the American Society of Addiction Medicine Patient Placement Criteria for Level III.1, or its equivalent as approved by the Administration; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#B(2)">(2)</span> Be capable of self-care but not ready to return to family or independent living.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#C">C.</span> Staffing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#C(1)">(1)</span> Services shall be provided by appropriately credentialed staff as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.06" title=".06 Staff Requirements.">COMAR 10.47.01.06</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#C(2)">(2)</span> A clinically managed low intensity treatment program shall employ:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#C(2)(a)">(a)</span> One individual as clinical supervisor who may also be the program's administrator;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#C(2)(b)">(b)</span> Another individual as house manager;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#C(2)(c)">(c)</span> At least one staff member to be on duty at all times; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#C(2)(d)">(d)</span> At least one staff member who is certified in cardiopulmonary resuscitation, and who has been trained in crisis intervention to be on duty between 11 p.m. and 7 a.m.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#C(3)">(3)</span> The patient to alcohol and drug counselor ratio may not exceed 15 patients to one full-time alcohol and drug counselor.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#C(4)">(4)</span> Staff may not dispense medications.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#D">D.</span> Program Services. A clinically managed low intensity treatment program shall provide the following services:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#D(1)">(1)</span> An assessment as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a> within 2 weeks of admission;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#D(2)">(2)</span> An individualized treatment plan as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a> completed and signed by the alcohol and drug counselor and patient within 7 working days of the comprehensive assessment and updated every 60 days;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#D(3)">(3)</span> Periodic group counseling that focuses on relapse prevention;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#D(4)">(4)</span> Case management services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#D(5)">(5)</span> Individual counseling, at least monthly; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#D(6)">(6)</span> Leisure and recreational activities.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#E">E.</span> Documentation. The clinical staff providing the service shall write a patient progress note after each counseling session and shall place the note in the patient's record.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#F">F.</span> Referral Services. The program shall offer the following services or maintain a listing of agency referral agreements for the following services:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#F(1)">(1)</span> Physical examinations as determined by medical condition, within a reasonable time;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#F(2)">(2)</span> Services through the Division of Rehabilitation Services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#F(3)">(3)</span> Vocational assistance;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#F(4)">(4)</span> Mental health services, which shall include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#F(4)(a)">(a)</span> Medication monitoring for patients who are admitted on or are prescribed psychotropic medications; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#F(4)(b)">(b)</span> Services appropriate to the severity and urgency of the patient's mental condition;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#F(5)">(5)</span> Legal assistance;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#F(6)">(6)</span> Substance abuse treatment programs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#F(7)">(7)</span> Social services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#F(8)">(8)</span> Family services; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.06#F(9)">(9)</span> Education.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.02.07" data-order="|10|47|02|.07|" data-ref-path="10|47|02|.07" class="h__section">.07 Residential Services — Clinically Managed Medium Intensity Treatment Level III.3.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#A">A.</span> Program Description. A clinically managed medium intensity treatment program provides a structured environment in combination with medium intensity treatment and ancillary services to support and promote recovery.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#B">B.</span> Patients who are appropriate for this level of treatment:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#B(1)">(1)</span> Meet the current edition of the American Society of Addiction Medicine Patient Placement Criteria for Level III.3, or its equivalent as approved by the Administration;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#B(2)">(2)</span> Are chronic alcohol or other drug dependent individuals;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#B(3)">(3)</span> Do not need skilled nursing care;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#B(4)">(4)</span> May have a history of multiple admissions to alcohol or drug abuse or dependence programs as defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01" title="Chapter 01 Requirements">COMAR 10.47.01</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#B(5)">(5)</span> May have physical and mental disabilities as a result of prolonged alcohol or other drug use; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#B(6)">(6)</span> Have been identified as individuals for whom a controlled environment and supportive therapy are necessary for an indefinite period of time.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#C">C.</span> Staffing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#C(1)">(1)</span> Services shall be provided by appropriately credentialed staff as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.06" title=".06 Staff Requirements.">COMAR 10.47.01.06</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#C(2)">(2)</span> The patient to alcohol and drug counselor ratio may not exceed 15 patients to one full-time alcohol and drug counselor.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#C(3)">(3)</span> At least one staff member certified in cardiopulmonary resuscitation and trained in crisis intervention shall be on duty between 11 p.m. and 7 a.m.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#D">D.</span> Program Services. A program shall provide the following services:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#D(1)">(1)</span> An assessment as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a> within 1 week of admission;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#D(2)">(2)</span> An individualized treatment plan as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a> completed and signed by the alcohol and drug counselor and patient within 3 working days of the comprehensive assessment and updated every 30 days;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#D(3)">(3)</span> Alcohol and drug education;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#D(4)">(4)</span> Individual counseling;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#D(5)">(5)</span> Leisure and recreation counseling; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#D(6)">(6)</span> Assistance with vocational issues.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#E">E.</span> Documentation. A designated clinical staff shall write a patient progress note at the end of each week services are provided and place the progress note in the patient's record.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#F">F.</span> Referral Services. The program shall offer the following services or maintain a listing of agency referral agreements for the following services:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#F(1)">(1)</span> Physical examinations as determined by medical condition, within a reasonable time;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#F(2)">(2)</span> Medical care;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#F(3)">(3)</span> Services through the Division of Rehabilitation Services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#F(4)">(4)</span> Vocational assistance;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#F(5)">(5)</span> Mental health services, which shall include, as appropriate to the severity and urgency of the patient's mental condition:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#F(5)(a)">(a)</span> Medication monitoring for patients who are admitted on or are prescribed psychotropic medications; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#F(5)(b)">(b)</span> At least one of the following services:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#F(5)(b)(i)">(i)</span> Services available by telephone within 8 hours of a request; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#F(5)(b)(ii)">(ii)</span> Services available onsite or closely coordinated off-site within 24 hours of a request;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#F(6)">(6)</span> Substance abuse treatment programs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#F(7)">(7)</span> Legal assistance;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#F(8)">(8)</span> Family services; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.07#F(9)">(9)</span> Social services.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.02.08" data-order="|10|47|02|.08|" data-ref-path="10|47|02|.08" class="h__section">.08 Residential Services — Clinically Managed High Intensity Treatment Level III.5.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#A">A.</span> Program Description. A clinically managed high intensity residential program shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#A(1)">(1)</span> Provide a highly structured environment in combination with moderate to high intensity treatment and ancillary services to support and promote recovery; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#A(2)">(2)</span> Be characterized by its reliance on the treatment community as a therapeutic agent.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#B">B.</span> Patients who are appropriate for this level of treatment meet the current edition of the American Society of Addiction Medicine Patient Placement Criteria for Level III.5, or its equivalent as approved by the Administration.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#C">C.</span> Staffing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#C(1)">(1)</span> Services shall be provided by appropriately credentialed staff as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.06" title=".06 Staff Requirements.">COMAR 10.47.01.06</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#C(2)">(2)</span> A program shall have sufficient physician, physician assistant, or nurse practitioner services to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#C(2)(a)">(a)</span> Provide initial diagnostic work-up;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#C(2)(b)">(b)</span> Provide identification of medical and surgical problems for referral; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#C(2)(c)">(c)</span> Handle medical emergencies when necessary.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#C(3)">(3)</span> The patient to alcohol and drug counselor ratio may not exceed 15 patients for one full-time alcohol and drug counselor.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#C(4)">(4)</span> At least one staff member certified in cardiopulmonary resuscitation and trained in crisis intervention shall be on duty between 11 p.m. and 7 a.m.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#D">D.</span> Program Services. A program shall provide the following services:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#D(1)">(1)</span> A preliminary medical assessment within 36 hours of the patient's admission;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#D(2)">(2)</span> A physical examination by a medical doctor, physician assistant, or nurse practitioner within the first week of the patient's admission;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#D(3)">(3)</span> An assessment as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a> within 2 days of admission;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#D(4)">(4)</span> An individualized treatment plan as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a> completed and signed by the alcohol and drug counselor and patient within 2 working days of the comprehensive assessment with a treatment plan update every 30 days;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#D(5)">(5)</span> Monitoring of medication, as necessary; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#D(6)">(6)</span> A minimum of 36 hours of therapeutic activities a week, including but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#D(6)(a)">(a)</span> At least weekly individual counseling;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#D(6)(b)">(b)</span> Group counseling;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#D(6)(c)">(c)</span> Alcohol and drug education;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#D(6)(d)">(d)</span> Career counseling;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#D(6)(e)">(e)</span> Nutrition education; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#D(6)(f)">(f)</span> Family services.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#E">E.</span> Documentation. A designated clinical staff shall write a patient progress note at the end of each week services are provided and place the progress note in the patient's record.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#F">F.</span> Referral Services. The program shall offer the following services or maintain a listing of agency referral agreements for the following services:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#F(1)">(1)</span> Medical care;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#F(2)">(2)</span> Services through the Division of Rehabilitation Services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#F(3)">(3)</span> Vocational assistance;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#F(4)">(4)</span> Mental health services, which shall include, as appropriate to the severity and urgency of the patient's mental condition:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#F(4)(a)">(a)</span> Medication monitoring for patients who are admitted on or are prescribed psychotropic medications; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#F(4)(b)">(b)</span> At least one of the following services:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#F(4)(b)(i)">(i)</span> Services available by telephone within 8 hours of a request; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#F(4)(b)(ii)">(ii)</span> Services available on-site or closely coordinated off-site within 24 hours of a request;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#F(5)">(5)</span> Substance abuse treatment programs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#F(6)">(6)</span> Legal assistance; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.08#F(7)">(7)</span> Social services.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.02.09" data-order="|10|47|02|.09|" data-ref-path="10|47|02|.09" class="h__section">.09 Residential Services — Medically Monitored Intensive Inpatient Treatment Level III.7.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#A">A.</span> Program Description. A medically monitored intensive inpatient treatment program shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#A(1)">(1)</span> Offer a planned regimen of 24-hour professionally directed evaluation, care, and treatment in an inpatient setting;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#A(2)">(2)</span> Act as an Intermediate Care Facility Type C/D; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#A(3)">(3)</span> Meet the certification requirements for detoxification services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.02.10#E" title="">COMAR 10.47.02.10E</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#B">B.</span> Patients who are appropriate for this level of treatment:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#B(1)">(1)</span> Meet the current edition of the American Society of Addiction Medicine Patient Placement Criteria for Level III.7, or its equivalent as approved by the Administration; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#B(2)">(2)</span> Require 24-hour monitoring and care for subacute biomedical and emotional or behavioral conditions severe enough to warrant inpatient treatment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#C">C.</span> Staffing. A program shall have:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#C(1)">(1)</span> Appropriately credentialed staff as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.06" title=".06 Staff Requirements.">COMAR 10.47.01.06</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#C(2)">(2)</span> Staffing which allows for detoxification and can provide services necessary for treatment of coexisting medical, emotional, or behavioral problems that could interfere with recovery;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#C(3)">(3)</span> A patient to alcohol and drug counselor ratio not exceeding eight patients for one full-time alcohol and drug counselor;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#C(4)">(4)</span> On-site physician, physician assistant, or nurse practitioner coverage available to provide initial assessment and documented referral for care, and to monitor progress in treatment;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#C(5)">(5)</span> A physician on call 24 hours a day;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#C(6)">(6)</span> Nursing services, between 7 a.m. and 11 p.m., 7 days a week, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#C(6)(a)">(a)</span> 8 hours a day, 5 days a week coverage by a registered nurse; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#C(6)(b)">(b)</span> The remainder of coverage by a licensed practical nurse; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#C(7)">(7)</span> At least two employees on duty between the hours of 11 p.m. and 7 a.m., 7 days a week, trained in crisis management and cardiopulmonary resuscitation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#D">D.</span> Program Services. A program shall provide:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#D(1)">(1)</span> An assessment as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a> within 2 days of admission;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#D(2)">(2)</span> An individualized treatment plan as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04#C" title="">COMAR 10.47.01.04C</a> completed and signed by the alcohol and drug counselor and patient within 7 working days of the comprehensive assessment with a treatment plan update completed every 7 days;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#D(3)">(3)</span> A minimum of 36 hours of therapeutic activities a week including, but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#D(3)(a)">(a)</span> A minimum of one weekly individual counseling session;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#D(3)(b)">(b)</span> Group counseling;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#D(3)(c)">(c)</span> Alcohol and drug education;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#D(3)(d)">(d)</span> Nutrition education;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#D(3)(e)">(e)</span> Weekly family sessions; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#D(3)(f)">(f)</span> Case management.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#E">E.</span> Medically Monitored Services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#E(1)">(1)</span> Nursing Services. Services shall include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#E(1)(a)">(a)</span> An assessment at the time of the patient's admission, including a mental health focused assessment:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#E(1)(a)(i)">(i)</span> Approved by the registered nurse and program physician;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#E(1)(a)(ii)">(ii)</span> Completed by qualified staff; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#E(1)(a)(iii)">(iii)</span> Overseen by a registered nurse for patients admitted with any prescribed medication; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#E(1)(b)">(b)</span> Medication monitoring conducted by:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#E(1)(b)(i)">(i)</span> The registered nurse or overseen by the registered nurse in conjunction with the program's physician; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#E(1)(b)(ii)">(ii)</span> Qualified nursing staff for patients who are admitted on or are prescribed any medications.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#E(2)">(2)</span> Physician, Physician Assistant, or Nurse Practitioner Services.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#E(2)(a)">(a)</span> A physician, physician assistant, or nurse practitioner shall:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#E(2)(a)(i)">(i)</span> Assess a patient within 24 hours of admission; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#E(2)(a)(ii)">(ii)</span> Continue to assess the patient as is medically necessary after the first 24 hours of admission.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#E(2)(b)">(b)</span> A physician, physician assistant, or nurse practitioner shall conduct a physical examination of a patient within 96 hours of admission to the program.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#E(2)(c)">(c)</span> A physician or physician assistant shall assess a patient undergoing detoxification within 24 hours of admission or earlier if it is medically necessary to conduct the assessment in less than 24 hours.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#E(2)(d)">(d)</span> A physician or physician assistant shall provide on-site monitoring and further evaluation of patients undergoing detoxification on a daily basis, if medically necessary.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#E(2)(e)">(e)</span> A physician or physician assistant shall be available by telephone at all times to consult about patients undergoing detoxification.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#F">F.</span> Documentation. A designated clinical staff shall write a patient progress note at the end of each day services are provided and place the progress note in the patient's record.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#G">G.</span> Referral Services. The program shall offer the following services or maintain a listing of agency referral agreements for the following services:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#G(1)">(1)</span> Services through the Division of Rehabilitation Services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#G(2)">(2)</span> Vocational assistance;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#G(3)">(3)</span> Mental health services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#G(4)">(4)</span> Substance abuse treatment programs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#G(5)">(5)</span> Legal assistance; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.09#G(6)">(6)</span> Social services.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.02.10" data-order="|10|47|02|.10|" data-ref-path="10|47|02|.10" class="h__section">.10 Detoxification Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#A">A.</span> Description of Services. A detoxification program shall provide services to an intoxicated patient by:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#A(1)">(1)</span> Monitoring the decreasing amount of psychoactive substances in the body;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#A(2)">(2)</span> Managing the withdrawal symptoms; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#A(3)">(3)</span> Motivating the individual to participate in an appropriate treatment program for alcohol or other drug dependence.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#B">B.</span> A detoxification program shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#B(1)">(1)</span> Avoid potentially harmful consequences of withdrawal from alcohol and drug dependence as medically possible;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#B(2)">(2)</span> Provide a space to house and observe patients suffering from withdrawal symptoms;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#B(3)">(3)</span> Ease physical discomfort during the withdrawal process; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#B(4)">(4)</span> Facilitate transition to a treatment continuum of care which may include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#B(4)(a)">(a)</span> Ongoing alcohol or drug treatment in a residential or outpatient treatment program;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#B(4)(b)">(b)</span> Referral to mental health treatment; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#B(4)(c)">(c)</span> Referral to self-help recovery programming.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C">C.</span> Level I-D Ambulatory Detoxification Without Extended On-Site Monitoring.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(1)">(1)</span> Description of Services.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(1)(a)">(a)</span> Ambulatory detoxification without extended on-site monitoring services offers evaluation, detoxification, and referral under medical supervision to patients who require services in an office setting or healthcare, correctional, or addictions treatment facility.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(1)(b)">(b)</span> This program may be certified as a separate program or be combined with a Level I outpatient program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(2)">(2)</span> Patients who are appropriate for this level of treatment meet the current edition of the American Society of Addiction Medicine Patient Placement Criteria, or its equivalent as approved by the Alcohol and Drug Abuse Administration.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(3)">(3)</span> Staffing.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(3)(a)">(a)</span> A program shall employ:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(3)(a)(i)">(i)</span> Appropriately credentialed staff as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.06" title=".06 Staff Requirements.">COMAR 10.47.01.06</a>;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(3)(a)(ii)">(ii)</span> A licensed physician; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(3)(a)(iii)">(iii)</span> A registered nurse.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(3)(b)">(b)</span> To perform the program's services, a program shall also employ sufficient licensed health care professionals, which may include:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(3)(b)(i)">(i)</span> Physician assistants;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(3)(b)(ii)">(ii)</span> Nurse practitioners;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(3)(b)(iii)">(iii)</span> Registered nurses; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(3)(b)(iv)">(iv)</span> Licensed practical nurses.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(4)">(4)</span> Services. Detoxification services shall include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(4)(a)">(a)</span> A physical examination by a medical doctor, physician assistant, or nurse practitioner within a reasonable time frame;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(4)(b)">(b)</span> An assessment as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(4)(c)">(c)</span> An individualized treatment plan as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(4)(d)">(d)</span> Administration and monitoring of medication, including administration and monitoring of psychotropic medication by qualified nursing staff, as necessary;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(4)(e)">(e)</span> Monitoring of vital signs;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(4)(f)">(f)</span> Discharge or transfer planning as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(4)(g)">(g)</span> A mental health focused assessment for patients taking or prescribed psychotropic medication:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(4)(g)(i)">(i)</span> Approved by the registered nurse and the program physician; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(4)(g)(ii)">(ii)</span> Overseen by the registered nurse.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(5)">(5)</span> Documentation. The clinical staff providing services shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(5)(a)">(a)</span> Write a patient progress note after each counseling session; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(5)(b)">(b)</span> Place the note in the patient's record.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(6)">(6)</span> Referral Services. The program shall offer the following services or maintain a listing of agency referral agreements for the following services:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(6)(a)">(a)</span> Medical, psychological, and psychiatric consultation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(6)(b)">(b)</span> Laboratory services;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(6)(c)">(c)</span> Transportation services; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(6)(d)">(d)</span> Substance abuse/dependence and mental health treatment programs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(7)">(7)</span> Emergency Services.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(7)(a)">(a)</span> A program shall have a written agreement with a nearby hospital to provide necessary emergency medical support services.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(7)(b)">(b)</span> The agreement shall include:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(7)(b)(i)">(i)</span> An emergency protocol describing the manner in which patients are referred to the hospital and provided appropriate care;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(7)(b)(ii)">(ii)</span> Cooperative arrangements that specifically assign responsibility to provide transportation;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(7)(b)(iii)">(iii)</span> The manner in which hospital on-call coverage is provided;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(7)(b)(iv)">(iv)</span> A mechanism to provide psychiatric evaluation, if necessary;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(7)(b)(v)">(v)</span> A prescreening protocol for patients referred to the ambulatory detoxification program from the hospital; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#C(7)(b)(vi)">(vi)</span> A written protocol for the transfer of a patient to continued treatment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D">D.</span> Level II-D Ambulatory Detoxification with Extended On-Site Monitoring.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(1)">(1)</span> Description of Services. An ambulatory detoxification with extended on-site monitoring services shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(1)(a)">(a)</span> Offer evaluation, detoxification, and referral under medical supervision to patients who require services in an office setting, healthcare, correctional, or addictions treatment facility; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(1)(b)">(b)</span> Be certified as a separate program or be combined with intensive outpatient or partial hospitalization treatment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(2)">(2)</span> Patients who are appropriate for this level of treatment meet the current edition of the American Society of Addiction Medicine Patient Placement Criteria for either Level II.1 or Level II.5, or its equivalent as approved by the Administration.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(3)">(3)</span> Staffing. A program shall employ:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(3)(a)">(a)</span> Appropriately credentialed staff as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.06" title=".06 Staff Requirements.">COMAR 10.47.01.06</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(3)(b)">(b)</span> A licensed physician, physician assistant, or a licensed nurse practitioner; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(3)(c)">(c)</span> Additional medical staff which shall be a:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(3)(c)(i)">(i)</span> Licensed physician's assistant;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(3)(c)(ii)">(ii)</span> Registered nurse; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(3)(c)(iii)">(iii)</span> Licensed practical nurse.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(4)">(4)</span> Services. Detoxification services shall include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(4)(a)">(a)</span> A physical examination by a medical doctor, physician assistant, or nurse practitioner within 24 hours of admission;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(4)(b)">(b)</span> An assessment as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(4)(c)">(c)</span> An individualized treatment plan as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(4)(d)">(d)</span> Administering and monitoring of medication, as necessary;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(4)(e)">(e)</span> Monitoring of vital signs; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(4)(f)">(f)</span> Discharge or transfer planning as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(5)">(5)</span> Documentation. The clinical staff person providing the service shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(5)(a)">(a)</span> Write a patient progress note after each counseling session; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(5)(b)">(b)</span> Place the note in the patient's record.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(6)">(6)</span> Referral Services. The program shall offer or maintain a listing of agency referral agreements for the following services:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(6)(a)">(a)</span> Medical, psychological, and psychiatric consultation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(6)(b)">(b)</span> Laboratory services;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(6)(c)">(c)</span> Transportation services; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(6)(d)">(d)</span> Substance abuse/dependence and mental health treatment programs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(7)">(7)</span> Emergency Services. A program shall have a written agreement with a nearby hospital to provide necessary emergency medical support services. This agreement shall include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(7)(a)">(a)</span> An emergency protocol describing the manner in which patients are referred to the hospital and provided appropriate care;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(7)(b)">(b)</span> Cooperative arrangements that specifically assign responsibility to provide transportation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(7)(c)">(c)</span> The manner in which hospital on-call coverage is provided;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(7)(d)">(d)</span> A mechanism to provide psychiatric evaluation, if necessary;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(7)(e)">(e)</span> A prescreening protocol for patients referred to the ambulatory detoxification program from the hospital; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#D(7)(f)">(f)</span> A written protocol for the transfer of a patient to continued treatment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E">E.</span> Level III.2-D Clinically Managed Residential Detoxification.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(1)">(1)</span> Description of Services. Clinically managed residential detoxification services are provided for patients whose intoxication or withdrawal signs and symptoms are sufficiently severe to require 24-hour structure and support and may be offered at Level III.3 or Level III.5 programs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(2)">(2)</span> Patients who are appropriate for this level of treatment:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(2)(a)">(a)</span> Meet the current edition of the American Society of Addiction Medicine Patient Placement Criteria, or its equivalent as approved by the Administration; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(2)(b)">(b)</span> Are intoxicated, show moderate withdrawal signs and symptoms, or evidence that withdrawal is imminent.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(3)">(3)</span> Staffing. A program:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(3)(a)">(a)</span> Shall employ appropriately credentialed staff as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.06" title=".06 Staff Requirements.">COMAR 10.47.01.06</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(3)(b)">(b)</span> May not have a patient to alcohol and drug counselor ratio that exceeds eight patients to one full-time alcohol and drug counselor if counseling services are available;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(3)(c)">(c)</span> Shall have a physician, physician assistant, or nurse practitioner available 24 hours a day;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(3)(d)">(d)</span> Shall provide licensed nursing services between 7 a.m. and 11 p.m. daily as follows:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(3)(d)(i)">(i)</span> A registered nurse shall provide at least 8 hours of coverage a day 5 days a week; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(3)(d)(ii)">(ii)</span> The remainder of coverage may be provided by either a licensed practical nurse or a registered nurse; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(3)(e)">(e)</span> Shall have at least two employees trained in crisis management and cardiopulmonary resuscitation on duty between the hours of 11 p.m. and 7 a.m., 7 days a week.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(4)">(4)</span> Program Services. A program shall provide the following services:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(4)(a)">(a)</span> Nursing assessment upon admission;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(4)(b)">(b)</span> Physical examination by a medical doctor, physician assistant, or nurse practitioner within 24 hours of admission if clinically indicated;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(4)(c)">(c)</span> Assessment as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(4)(d)">(d)</span> Individualized treatment plan appropriate to a short term detoxification treatment regimen;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(4)(e)">(e)</span> Discharge or transfer planning as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(4)(f)">(f)</span> Monitoring of vital signs as clinically indicated;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(4)(g)">(g)</span> Administering of medication, as necessary; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(4)(h)">(h)</span> Adjunct services, which may include:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(4)(h)(i)">(i)</span> Basic alcohol or other drug education;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(4)(h)(ii)">(ii)</span> Family services; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(4)(h)(iii)">(iii)</span> Motivational counseling.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(5)">(5)</span> Documentation. Designated clinical staff shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(5)(a)">(a)</span> Write a patient progress note at the end of each day services are provided; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(5)(b)">(b)</span> Place the progress note in the patient's record.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(6)">(6)</span> Referral Services. The program shall offer the following services or maintain a listing of agency referral agreements for the following services:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(6)(a)">(a)</span> Medical, psychological, and psychiatric consultation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(6)(b)">(b)</span> Laboratory services;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(6)(c)">(c)</span> Transportation services; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(6)(d)">(d)</span> Substance abuse or dependence and mental health treatment programs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(7)">(7)</span> Emergency Services.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(7)(a)">(a)</span> A program shall have a written agreement with a nearby hospital to provide necessary emergency medical support services.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(7)(b)">(b)</span> The agreement shall include:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(7)(b)(i)">(i)</span> An emergency protocol describing the manner in which patients are referred to the hospital and provided appropriate care;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(7)(b)(ii)">(ii)</span> Cooperative arrangements that specifically assign responsibility to provide transportation;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(7)(b)(iii)">(iii)</span> The manner in which hospital on-call coverage is provided;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(7)(b)(iv)">(iv)</span> A mechanism to provide psychiatric evaluation, if necessary;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(7)(b)(v)">(v)</span> A prescreening protocol for patients referred to the inpatient detoxification program from the hospital; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(7)(b)(vi)">(vi)</span> A written protocol for the transfer of a patient to continued treatment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(8)">(8)</span> Patients Treated with Opioid Maintenance Medication.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(8)(a)">(a)</span> A detoxification facility is not limited in the number of admissions for detoxification of patients who are treated with opioid maintenance medication.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(8)(b)">(b)</span> A detoxification facility is not limited in the total number of doses of opioid maintenance medication that it will accept from patients who:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(8)(b)(i)">(i)</span> Attend the detoxification program; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#E(8)(b)(ii)">(ii)</span> Require opioid maintenance medication for opioid detoxification or detoxification for substances other than opioids.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F">F.</span> Level III.7-D Medically Monitored Inpatient Detoxification.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(1)">(1)</span> Description of Services.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(1)(a)">(a)</span> Medically monitored inpatient detoxification services offer 24-hour medically supervised evaluation and withdrawal management by medical professionals at an inpatient facility and may be offered with therapeutic community or medically monitored intensive inpatient treatment.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(1)(b)">(b)</span> This is an Intermediate Care Facility/C.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(2)">(2)</span> Patients who are appropriate for this level of treatment:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(2)(a)">(a)</span> Meet the current edition of the American Society of Addiction Medicine Patient Placement Criteria, or its equivalent as approved by the Administration, for this level of treatment; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(2)(b)">(b)</span> Are intoxicated, show physical signs of withdrawal, or both.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(3)">(3)</span> Staffing. A program:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(3)(a)">(a)</span> Shall employ appropriately credentialed staff as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.06" title=".06 Staff Requirements.">COMAR 10.47.01.06</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(3)(b)">(b)</span> May not have a patient to alcohol and drug counselor ratio that exceeds eight patients to one full-time alcohol and drug counselor if counseling services are available;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(3)(c)">(c)</span> Shall have on-site physician, physician assistant, or nurse practitioner coverage available to provide initial assessment and documented referral for care, and to monitor progress in treatment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(3)(d)">(d)</span> Shall have a physician, physician assistant, or nurse practitioner on call 24 hours a day; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(3)(e)">(e)</span> Shall have nursing services during all hours of service, including at least 8 hours of service provided by a licensed registered nurse.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(4)">(4)</span> Program Services. A program shall provide the following services:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(4)(a)">(a)</span> Nursing assessment upon admission;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(4)(b)">(b)</span> Physical examination by a medical doctor, physician assistant, or nurse practitioner within 24 hours of admission;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(4)(c)">(c)</span> An assessment as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(4)(d)">(d)</span> Individualized treatment plan appropriate to a short term detoxification treatment regimen;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(4)(e)">(e)</span> Discharge or transfer planning as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(4)(f)">(f)</span> Monitoring of vital signs;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(4)(g)">(g)</span> Administering of medication, as necessary; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(4)(h)">(h)</span> Adjunct services, which may include:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(4)(h)(i)">(i)</span> Basic alcohol and drug education;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(4)(h)(ii)">(ii)</span> Family services; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(4)(h)(iii)">(iii)</span> Motivational counseling.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(5)">(5)</span> Documentation. Designated clinical staff shall write a patient progress note at the end of each day services are provided and place the progress note in the patient's record.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(6)">(6)</span> Referral Services. The program shall offer or have available through referral the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(6)(a)">(a)</span> Medical, psychological, and psychiatric consultation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(6)(b)">(b)</span> Laboratory services;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(6)(c)">(c)</span> Transportation services; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(6)(d)">(d)</span> Substance abuse or dependence and mental health treatment programs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(7)">(7)</span> A program shall have a written agreement with a nearby hospital to provide necessary emergency medical support services. This agreement shall include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(7)(a)">(a)</span> An emergency protocol describing the manner in which patients are referred to the hospital and provided appropriate care;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(7)(b)">(b)</span> Cooperative arrangements that specifically assign responsibility to provide transportation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(7)(c)">(c)</span> The manner in which hospital on-call coverage is provided;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(7)(d)">(d)</span> A mechanism to provide psychiatric evaluation, if necessary;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(7)(e)">(e)</span> A prescreening protocol for patients referred to the inpatient detoxification program from the hospital; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(7)(f)">(f)</span> A written protocol for the transfer of a patient to continued treatment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(8)">(8)</span> Patients Treated with Opioid Maintenance Medication.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(8)(a)">(a)</span> A detoxification facility is not limited in the number of admissions for detoxification of patients who are treated with opioid maintenance medication.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(8)(b)">(b)</span> A detoxification facility is not limited in the total number of doses of opioid maintenance medication that it will accept from patients who:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(8)(b)(i)">(i)</span> Attend the detoxification program; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.10#F(8)(b)(ii)">(ii)</span> Require opioid maintenance medication for opioid detoxification or detoxification for substances other than opioids</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.02.11" data-order="|10|47|02|.11|" data-ref-path="10|47|02|.11" class="h__section">.11 Opioid Maintenance Therapy.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#A">A.</span> Program Description. Opioid maintenance therapy:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#A(1)">(1)</span> Uses pharmacological interventions, including full and partial opiate agonist treatment medications, to provide treatment, support, and recovery to opioid-addicted patients;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#A(2)">(2)</span> Is a separate service that is certified and offered by a program as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.02.03" title=".03 Early Intervention Level 0.5.">COMAR 10.47.02.03</a> — .11;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#A(3)">(3)</span> Complies with the requirements under this regulation; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#A(4)">(4)</span> Can be provided in correctional facility based programs.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#B">B.</span> The program shall comply with federal regulation 42 CFR 8.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#C">C.</span> Staffing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#C(1)">(1)</span> The patient to alcohol and drug counselor ratio may not exceed 50 patients to one full-time counselor.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#C(2)">(2)</span> Medical Director. The program shall have a medical director who is a physician and who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#C(2)(a)">(a)</span> Has 3 years documented experience providing services to persons who are addicted to alcohol or other drugs, including at least 1 year of experience in the treatment of opioid addiction with opioid maintenance therapy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#C(2)(b)">(b)</span> Meets at least one of the following criteria:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#C(2)(b)(i)">(i)</span> Has been continuously employed as the medical director for opioid maintenance therapy programs from or before August 1, 2002;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#C(2)(b)(ii)">(ii)</span> Is certified in addiction medicine by the American Society of Addiction Medicine;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#C(2)(b)(iii)">(iii)</span> Is certified in added qualifications in addiction psychiatry by the American Board of Psychiatry and Neurology, Inc.; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#C(2)(b)(iv)">(iv)</span> Is certified in added qualifications in addiction medicine by the appropriate specialty boards of the American Osteopathic Association; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#C(2)(c)">(c)</span> Takes an active part in interdisciplinary team meetings, not less than every 2 weeks.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#C(3)">(3)</span> A program unable to hire a medical director who meets the criteria set forth in §C(2) of this chapter may hire an interim medical director under the following conditions:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#C(3)(a)">(a)</span> The program shall submit a training plan for the interim medical director to the Administration for approval;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#C(3)(b)">(b)</span> The plan shall address a means for achieving minimal competencies and proficiencies until the interim medical director meets qualifications set forth in §C(1) of this chapter; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#C(3)(c)">(c)</span> The interim medical director shall meet the qualifications within 48 months of being hired.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#D">D.</span> An opioid maintenance therapy program shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#D(1)">(1)</span> Have hours that meet the needs of the patients;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#D(2)">(2)</span> Establish an answering system when the program is closed which provides direct contact or call back by a staff member capable of addressing emergency patient issues; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#D(3)">(3)</span> Complete an individualized treatment plan which is described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a> as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#D(3)(a)">(a)</span> Completed and signed by the alcohol and drug counselor and patient within 7 working days of the comprehensive assessment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#D(3)(b)">(b)</span> Updated every 90 days for the first year of treatment; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#D(3)(c)">(c)</span> After completion of 1 year of continuous treatment and if the patient meets the requirements for unsupervised or take home use set forth in CFR 42 §8.12(i), the individualized treatment plan may be updated every 180 days and signed by the alcohol and drug counselor and patient.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#E">E.</span> Random Drug Testing. The program shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#E(1)">(1)</span> Conduct random drug testing on each patient at least monthly, in accordance with State law;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#E(2)">(2)</span> Conduct random drug testing at a minimum for the following substances:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#E(2)(a)">(a)</span> Benzodiazepines;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#E(2)(b)">(b)</span> Marijuana;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#E(2)(c)">(c)</span> Cocaine;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#E(2)(d)">(d)</span> Opiates;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#E(2)(e)">(e)</span> Alcohol; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#E(2)(f)">(f)</span> Methadone;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#E(3)">(3)</span> Ensure that positive screens are validated using federally approved, State-certified laboratories;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#E(4)">(4)</span> If appropriate, use temperature sensitive cups in place of direct observation; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#E(5)">(5)</span> Develop procedures, approved by the Administration, that mandate clinical intervention if a patient's drug test result indicates substance use.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#F">F.</span> Dosage. The program shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#F(1)">(1)</span> Maintain patients with a dose adequate to alleviate all withdrawal symptoms;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#F(2)">(2)</span> Employ dose increases and behavior therapy before mandatory detoxification for patients continuing to use drugs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#F(3)">(3)</span> Establish patient dosing on an individual need;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#F(4)">(4)</span> Provide flexible dosage tapering at patient request; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#F(5)">(5)</span> Develop a detoxification schedule at least 21 days long with daily dosage reductions less than 5 percent of the original total dose, regardless of the patient's ability to pay.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#G">G.</span> Opioid maintenance programs shall arrange for transportation of medication to and from the following levels of care:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#G(1)">(1)</span> Residential treatment at Levels III.3, III.5, and III.7, as described in Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.02.07" title=".07 Residential Services — Clinically Managed Medium Intensity Treatment Level III.3.">.07</a> — <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.02.09" title=".09 Residential Services — Medically Monitored Intensive Inpatient Treatment Level III.7.">.09</a> of this chapter;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#G(2)">(2)</span> Detoxification services at Level III.2-D and III.7-D, as described in <a class="internal-link " href="/us/md/exec/comar/10.47.02.10" title=".10 Detoxification Services.">Regulation .10 of this chapter</a>; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#G(3)">(3)</span> Residential treatment at Level III.1, when the patient cannot obtain or transport his or her own take-home opioid maintenance medication because of developmental or physical disabilities or because the patient does not have access to transportation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#H">H.</span> Opioid maintenance programs may transfer care of a patient to a closer opioid maintenance program when the patient is also being treated at a residential program or for detoxification services in a different county or jurisdiction.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#I">I.</span> Programs may administratively detoxify or transfer a patient only if the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#I(1)">(1)</span> Patient's behavior on program premises is abusive, violent, or illegal;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#I(2)">(2)</span> Patient fails to pay fees and has been informed in writing and counseled as to responsibility and possible sanctions including detoxification;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#I(3)">(3)</span> Patient misses 3 consecutive medication days, and the program physician after a reevaluation has determined that administrative detoxification is warranted; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#I(4)">(4)</span> Clinical staff documents therapeutic reasons for detoxification, which may include continued use of illicit drugs or an unwillingness to follow appropriate clinical interventions.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#J">J.</span> Criteria for Take-Home Privileges. Before the patient may take home any dose the patient shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#J(1)">(1)</span> Meet the criteria set within 42 CFR Part 8; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#J(2)">(2)</span> Provide the program with a working lock box for the take-home medication.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#K">K.</span> Referral Services. Programs shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#K(1)">(1)</span> Provide referral services as required by the level of treatment under which the program is certified; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.02.11#K(2)">(2)</span> Maintain a listing of agency referral agreements for the services.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.47.03" data-order="|10|47|03|" data-ref-path="10|47|03" class="h__chapter">Chapter 03 Specific Program Requirements for Correctional Levels of Care</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date:</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.03" title="Chapter 03 Specific Program Requirements for Correctional Levels of Care">COMAR 10.47.03</a>, Certification Requirements, recodified to be <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.04" title="Chapter 04 Certification Requirements">COMAR 10.47.04</a> and new chapter, Specific Program Requirements for Correctional Levels of Care, adopted as an emergency provision effective April 1, 2008 (35:9 Md. R. 894); adopted permanently effective May 5, 2008 (35:9 Md. R. 898)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §§8-401 — 8-405 and 19-308, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.47.03.01" data-order="|10|47|03|.01|" data-ref-path="10|47|03|.01" class="h__section">.01 Scope.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.01#A">A.</span> This chapter sets forth:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.01#A(1)">(1)</span> Additional requirements that a program shall meet to be certified to offer the correctional levels of care; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.01#A(2)">(2)</span> Requirement exemptions for a program certified as a correctional level of care, which shall meet the requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01" title="Chapter 01 Requirements">COMAR 10.47.01</a> and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.04" title="Chapter 04 Certification Requirements">10.47.04</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.01#B">B.</span> Correctional levels are exempt from the following requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01" title="Chapter 01 Requirements">COMAR 10.47.01</a>:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.01#B(1)">(1)</span> COMAR 10.47.01.03C(2)(h), if the correctional facility's requirements are more stringent;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.01#B(2)">(2)</span> <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04#A(1)(a)" title="">COMAR 10.47.01.04A(1)(a)</a> and (b);</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.01#B(3)">(3)</span> <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04#E(2)" title="">COMAR 10.47.01.04E(2)</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.01#B(4)">(4)</span> <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.07#A(1)(e)" title="">COMAR 10.47.01.07A(1)(e)</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.01#B(5)">(5)</span> <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.09" title=".09 Referral Agreements and Program Cooperation.">COMAR 10.47.01.09</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.03.02" data-order="|10|47|03|.02|" data-ref-path="10|47|03|.02" class="h__section">.02 Definitions.</h3>
                <p>In this chapter, terms have the meanings stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.02" title=".02 Definitions.">COMAR 10.47.01.02</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.03.03" data-order="|10|47|03|.03|" data-ref-path="10|47|03|.03" class="h__section">.03 Correctional Level I.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.03#A">A.</span> Program Description.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.03#A(1)">(1)</span> The program shall provide evaluation and treatment to patients who require services for less than 9 hours weekly in a correctional facility.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.03#A(2)">(2)</span> Inmates receiving treatment may be housed throughout the correctional facility.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.03#B">B.</span> Inmates who are appropriate for this level of treatment shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.03#B(1)">(1)</span> Meet the current edition of the American Society of Addiction Medicine Patient Placement Criteria for Level I, or its equivalent as approved by the Administration, for the 30 days before incarceration; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.03#B(2)">(2)</span> Have a physical and emotional status that allows the inmate to function in the inmate's usual environment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.03#C">C.</span> Staffing. Services shall be provided by appropriately credentialed staff as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.06" title=".06 Staff Requirements.">COMAR 10.47.01.06</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.03#D">D.</span> Program Services. A program shall provide the following services:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.03#D(1)">(1)</span> An assessment as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a> within 30 days of admission;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.03#D(2)">(2)</span> An individualized treatment plan as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a> with a treatment plan update completed every 90 days in accordance with the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.03.03#D(2)(a)">(a)</span> The alcohol and drug counselor and patient shall complete and sign the initial treatment plan within 10 working days of the comprehensive assessment; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.03.03#D(2)(b)">(b)</span> If the alcohol and drug counselor is unable to develop a treatment plan within the required time, the clinical director or the clinical supervisor shall:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.03.03#D(2)(b)(i)">(i)</span> Determine the reason for a delay in development of a treatment plan;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.03.03#D(2)(b)(ii)">(ii)</span> Document the reason in the patient's record; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.03.03#D(2)(b)(iii)">(iii)</span> Direct an appropriate clinical staff person to develop a treatment plan within 7 working days of the clinical director or clinical supervisor's documentation of the delay;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.03#D(3)">(3)</span> Case management services; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.03#D(4)">(4)</span> Group or individual counseling sessions.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.03#E">E.</span> Documentation. The clinical staff person providing the service shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.03#E(1)">(1)</span> Write a patient progress note after each counseling session; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.03#E(2)">(2)</span> Place the note in the patient's record.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.03#F">F.</span> Referral Services. The program shall have available through referral the following at the time of the patient's release from the institution:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.03#F(1)">(1)</span> Medical examinations;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.03#F(2)">(2)</span> Services through the Division of Rehabilitation Services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.03#F(3)">(3)</span> Vocational assistance;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.03#F(4)">(4)</span> Mental health services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.03#F(5)">(5)</span> Substance abuse treatment programs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.03#F(6)">(6)</span> Legal assistance; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.03#F(7)">(7)</span> Social services.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.03.04" data-order="|10|47|03|.04|" data-ref-path="10|47|03|.04" class="h__section">.04 Correctional Level II.1.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.04#A">A.</span> Program Description.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.04#A(1)">(1)</span> A program shall provide structured evaluation and treatment to patients who require services from 9 to 20 hours weekly in a correctional facility.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.04#A(2)">(2)</span> Inmates receiving treatment may be housed throughout the institution.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.04#B">B.</span> Inmates who are appropriate for this level of treatment shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.04#B(1)">(1)</span> Meet the current edition of the American Society of Addiction Medicine Patient Placement Criteria for Level II.1, or its equivalent as approved by the Administration, for the 30 days before incarceration; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.04#B(2)">(2)</span> Have a physical and emotional status that allows the inmate to function in the inmate's usual environment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.04#C">C.</span> Staffing. Services shall be provided by appropriately credentialed staff as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.06" title=".06 Staff Requirements.">COMAR 10.47.01.06</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.04#D">D.</span> Program Services. A program shall provide the following services:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.04#D(1)">(1)</span> An assessment as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a> within 30 days of admission;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.04#D(2)">(2)</span> An individualized treatment plan as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a> with a treatment plan update completed every 30 days in accordance with the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.03.04#D(2)(a)">(a)</span> The alcohol and drug counselor and patient shall complete and sign the initial treatment plan within 10 working days of the comprehensive assessment; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.03.04#D(2)(b)">(b)</span> If the alcohol and drug counselor is unable to develop a treatment plan within the required time, the clinical director or the clinical supervisor shall:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.03.04#D(2)(b)(i)">(i)</span> Determine the reason for a delay in development of a treatment plan;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.03.04#D(2)(b)(ii)">(ii)</span> Document the reason in the patient's record; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.03.04#D(2)(b)(iii)">(iii)</span> Direct an appropriate clinical staff person to develop a treatment plan within 3 working days of the clinical director's or clinical supervisor's documentation of the delay;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.04#D(3)">(3)</span> Case management services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.04#D(4)">(4)</span> At least one group counseling session a week; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.04#D(5)">(5)</span> At least one individual session every 2 weeks.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.04#E">E.</span> Documentation. A designated clinical staff person shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.04#E(1)">(1)</span> Write a patient progress note at the end of each week that services are provided; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.04#E(2)">(2)</span> Place the progress note in the patient's record.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.04#F">F.</span> Referral Services. The program shall have available through referral the following at the time of the patient's release from the institution:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.04#F(1)">(1)</span> Medical services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.04#F(2)">(2)</span> Services through the Division of Rehabilitation Services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.04#F(3)">(3)</span> Vocational assistance;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.04#F(4)">(4)</span> Mental health services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.04#F(5)">(5)</span> Substance abuse treatment programs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.04#F(6)">(6)</span> Legal assistance; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.04#F(7)">(7)</span> Social services.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.03.05" data-order="|10|47|03|.05|" data-ref-path="10|47|03|.05" class="h__section">.05 Correctional Level II.5.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.05#A">A.</span> Program Description.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.05#A(1)">(1)</span> A program shall provide structured evaluation and treatment to patients who require programming from 20 to 35 hours weekly in a correctional facility.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.05#A(2)">(2)</span> Inmates receiving treatment may be housed together in a separate unit.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.05#B">B.</span> Inmates who are appropriate for this level of treatment shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.05#B(1)">(1)</span> Meet the current edition of the American Society of Addiction Medicine Patient Placement Criteria for Level II.5, or its equivalent as approved by the Administration, for the 30 days before incarceration; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.05#B(2)">(2)</span> Have a physical and emotional status that allows the inmate to function in the inmate's usual environment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.05#C">C.</span> Staffing. Services shall be provided by appropriately credentialed staff as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.06" title=".06 Staff Requirements.">COMAR 10.47.01.06</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.05#D">D.</span> Program Services. A program shall provide the following services:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.05#D(1)">(1)</span> An assessment as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a> within 30 days of admission;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.05#D(2)">(2)</span> An individualized treatment plan as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a> with a treatment plan update completed every 30 days in accordance with the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.03.05#D(2)(a)">(a)</span> The alcohol and drug counselor and patient shall complete and sign the initial treatment plan within 10 working days of the comprehensive assessment; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.03.05#D(2)(b)">(b)</span> If the alcohol and drug counselor is unable to develop a treatment plan within the required time, the clinical director or the clinical supervisor shall:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.03.05#D(2)(b)(i)">(i)</span> Determine the reason for a delay in development of a treatment plan;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.03.05#D(2)(b)(ii)">(ii)</span> Document the reason in the patient's record; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.03.05#D(2)(b)(iii)">(iii)</span> Direct an appropriate clinical staff person to develop a treatment plan within 3 working days of the clinical director's or clinical supervisor's documentation of the delay;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.05#D(3)">(3)</span> Case management services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.05#D(4)">(4)</span> At least one group counseling session a week; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.05#D(5)">(5)</span> At least one individual session every 2 weeks.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.05#E">E.</span> Documentation. A designated clinical staff person shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.05#E(1)">(1)</span> Write a patient progress note at the end of each week that services are provided; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.05#E(2)">(2)</span> Place the progress note in the patient's record.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.05#F">F.</span> Referral Services. The program shall have available through referral the following at the time of the patient's release from the institution:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.05#F(1)">(1)</span> Medical services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.05#F(2)">(2)</span> Services through the Division of Rehabilitation Services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.05#F(3)">(3)</span> Vocational assistance;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.05#F(4)">(4)</span> Mental health services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.05#F(5)">(5)</span> Substance abuse treatment programs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.05#F(6)">(6)</span> Legal assistance; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.05#F(7)">(7)</span> Social services.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.03.06" data-order="|10|47|03|.06|" data-ref-path="10|47|03|.06" class="h__section">.06 Correctional Level III.1.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#A">A.</span> Program Description.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#A(1)">(1)</span> A program shall offer treatment services at least 5 hours a week directed toward preventing relapse, applying recovery skills, promoting personal responsibility, and reintegration into the community.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#A(2)">(2)</span> Inmates receiving this level of treatment shall be housed:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#A(2)(a)">(a)</span> Together in a prerelease center or a correctional halfway house; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#A(2)(b)">(b)</span> Separately from inmates not receiving this level of treatment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#B">B.</span> Inmates who are appropriate for this level of treatment shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#B(1)">(1)</span> Meet the current edition of the American Society of Addiction Medicine Patient Placement Criteria for Level III.1, or its equivalent as approved by the Administration, for the 30 days before incarceration; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#B(2)">(2)</span> Be capable of self care but not ready to return to independent living.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#C">C.</span> Staffing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#C(1)">(1)</span> Services shall be provided by appropriately credentialed staff as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.06" title=".06 Staff Requirements.">COMAR 10.47.01.06</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#C(2)">(2)</span> A correctional Level III.1 program shall employ:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#C(2)(a)">(a)</span> One individual as clinical supervisor, who may also be the program's administrator; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#C(2)(b)">(b)</span> At least one staff member to be on duty at all times.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#C(3)">(3)</span> Staff may not dispense medications.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#D">D.</span> Program Services. A correctional Level III.1 program shall provide the following services:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#D(1)">(1)</span> An assessment as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a> within 30 days of admission;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#D(2)">(2)</span> An individualized treatment plan as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a> with a treatment plan update completed every 60 days in accordance with the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#D(2)(a)">(a)</span> The alcohol and drug counselor and patient shall complete and sign the initial treatment plan within 10 working days of the comprehensive assessment; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#D(2)(b)">(b)</span> If the alcohol and drug counselor is unable to develop a treatment plan within the required time, the clinical director or the clinical supervisor shall:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#D(2)(b)(i)">(i)</span> Determine the reason for a delay in development of a treatment plan;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#D(2)(b)(ii)">(ii)</span> Document the reason in the patient's record; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#D(2)(b)(iii)">(iii)</span> Direct an appropriate clinical staff person to develop a treatment plan within 7 working days of the clinical director's or clinical supervisor's documentation of the delay;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#D(3)">(3)</span> Periodic group counseling that focuses on relapse prevention;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#D(4)">(4)</span> Case management services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#D(5)">(5)</span> Individual counseling, at least monthly; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#D(6)">(6)</span> Leisure and recreational activities.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#E">E.</span> Documentation. The clinical staff person providing the service shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#E(1)">(1)</span> Write a patient progress note after each counseling session; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#E(2)">(2)</span> Place the note in the patient's record.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#F">F.</span> Referral Services. The program shall have available through referral the following at the time of the patient's release from the institution:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#F(1)">(1)</span> Medical examinations;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#F(2)">(2)</span> Services through the Division of Rehabilitation Services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#F(3)">(3)</span> Vocational assistance;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#F(4)">(4)</span> Mental health services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#F(5)">(5)</span> Legal assistance;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#F(6)">(6)</span> Substance abuse treatment programs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#F(7)">(7)</span> Social services; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.06#F(8)">(8)</span> Education.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.03.07" data-order="|10|47|03|.07|" data-ref-path="10|47|03|.07" class="h__section">.07 Correctional Level III.5.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#A">A.</span> Program Description. A correctional Level III.5 program:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#A(1)">(1)</span> Shall provide a highly structured environment in combination with moderate to high intensity treatment and ancillary services to support and promote recovery;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#A(2)">(2)</span> Shall be characterized by its reliance on the treatment community as a therapeutic agent; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#A(3)">(3)</span> May not allow a structure whereby inmates have authority over one another.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#B">B.</span> Inmates who are appropriate for this level of treatment shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#B(1)">(1)</span> Meet the current edition of the American Society of Addiction Medicine Patient Placement Criteria for Level III.5, or its equivalent as approved by the Administration, for the 30 days before incarceration; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#B(2)">(2)</span> Be housed separately from inmates not receiving this level of treatment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#C">C.</span> Staffing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#C(1)">(1)</span> Services shall be provided by appropriately credentialed staff as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.06" title=".06 Staff Requirements.">COMAR 10.47.01.06</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#C(2)">(2)</span> A program shall have sufficient medical services to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#C(2)(a)">(a)</span> Provide initial diagnostic work-up;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#C(2)(b)">(b)</span> Provide identification of medical and surgical problems for referral; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#C(2)(c)">(c)</span> Handle medical emergencies when necessary.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#D">D.</span> Program Services. A program shall provide the following services:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#D(1)">(1)</span> An assessment as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a> within 2 days of admission;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#D(2)">(2)</span> An individualized treatment plan as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.04" title=".04 Clinical Requirements.">COMAR 10.47.01.04</a> with a treatment plan update every 30 days in accordance with the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#D(2)(a)">(a)</span> The alcohol and drug counselor and patient shall complete and sign the initial treatment plan within 10 working days of the comprehensive assessment; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#D(2)(b)">(b)</span> If the alcohol and drug counselor is unable to develop a treatment plan within the required time, the clinical director or the clinical supervisor shall:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#D(2)(b)(i)">(i)</span> Determine the reason for a delay in development of a treatment plan;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#D(2)(b)(ii)">(ii)</span> Document the reason in the patient's record; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#D(2)(b)(iii)">(iii)</span> Direct an appropriate clinical staff person to develop a treatment plan within 2 working days of the clinical director's or clinical supervisor's documentation of the delay; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#D(3)">(3)</span> A minimum of 36 hours of therapeutic activities a week, including but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#D(3)(a)">(a)</span> One individual counseling session a week;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#D(3)(b)">(b)</span> Group counseling;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#D(3)(c)">(c)</span> Alcohol and drug education;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#D(3)(d)">(d)</span> Career counseling; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#D(3)(e)">(e)</span> Nutrition education.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#E">E.</span> Documentation. A designated clinical staff person shall write a patient progress note at the end of each week that services are provided and place the progress note in the patient's record.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#F">F.</span> Referral Services. At the time of the patient's release from the institution, the program shall have available through referral the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#F(1)">(1)</span> Medical care;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#F(2)">(2)</span> Services through the Division of Rehabilitation Services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#F(3)">(3)</span> Vocational assistance;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#F(4)">(4)</span> Mental health services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#F(5)">(5)</span> Substance abuse treatment programs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#F(6)">(6)</span> Legal assistance; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.03.07#F(7)">(7)</span> Social services.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.47.04" data-order="|10|47|04|" data-ref-path="10|47|04" class="h__chapter">Chapter 04 Certification Requirements</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: June 10, 2002 (29:11 Md. R. 882)</p>
                  <p>——————</p>
                  <p>Chapter recodified from <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.03" title="Chapter 03 Specific Program Requirements for Correctional Levels of Care">COMAR 10.47.03</a> to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.04" title="Chapter 04 Certification Requirements">10.47.04</a> as an emergency provision effective April 1, 2008 (35:9 Md. R. 894); recodified permanently effective May 5, 2008 (35:9 Md. R. 898)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.04.01" title=".01 Scope.">Regulation .01</a> amended as an emergency provision effective April 1, 2008 (35:9 Md. R. 894); amended permanently effective May 5, 2008 (35:9 Md. R. 898)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.04.03" title=".03 Certification Required.">Regulation .03</a> amended as an emergency provision effective April 1, 2008 (35:9 Md. R. 894); amended permanently effective May 5, 2008 (35:9 Md. R. 898)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.04.04#A" title="">Regulation .04A</a>, B amended effective March 13, 2017 (44:5 Md. R. 292)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.04.04#D" title="">Regulation .04D</a> adopted as an emergency provision effective April 1, 2008 (35:9 Md. R. 894); adopted permanently effective May 5, 2008 (35:9 Md. R. 898)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.04.05#A" title="">Regulation .05A</a> amended effective March 13, 2017 (44:5 Md. R. 292)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.04.05#A" title="">Regulation .05A</a>, B amended as an emergency provision effective April 1, 2008 (35:9 Md. R. 894); amended permanently effective May 5, 2008 (35:9 Md. R. 898)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.04.05#E" title="">Regulation .05E</a> adopted effective November 24, 2014 (41:23 Md. R. 1374)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.04.07" title=".07 Investigation or Inspection by the Administration or Office of Health Care Quality.">Regulation .07</a> recodified to be Regulation .08 and new Regulation .07 adopted as an emergency provision effective April 1, 2008 (35:9 Md. R. 894); adopted permanently effective May 5, 2008 (35:9 Md. R. 898)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.04.08" title=".08 Denial, Probation, Intermediate Sanctions, Suspension, or Revocation.">Regulation .08</a> amended as an emergency provision effective April 1, 2008 (35:9 Md. R. 894); amended permanently effective May 5, 2008 (35:9 Md. R. 898)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §§7.5-205, 8-401 — 8-405, and 19-308, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.47.04.01" data-order="|10|47|04|.01|" data-ref-path="10|47|04|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter sets forth additional requirements that a program shall meet to be certified to offer a particular level of treatment. The program shall meet the requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01" title="Chapter 01 Requirements">COMAR 10.47.01</a> and this chapter.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.04.02" data-order="|10|47|04|.02|" data-ref-path="10|47|04|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.04.02#A">A.</span> In this chapter, terms have the meanings stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.02" title=".02 Definitions.">COMAR 10.47.01.02</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.04.02#B">B.</span> In addition to terms referenced under <a class="internal-link " href="/us/md/exec/comar/10.47.04.02#A" title="">§A of this regulation</a>, in this chapter the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.04.02#C">C.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.02#C(1)">(1)</span> "Deficiency" means a failure to meet a regulation or its intent.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.02#C(2)">(2)</span> "Plan of correction" means the program's proposed response to findings of noncompliance identified by the Office of Health Care Quality or the Administration.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.02#C(3)">(3)</span> "Sale" means the transfer of a majority interest of ownership.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.04.03" data-order="|10|47|04|.03|" data-ref-path="10|47|04|.03" class="h__section">.03 Certification Required.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.04.03#A">A.</span> All programs and prevention programs shall be certified by the Department before program services and prevention program services may be provided in the State.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.04.03#B">B.</span> The following are exempt from certification under this chapter:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.03#B(1)">(1)</span> A health professional licensed under the Health Occupations Article who is treating patients within the scope of the professional's practice and who does not advertise the practice as an alcohol abuse or drug abuse program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.03#B(2)">(2)</span> Alcoholics Anonymous, Narcotics Anonymous, transitional housing programs, or other similar organizations, if the organization holds meetings or provides support services to help individuals who show the effects of drug abuse or alcohol abuse;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.03#B(3)">(3)</span> An employees' assistance program of a business entity; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.03#B(4)">(4)</span> A hospital as defined in Health-General Article, §19-301, Annotated Code of Maryland, accredited by the Joint Commission on Accreditation of Health Care Organizations with a separately accredited alcohol and drug abuse program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.04.03#C">C.</span> All programs offering drug and alcohol treatment, care, and rehabilitation are required to be certified except as in <a class="internal-link " href="/us/md/exec/comar/10.47.04.03#A" title="">§A of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.04.03#D">D.</span> Each level of service offered by a program requires a certification.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.04.03#E">E.</span> A separate certification is required for each physical site regardless of the service.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.04.03#F">F.</span> A certification is valid only for the program to which it is issued and is not subject to voluntary or involuntary sale, assignment, or transfer.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.04.03#G">G.</span> Upon sale, transfer, assignment, lease, or relocation, the program shall obtain a new certification.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.04.04" data-order="|10|47|04|.04|" data-ref-path="10|47|04|.04" class="h__section">.04 Type and Duration of Certification.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.04.04#A">A.</span> Initial Certification.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.04#A(1)">(1)</span> After receipt of the completed written or electronic application provided by the Administration and after inspection by the Office of Health Care Quality, if there are no deficiencies, the Administration shall grant an initial certification.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.04#A(2)">(2)</span> The initial certification is valid for a period in the discretion of the Administration, not to exceed 6 months.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.04.04#B">B.</span> Provisional Certification.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.04#B(1)">(1)</span> After a program has been in operation for 4 months, after inspection by the Office of Health Care Quality, and, if there are deficiencies which are not life threatening, the Administration, with the program's consent, may grant a provisional certification to permit the program to correct its deficiencies as set forth in its plan of correction.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.04#B(2)">(2)</span> If upon review of a written or electronic renewal application provided by the Administration, the Office of Health Care Quality finds deficiencies which are not life threatening, the Administration may grant a provisional certification to permit the program to correct the deficiencies as set forth in the plan of correction.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.04#B(3)">(3)</span> A provisional certification is valid for a period in the discretion of the Administration, not to exceed 6 months, and may be issued once.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.04.04#C">C.</span> General Certification.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.04#C(1)">(1)</span> After a program has been in operation for 4 months, after inspection by the Office of Health Care Quality, if there are no deficiencies, the Administration shall grant the program a general certification.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.04#C(2)">(2)</span> A general certification is valid for 2 years from date of issue.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.04.04#D">D.</span> Surrender of Certification. A program shall surrender its certificate to the Administration on:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.04#D(1)">(1)</span> Revocation of the program's certification by the Administration;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.04#D(2)">(2)</span> Sale of the program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.04#D(3)">(3)</span> Transfer of the program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.04#D(4)">(4)</span> Assignment of the program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.04#D(5)">(5)</span> Lease of the program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.04#D(6)">(6)</span> Relocation of the program; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.04#D(7)">(7)</span> Voluntary decision to close the program.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.04.05" data-order="|10|47|04|.05|" data-ref-path="10|47|04|.05" class="h__section">.05 Application Process and Evaluation.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#A">A.</span> Application. An applicant for certification of a program or renewal of certification shall submit to the Office of Health Care Quality:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#A(1)">(1)</span> A completed application on a written or electronic form approved by the Administration;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#A(2)">(2)</span> Documentation of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#A(2)(a)">(a)</span> The program service plan;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#A(2)(b)">(b)</span> Satisfactory fire, safety, and health inspection reports; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#A(2)(c)">(c)</span> Compliance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01" title="Chapter 01 Requirements">COMAR 10.47.01</a> and the applicable specific program requirements under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.02" title="Chapter 02 Specific Program Requirements">COMAR 10.47.02</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#A(3)">(3)</span> A request for a variance or a waiver of a regulation; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#A(4)">(4)</span> An application fee of $700 with initial application and at recertification, if the program provides opioid maintenance therapy as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.02.11" title=".11 Opioid Maintenance Therapy.">COMAR 10.47.02.11</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#B">B.</span> Incomplete Application or Information.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#B(1)">(1)</span> After reviewing the application, if the Office of Health Care Quality or the Administration finds it needs more information, the Office of Health Care Quality or the Administration shall request the information in writing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#B(2)">(2)</span> The application shall remain open for 6 months after the information is requested. If the program does not provide the requested information, the Office of Health Care Quality shall close the application.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#C">C.</span> Initial Site Visit and Written Report.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#C(1)">(1)</span> On receipt of a completed application under this regulation and the required documentation, the Office of Health Care Quality shall conduct a site visit and issue a written report. If deficiencies are found, the Office of Health Care Quality shall require the program to submit a written plan of correction within 15 working days.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#C(2)">(2)</span> Deficiencies in a New Program. If a new program with deficiencies:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#C(2)(a)">(a)</span> Fails to submit a plan of correction, the Office of Health Care Quality shall considered the application withdrawn; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#C(2)(b)">(b)</span> Submits a plan of correction that the Office of Health Care Quality believes:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#C(2)(b)(i)">(i)</span> Corrects the deficiencies, the Office of Health Care Quality shall recommend the Administration grant the program initial certification; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#C(2)(b)(ii)">(ii)</span> Does not correct the deficiencies, the Office of Health Care Quality may issue a denial or permit the program to submit an additional plan of correction.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#C(3)">(3)</span> Deficiencies in a Program Being Renewed. If a renewal program with deficiencies:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#C(3)(a)">(a)</span> Fails to submit a plan of correction, the Office of Health Care Quality may recommend disciplinary action; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#C(3)(b)">(b)</span> Submits a plan of correction which the Office of Health Care Quality believes:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#C(3)(b)(i)">(i)</span> Corrects the deficiencies, the Office of Health Care Quality shall recommend the Administration grant the program general certification;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#C(3)(b)(ii)">(ii)</span> Does not immediately correct the deficiencies but which brings the program into compliance within 4 months, the Office of Health Care Quality may recommend a provisional certification; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#C(3)(b)(iii)">(iii)</span> Cannot bring the program into compliance within 4 months, the Office of Health Care Quality may recommend disciplinary action, or request another plan of correction.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#C(4)">(4)</span> No Deficiencies. If no deficiencies are found, the Office of Health Care Quality shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#C(4)(a)">(a)</span> For new applicants, recommend an initial certification; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#C(4)(b)">(b)</span> For renewal applicants, recommend general certification.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#D">D.</span> Site Visit and Written Report After Issuing Initial or Provisional Certificate.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#D(1)">(1)</span> Within 4 months after the issuance of an initial certification or provisional certification, the Office of Health Care Quality shall conduct a site visit and submit a written report.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#D(2)">(2)</span> Deficiencies in a Program with Initial Certification. If deficiencies are found, the Office of Health Care Quality shall require the program to submit a plan of correction within 15 days. If the program:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#D(2)(a)">(a)</span> Fails to submit a plan of correction, the Office of Health Care Quality may recommend disciplinary action; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#D(2)(b)">(b)</span> Submits a plan of correction which the Office of Health Care Quality believes:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#D(2)(b)(i)">(i)</span> Corrects the deficiencies, the Office of Health Care Quality shall recommend the Administration grant the program general certification;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#D(2)(b)(ii)">(ii)</span> Does not immediately correct the deficiencies but which brings the program into compliance within 4 months, the Office of Health Care Quality may recommend a provisional certification; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#D(2)(b)(iii)">(iii)</span> Cannot bring the program into compliance within 4 months, the Office of Health Care Quality may recommend disciplinary action, or request another plan of correction.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#D(3)">(3)</span> Deficiencies in a Program with Provisional Certification. The Office of Health Care Quality shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#D(3)(a)">(a)</span> For good cause, permit the program to submit a plan of correction within 15 days and follow <a class="internal-link " href="/us/md/exec/comar/10.47.04.05#C(1)" title="">§C(1) of this regulation</a>; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#D(3)(b)">(b)</span> Recommend disciplinary action.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#D(4)">(4)</span> No Deficiencies. If no deficiencies are found, the Office of Health Care Quality shall recommend a general certification.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.04.05#E">E.</span> In considering a renewal application, the Administration may accept accreditation of the program by an accreditation organization approved in accordance with Health-General Article, §19-2302(a) and (b), Annotated Code of Maryland, in lieu of the site visit and written report by the Office of Health Care Quality that is otherwise required by this regulation.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.04.06" data-order="|10|47|04|.06|" data-ref-path="10|47|04|.06" class="h__section">.06 Waiver and Variances.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.04.06#A">A.</span> Upon written request by the program, the Director shall issue a written decision which may:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.06#A(1)">(1)</span> Grant a variance or waiver from a regulation if the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.06#A(1)(a)">(a)</span> Variance or waiver would not endanger the life or safety of a patient in a program; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.06#A(1)(b)">(b)</span> Intent of the regulation to which a variance or waiver is sought meets the alternative proposed by the program; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.06#A(2)">(2)</span> Deny the variance or waiver.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.04.06#B">B.</span> The Director may grant a variance or waiver that:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.06#B(1)">(1)</span> Remains in effect for as long as the program continues to comply with the conditions under which the variance or waiver is granted; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.06#B(2)">(2)</span> Is time limited.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.04.06#C">C.</span> The program is responsible for maintaining a copy of the decision in its certification file.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.04.07" data-order="|10|47|04|.07|" data-ref-path="10|47|04|.07" class="h__section">.07 Investigation or Inspection by the Administration or Office of Health Care Quality.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.04.07#A">A.</span> A program shall be open at all reasonable times for announced and unannounced inspections or investigations by the Administration or its designees.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.04.07#B">B.</span> A program shall be open at all reasonable times for announced and unannounced inspections or investigations by the Office of Health Care Quality.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.04.08" data-order="|10|47|04|.08|" data-ref-path="10|47|04|.08" class="h__section">.08 Denial, Probation, Intermediate Sanctions, Suspension, or Revocation.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#A">A.</span> If an applicant or program fails to comply with the applicable State and federal laws, rules, or regulations, the Director may:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#A(1)">(1)</span> Deny approval to the applicant; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#A(2)">(2)</span> Take disciplinary action, such as:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#A(2)(a)">(a)</span> Placing the program on probation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#A(2)(b)">(b)</span> Suspending or revoking the certification of the program; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#A(2)(c)">(c)</span> Imposing intermediate sanctions on the program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#B">B.</span> For purposes of <a class="internal-link " href="/us/md/exec/comar/10.47.04.08#A" title="">§A of this regulation</a>, intermediate sanctions include:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#B(1)">(1)</span> A directed plan of correction, if the program is directed to take a specific action by a certain date;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#B(2)">(2)</span> A mandatory staffing pattern that is stricter than that required under the appropriate level of care required under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.02" title="Chapter 02 Specific Program Requirements">COMAR 10.47.02</a>, if the Administration defines for the program the level of individual supervision;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#B(3)">(3)</span> Mandatory training, if the Administration identifies deficient areas in which training is needed;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#B(4)">(4)</span> Patient relocation, if the Administration reserves the right to relocate a patient to another program in order to protect the health and safety of the patient;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#B(5)">(5)</span> Expansion ban, if the Administration retains the authority to prohibit the program from obtaining additional sites, admitting individuals, or providing additional services at the site;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#B(6)">(6)</span> Imposition of an intensive monitoring protocol by the Administration; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#B(7)">(7)</span> Imposition of a temporary site monitor, if the Administration maintains an ongoing physical presence for the purpose of providing assistance and evaluating the extent of the program's corrective actions.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#C">C.</span> If the Director proposes to deny approval to an applicant or to take disciplinary action against a program, the Director shall give written notice to the governing body or the health officer and the administrator of the program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#D">D.</span> In the written notice under <a class="internal-link " href="/us/md/exec/comar/10.47.04.08#C" title="">§C of this regulation</a>, the Director shall include:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#D(1)">(1)</span> The statutory and regulatory authority upon which the proposed action is based;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#D(2)">(2)</span> The facts supporting the alleged violation of law; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#D(3)">(3)</span> The applicant's or program's right to a hearing before final action under <a class="internal-link " href="/us/md/exec/comar/10.47.04.08#F" title="">§F of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#E">E.</span> Summary Suspension.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#E(1)">(1)</span> Under the <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-226" title="">State Government Article, §10-226(c)(2), Annotated Code of Maryland</a>, and if appropriate, after a predeprivation hearing, the Director may summarily order the suspension of a certification if the Administration finds that the public health, safety, or welfare imperatively requires emergency action.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#E(2)">(2)</span> The Director shall notify the program in writing of the suspension, findings, and reasons that support the findings, and, if appropriate, the opportunity for a predeprivation hearing. The notice shall include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#E(2)(a)">(a)</span> The proposed order for summary suspension which includes:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#E(2)(a)(i)">(i)</span> The statutory and regulatory authority upon which the order is based;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#E(2)(a)(ii)">(ii)</span> The facts supporting the alleged violations of law;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#E(2)(a)(iii)">(iii)</span> The facts supporting the belief that there is an imminent danger to the health, safety, and welfare of individuals; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#E(2)(a)(iv)">(iv)</span> The program's right to appeal the summary suspension, if executed by the Director; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#E(2)(b)">(b)</span> A show cause notice providing an opportunity for the program to show cause as to why an order under §C(1) of this regulation should not be issued.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#E(3)">(3)</span> The Director may suspend an approval without prior notice and the opportunity to be heard if:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#E(3)(a)">(a)</span> The Director determines that the health, welfare, and safety of the public imperatively requires immediate suspension;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#E(3)(b)">(b)</span> Notice of an opportunity to be heard before the action is not feasible; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#E(3)(c)">(c)</span> The Administration provides the program with a post-deprivation hearing opportunity within 15 working days of the suspension.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#E(4)">(4)</span> The Administration shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#E(4)(a)">(a)</span> Notify the individuals being served by the program and, if appropriate, their families or proponents, regarding the summary suspension; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#E(4)(b)">(b)</span> Assist the individuals in finding alternative services if the approval is summarily suspended.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#F">F.</span> Procedures for Hearings.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#F(1)">(1)</span> If the Director proposes to deny an approval or take disciplinary action against a program, the Director shall give the program written notice according to <a class="internal-link " href="/us/md/exec/comar/10.47.04.08#D" title="">§D of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#F(2)">(2)</span> Within 10 working days of receipt of the notice, the governing body or health officer may file a written request for a hearing with the Office of Administrative Hearings and send copies of the request to the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#F(2)(a)">(a)</span> Director; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#F(2)(b)">(b)</span> Administrative prosecutor.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#F(3)">(3)</span> If the governing body or the health officer does not file a request for a hearing within 10 working days of receipt of the notification, the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#F(3)(a)">(a)</span> Program waives its right to request a hearing; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#F(3)(b)">(b)</span> Director may implement the proposed action.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#F(4)">(4)</span> If a timely request for a hearing has been received, the Office of Administrative Hearings shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#F(4)(a)">(a)</span> Notify the Director, the governing body or health officer, and administrative prosecutor of the date, time, and location of the hearing; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#F(4)(b)">(b)</span> In accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/28.02.01" title="Chapter 01 Rules of Procedure">COMAR 28.02.01</a>, hold a hearing and, unless the final decision is delegated to the Office of Administrative Hearings, render a proposed decision to the Director.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#F(5)">(5)</span> After giving the parties the opportunity to file exceptions under the provisions of <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-216" title="">State Government Article, §10-216, Annotated Code of Maryland</a>, the Director shall issue a final decision and send notice to the governing body or the health officer.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#F(6)">(6)</span> A program may appeal any final decision from a contested case by following the provisions of Health-General Article, §2-207, Annotated Code of Maryland, and <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gsg/gsg.pdf" title="">State Government Article, Title 10, Subtitle 2, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#F(7)">(7)</span> In addition to disposing of a case by a hearing, the Director may dispose of a contested case by:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#F(7)(a)">(a)</span> Stipulation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#F(7)(b)">(b)</span> Settlement;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#F(7)(c)">(c)</span> Consent order;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#F(7)(d)">(d)</span> Default;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#F(7)(e)">(e)</span> Withdrawal;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#F(7)(f)">(f)</span> Summary disposition; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.04.08#F(7)(g)">(g)</span> Dismissal.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.47.05" data-order="|10|47|05|" data-ref-path="10|47|05" class="h__chapter">Chapter 05 Education Programs</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: June 10, 2002 (29:11 Md. R. 882)</p>
                  <p>——————</p>
                  <p>Chapter recodified from <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.04" title="Chapter 04 Certification Requirements">COMAR 10.47.04</a> to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.05" title="Chapter 05 Education Programs">10.47.05</a> as an emergency provision effective April 1, 2008 (35:9 Md. R. 894); recodified permanently effective May 5, 2008 (35:9 Md. R. 898)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.05.01" title=".01 Scope.">Regulation .01</a> amended as an emergency provision effective April 1, 2008 (35:9 Md. R. 894); amended permanently effective May 5, 2008 (35:9 Md. R. 898)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.05.04" title=".04 Program Requirements.">Regulation .04</a> amended as an emergency provision effective April 1, 2008 (35:9 Md. R. 894); amended permanently effective May 5, 2008 (35:9 Md. R. 898)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.05.05" title=".05 Denial, Probation, Intermediate Sanctions, Suspension, or Revocation.">Regulation .05</a> amended as an emergency provision effective April 1, 2008 (35:9 Md. R. 894); amended permanently effective May 5, 2008 (35:9 Md. R. 898)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §§8-401 — 8-405 and 19-308, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.47.05.01" data-order="|10|47|05|.01|" data-ref-path="10|47|05|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter sets forth additional requirements that a program shall meet as a private or public education program for individuals convicted under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gtr&amp;section=21-902" title="">Transportation Article, §21-902, Annotated Code of Maryland</a>, and ordered to attend an education program.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.05.02" data-order="|10|47|05|.02|" data-ref-path="10|47|05|.02" class="h__section">.02 Definitions.</h3>
                <p>In this chapter, terms have the meanings set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.02" title=".02 Definitions.">COMAR 10.47.01.02</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.05.03" data-order="|10|47|05|.03|" data-ref-path="10|47|05|.03" class="h__section">.03 Application Process and Evaluation.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.05.03#A">A.</span> The applicant shall complete an application on a form approved by the Administration and submit the application and documentation to indicate the applicant is in compliance with the requirements of this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.05.03#B">B.</span> After the Administration receives the application the Administration shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.03#B(1)">(1)</span> Return the application if it is incomplete; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.03#B(2)">(2)</span> Arrange a site visit.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.05.03#C">C.</span> After the site visit, the Administration shall</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.03#C(1)">(1)</span> Grant approval;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.03#C(2)">(2)</span> Grant approval with conditions; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.03#C(3)">(3)</span> Deny approval.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.05.04" data-order="|10|47|05|.04|" data-ref-path="10|47|05|.04" class="h__section">.04 Program Requirements.</h3>
                <p>The program shall:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.05.04#A">A.</span> Comply with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01" title="Chapter 01 Requirements">COMAR 10.47.01</a> and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.02.03" title=".03 Early Intervention Level 0.5.">10.47.02.03</a>;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.05.04#B">B.</span> At minimum, offer six weekly 2-hour sessions for a total of 12 hours;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.05.04#C">C.</span> Have instructors approved by the Administration who are:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.04#C(1)">(1)</span> Instructors before October 1, 2002; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.04#C(2)">(2)</span> At a minimum, certified as a Certified Supervised Counselor-Alcohol and Drug, as defined by <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 17, Annotated Code of Maryland</a>;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.05.04#D">D.</span> Ensure that staff is appropriately credentialed and privileged to teach the curriculum;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.05.04#E">E.</span> Teach the Administration's curriculum or an equivalent curriculum approved by the Administration, which covers:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.04#E(1)">(1)</span> Scope of drinking-driver problem;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.04#E(2)">(2)</span> Drinking driver patterns and characteristics;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.04#E(3)">(3)</span> The pharmacology of substance abuse;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.04#E(4)">(4)</span> The process of addiction to drugs and alcohol;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.04#E(5)">(5)</span> The relationship of substance use to crime, health, family, and other social problems; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.04#E(6)">(6)</span> Treatment resources; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.05.04#F">F.</span> Report to the court or probation agent as specified by the court order.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.05.05" data-order="|10|47|05|.05|" data-ref-path="10|47|05|.05" class="h__section">.05 Denial, Probation, Intermediate Sanctions, Suspension, or Revocation.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#A">A.</span> If an applicant or Program fails to comply with the applicable State and federal laws, rules, or regulations, the Director may:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#A(1)">(1)</span> Deny approval to the applicant; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#A(2)">(2)</span> Take disciplinary action, such as:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#A(2)(a)">(a)</span> Placing the program on probation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#A(2)(b)">(b)</span> Suspending or revoking the certification of the program; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#A(2)(c)">(c)</span> Imposing intermediate sanctions on the program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#B">B.</span> For purposes of <a class="internal-link " href="/us/md/exec/comar/10.47.05.05#A" title="">§A of this regulation</a>, intermediate sanctions include:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#B(1)">(1)</span> A directed plan of correction, if the program is directed to take a specific action by a certain date;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#B(2)">(2)</span> A mandatory staffing pattern that is stricter than that required under the appropriate level of care in these regulations, if the Administration defines for the program the level of individual supervision;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#B(3)">(3)</span> Mandatory training, if the Administration identifies deficient areas in which training is needed;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#B(4)">(4)</span> Expansion ban, if the Administration retains the authority to prohibit the program from obtaining additional sites, admitting individuals, or providing additional services at the site;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#B(5)">(5)</span> Imposition of an intensive monitoring protocol by the Administration; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#B(6)">(6)</span> Imposition of a temporary site monitor, if the Administration maintains an ongoing physical presence for the purpose of providing assistance and evaluating the extent of the program's corrective actions.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#C">C.</span> If the Director proposes to deny approval to an applicant or to take disciplinary action against a program, the Director shall give written notice to the health officer or executive director of the program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#D">D.</span> In the written notice under <a class="internal-link " href="/us/md/exec/comar/10.47.05.05#C" title="">§C of this regulation</a>, the Director shall include:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#D(1)">(1)</span> The statutory and regulatory authority upon which the proposed action is based;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#D(2)">(2)</span> The facts supporting the alleged violation of law; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#D(3)">(3)</span> The applicant's or program's right to a hearing before final action under <a class="internal-link " href="/us/md/exec/comar/10.47.05.05#F" title="">§F of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#E">E.</span> Summary Suspension.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#E(1)">(1)</span> Under the <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-226" title="">State Government Article, §10-226(c)(2), Annotated Code of Maryland</a>, and if appropriate, after a predeprivation hearing, the Director may summarily order the suspension of the approval if the Administration finds that the public health, safety, or welfare imperatively requires emergency action.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#E(2)">(2)</span> The Director shall notify the program in writing of the suspension, findings, and reasons that support the findings, and, if appropriate, the opportunity for a predeprivation hearing. The notice shall include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#E(2)(a)">(a)</span> The proposed order for summary suspension which includes:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#E(2)(a)(i)">(i)</span> The statutory and regulatory authority upon which the order is based;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#E(2)(a)(ii)">(ii)</span> The facts supporting the alleged violations of law;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#E(2)(a)(iii)">(iii)</span> The facts supporting the belief that there is an imminent danger to the health, safety, and welfare of individuals; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#E(2)(a)(iv)">(iv)</span> The program's right to appeal the summary suspension, if executed by the Director; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#E(2)(b)">(b)</span> A show cause notice providing an opportunity for the program to show cause as to why the order may not be issued if the public health, safety, and welfare permits.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#E(3)">(3)</span> The Director may suspend approval without prior notice and the opportunity to be heard if:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#E(3)(a)">(a)</span> The Director determines that the health, welfare, and safety of the public imperatively requires immediate suspension;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#E(3)(b)">(b)</span> Notice of an opportunity to be heard before the action is not feasible; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#E(3)(c)">(c)</span> The Administration provides the program with a post-deprivation hearing opportunity within 15 working days of the suspension.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#F">F.</span> Procedures for Hearings.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#F(1)">(1)</span> If the Director proposes to deny an approval or take disciplinary action against a program, the Director shall give the program written notice according to <a class="internal-link " href="/us/md/exec/comar/10.47.05.05#C" title="">§C of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#F(2)">(2)</span> Within 10 working days of receipt of the notice, the executive director or health officer may file a written request for a hearing with the Office of Administrative Hearings and send copies of the request to the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#F(2)(a)">(a)</span> Director; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#F(2)(b)">(b)</span> Administrative prosecutor.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#F(3)">(3)</span> If the executive director or health officer does not file a request for a hearing within 10 working days of receipt of the notification, the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#F(3)(a)">(a)</span> Program waives its right to request a hearing; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#F(3)(b)">(b)</span> Director may implement the proposed action.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#F(4)">(4)</span> If a timely request for a hearing has been received, the Office of Administrative Hearings shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#F(4)(a)">(a)</span> Notify the Director, the executive director or health officer, and administrative prosecutor of the date, time, and location of the hearing; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#F(4)(b)">(b)</span> In accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/28.02.01" title="Chapter 01 Rules of Procedure">COMAR 28.02.01</a>, hold a hearing and, unless the final decision is delegated to the Office of Administrative Hearings, render a proposed decision to the Director.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#F(5)">(5)</span> After giving the parties the opportunity to file exceptions under the provisions of <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-216" title="">State Government Article, §10-216, Annotated Code of Maryland</a>, the Director shall issue a final decision and send notice to the governing body or the health officer.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#F(6)">(6)</span> A program may appeal any final decision from a contested case by following the provisions of Health-General Article, §2-207, and <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gsg/gsg.pdf" title="">State Government Article, Title 10, Subtitle 2, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#F(7)">(7)</span> In addition to disposing of a case by a hearing, the Director may dispose of a contested case by:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#F(7)(a)">(a)</span> Stipulation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#F(7)(b)">(b)</span> Settlement;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#F(7)(c)">(c)</span> Consent order;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#F(7)(d)">(d)</span> Default;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#F(7)(e)">(e)</span> Withdrawal;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#F(7)(f)">(f)</span> Summary disposition; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.05.05#F(7)(g)">(g)</span> Dismissal.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.47.06" data-order="|10|47|06|" data-ref-path="10|47|06" class="h__chapter">Chapter 06 Substance Abuse Treatment Outcomes Partnerships — (S.T.O.P.) Fund</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date:</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.06.01" title=".01 Scope.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.06.04" title=".04 Fiscal Responsibility by Jurisdiction.">.04</a> adopted as an emergency provision effective January 30, 2001 (28:3 Md. R. 203); adopted permanently effective April 30, 2001 (28:8 Md. R. 762)</p>
                  <p>——————</p>
                  <p>——————</p>
                  <p>Chapter recodified from <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.03" title="Chapter 03 Specific Program Requirements for Correctional Levels of Care">COMAR 10.47.03</a> to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.05" title="Chapter 05 Education Programs">10.47.05</a> effective June 10, 2002 (29:11 Md. R. 882)</p>
                  <p>Chapter recodified from <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.05" title="Chapter 05 Education Programs">10.47.05</a> to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.06" title="Chapter 06 Substance Abuse Treatment Outcomes Partnerships — (S.T.O.P.) Fund">10.47.06</a> as an emergency provision effective April 1, 2008 (35:9 Md. R. 894); recodified permanently effective May 5, 2008 (35:9 Md. R. 898)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.06.02#B" title="">Regulation .02B</a> amended effective August 15, 2016 (43:16 Md. R. 901)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.06.03" title=".03 Requests for Partnership Funding and Criteria for Awarding Funding.">Regulation .03</a> amended effective August 15, 2016 (43:16 Md. R. 901)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.06.04#D" title="">Regulation .04D</a> adopted effective August 15, 2016 (43:16 Md. R. 901)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §§8-6C-01 — 8-6C-04, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.47.06.01" data-order="|10|47|06|.01|" data-ref-path="10|47|06|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter specifies the requirements for applying for funding from the Substance Abuse Treatment Outcomes Partnership Fund. This chapter establishes time lines and procedures for requests for partnership funding, guidelines that require programs to bill third-party insurers, and fund management including, but not limited to, authorization of distribution of money.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.06.02" data-order="|10|47|06|.02|" data-ref-path="10|47|06|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#B(1)">(1)</span> "Department" means the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#B(2)">(2)</span> “Eligible functions” means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#B(2)(a)">(a)</span> Transportation to and from treatment services;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#B(2)(b)">(b)</span> Treatment, prevention, or coordination staff;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#B(2)(c)">(c)</span> Data sharing services among counties and other appropriate treatment providers;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#B(2)(d)">(d)</span> Education or outreach programs and materials;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#B(2)(e)">(e)</span> In-community emergency behavioral health services or crisis stabilization units; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#B(2)(f)">(f)</span> Behavioral health programs in schools.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#B(3)">(3)</span> "Eligible population" means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#B(3)(a)">(a)</span> Mothers of drug-addicted infants;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#B(3)(b)">(b)</span> Parents of children in need of assistance;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#B(3)(c)">(c)</span> Hospital emergency room admittees;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#B(3)(d)">(d)</span> Needy families receiving temporary cash assistance;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#B(3)(e)">(e)</span> Foster care children and parents;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#B(3)(f)">(f)</span> Children in after-school programs and their parents, including children and parents in programs supported by the Maryland After-School Opportunity Fund;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#B(3)(g)">(g)</span> Adolescents;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#B(3)(h)">(h)</span> Parents subject to arrearages in child support payments;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#B(3)(i)">(i)</span> Drug offenders under the supervision of the Division of Parole and Probation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#B(3)(j)">(j)</span> Pretrial correctional inmates;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#B(3)(k)">(k)</span> Prerelease correctional inmates;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#B(3)(l)">(l)</span> The general inmate population within county-managed correctional facilities;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#B(3)(m)">(m)</span> Parents of children entering out-of-home placements or at risk of entering out-of-home placements; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#B(3)(n)">(n)</span> Drug offenders under the supervision of the problem solving courts.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#B(4)">(4)</span> "Jurisdiction" means Baltimore City or one of the 23 counties in Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#B(5)">(5)</span> "Partnership funding" means money granted from the Substance Abuse Treatment Outcomes Partnership Fund.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#B(6)">(6)</span> "Proposal" means a plan under this chapter to provide new or expanded substance abuse treatment services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#B(7)">(7)</span> “Request for partnership funding” means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#B(7)(a)">(a)</span> A proposal, submitted by the governing bodies of one or more jurisdictions, to provide substance-related disorder treatment services to one or more eligible populations; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#B(7)(b)">(b)</span> To provide funding for eligible functions within the requesting jurisdiction or jurisdictions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.06.02#B(8)">(8)</span> "Task Force" means the Task Force to Study Increasing the Availability of Substance Abuse Programs.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.06.03" data-order="|10|47|06|.03|" data-ref-path="10|47|06|.03" class="h__section">.03 Requests for Partnership Funding and Criteria for Awarding Funding.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.06.03#A">A.</span> Requests for partnership funding may be submitted to the Department by:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.06.03#A(1)">(1)</span> The governing body of a jurisdiction or its designee; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.06.03#A(2)">(2)</span> The governing bodies of more than one jurisdiction or their designee.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.06.03#B">B.</span> Proposals shall include the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.06.03#B(1)">(1)</span> Identification of one or more eligible populations per jurisdiction;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.06.03#B(2)">(2)</span> Eligible functions that will be funded under the plan;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.06.03#B(3)">(3)</span> A description of the plan to provide substance-related disorder services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.06.03#B(4)">(4)</span> Identification of local providers able to provide these services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.06.03#B(5)">(5)</span> A plan to reach the eligible populations using relevant means of contact;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.06.03#B(6)">(6)</span> Performance and outcome indicators to evaluate the program effectiveness including a description of the expected schedule and methods for measuring performance and outcome;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.06.03#B(7)">(7)</span> A plan to bill third-party insurers;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.06.03#B(8)">(8)</span> A prepared annual expenditure plan which reflects all anticipated income including partnership funding, local, third party, and cash revenue to the partnership program; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.06.03#B(9)">(9)</span> A statement of the local cash match or local in-kind match, including but not limited to provision of space, staff, or services, that the applicant intends to commit to the effort.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.06.03#C">C.</span> Time Line. Requests for partnership funding shall be received by the Department by April 1 for the following fiscal year.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.06.03#D">D.</span> The Department shall consider the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.06.03#D(1)">(1)</span> Performance and outcome indicators specified;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.06.03#D(2)">(2)</span> The degree to which the proposal may reduce the need for other State or local public services or programs intended for the populations targeted by the proposal;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.06.03#D(3)">(3)</span> The extent to which the proposal incorporates the use of excess or otherwise available medical-related facilities, including vacant hospital beds;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.06.03#D(4)">(4)</span> How the proposal fits into a balanced approach to the State’s variety of substance-related disorder needs and populations that serve different geographic areas of the State with partnership funding;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.06.03#D(5)">(5)</span> The extent to which the proposal is part of or consistent with a regional strategy for substance-related disorder treatment programs affecting adjoining jurisdictions; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.06.03#D(6)">(6)</span> Other factors consistent with Health-General Article, §8-6C-04, Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.06.03#E">E.</span> The Department may specify in a request for proposals the types of treatment services that are eligible for funding awards.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.06.04" data-order="|10|47|06|.04|" data-ref-path="10|47|06|.04" class="h__section">.04 Fiscal Responsibility by Jurisdiction.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.06.04#A">A.</span> The Department may award partnership funding that results in a county being responsible for less than 1/2 of the cost of the approved partnership funding after considering:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.06.04#A(1)">(1)</span> The financial hardship of the participating county;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.06.04#A(2)">(2)</span> Prior and current contributions of funds for substance abuse treatment programs made by the participating county; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.06.04#A(3)">(3)</span> Other relevant considerations considered appropriate by the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.06.04#B">B.</span> A participating jurisdiction shall use partnership funding only to supplement levels of spending by the participating jurisdiction on drug treatment programs.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.06.04#C">C.</span> A participating jurisdiction may not use partnership funding to supplant spending by the participating jurisdiction on drug treatment programs.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.06.04#D">D.</span> A participating jurisdiction may use partnership funding to continue or expand funding for eligible functions if the participating jurisdiction began spending funds on eligible functions after October 1, 2010.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.47.07" data-order="|10|47|07|" data-ref-path="10|47|07" class="h__chapter">Chapter 07 Prescription Drug Monitoring Program</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: January 7, 2013 (39:26 Md. R. 1665)</p>
                  <p>Regulation .04H amended effective October 28, 2013 (40:21 Md. R. 1775)</p>
                  <p>Regulation .08D amended effective October 28, 2013 (40:21 Md. R. 1775)</p>
                  <p>——————</p>
                  <p>Chapter revised effective June 8, 2015 (42:11 Md. R.725)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.07.02#B" title="">Regulation .02B</a> amended effective October 8, 2018 (45:20 Md. R. 918); May 18, 2020 (47:10 Md. R. 519); July 20, 2023 (50:8 Md. R. 338)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.07.03" title=".03 Dispenser Reporting.">Regulation .03</a> amended effective July 20, 2023 (50:8 Md. R. 338)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.07.03#B" title="">Regulation .03B</a>, F amended effective October 8, 2018 (45:20 Md. R. 918)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.07.04" title=".04 Review of Prescription Monitoring Data.">Regulation .04</a> amended effective May 18, 2020 (47:10 Md. R. 519)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.07.04#A" title="">Regulation .04A</a> amended effective July 20, 2023 (50:8 Md. R. 338)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.07.05" title=".05 Disclosure of Prescription Monitoring Data.">Regulation .05</a> amended effective February 29, 2016 (43:4 Md. R. 332); October 8, 2018 (45:20 Md. R. 918); May 18, 2020 (47:10 Md. R. 519)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.07.05#D" title="">Regulation .05D</a>, F amended effective July 20, 2023 (50:8 Md. R. 338)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.07.05" title=".05 Disclosure of Prescription Monitoring Data.">Regulation .05</a>-1 adopted effective July 20, 2023 (50:8 Md. R. 338)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.07.06#A" title="">Regulation .06A</a> amended effective October 8, 2018 (45:20 Md. R. 918)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.07.07#A" title="">Regulation .07A</a>, C amended effective July 20, 2023 (50:8 Md. R. 338)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.07.08" title=".08 Penalties and Sanctions.">Regulation .08</a> amended effective July 20, 2023 (50:8 Md. R. 338)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.07.08#C" title="">Regulation .08C</a> amended effective October 8, 2018 (45:20 Md. R. 918)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.07.09" title=".09 General Provisions.">Regulation .09</a> amended effective July 20, 2023 (50:8 Md. R. 338)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.07.09#C" title="">Regulation .09C</a>—E amended effective October 8, 2018 (45:20 Md. R. 918)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, Title 21, Subtitle 2A, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.47.07.01" data-order="|10|47|07|.01|" data-ref-path="10|47|07|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter sets forth the requirements for monitoring the prescribing and dispensing of controlled dangerous substances under the Prescription Drug Monitoring Program.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.07.02" data-order="|10|47|07|.02|" data-ref-path="10|47|07|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(1)">(1)</span> “Authorized user” means a licensed prescriber, a prescriber delegate, a licensed pharmacist, a pharmacist delegate, or a licensed health care practitioner registered with another state’s prescription drug monitoring program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(2)">(2)</span> “Business day” means any day except Saturday, Sunday, or a holiday on which State offices are closed.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(3)">(3)</span> “Dispense” has the meaning stated in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-101" title="">Health Occupations Article, §12-101, Annotated Code of Maryland</a>, but does not include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(3)(a)">(a)</span> Directly administering a monitored prescription drug to a patient; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(3)(b)">(b)</span> Giving a patient prescription drug samples in accordance with <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-102" title="">Health Occupations Article, §12-102(d), Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(4)">(4)</span> Dispenser.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(4)(a)">(a)</span> “Dispenser” means person authorized by law to dispense a monitored prescription drug to a patient or a patient’s agent in the State, including a nonresident pharmacy so authorized.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(4)(b)">(b)</span> “Dispenser” does not include:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(4)(b)(i)">(i)</span> A licensed hospital pharmacy that only dispenses a monitored prescription drug for direct administration to an inpatient of the hospital;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(4)(b)(ii)">(ii)</span> An opioid treatment services program;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(4)(b)(iii)">(iii)</span> A veterinarian licensed under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gag/gag.pdf" title="">Agriculture Article, Title 2, Subtitle 3, Annotated Code of Maryland</a>, when prescribing controlled substances for animals in the usual course of providing professional services;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(4)(b)(iv)">(iv)</span> A pharmacy issued a waiver permit under COMAR 10.34.17.03 that provides pharmaceutical specialty services exclusively to persons living in assisted living facilities, comprehensive care facilities, and developmental disabilities facilities; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(4)(b)(v)">(v)</span> A pharmacy issued a waiver from reporting dispensing of monitored prescription drugs to hospice inpatients under <a class="internal-link " href="/us/md/exec/comar/10.47.07.03#G" title="">Regulation .03G of this chapter</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(5)">(5)</span> “Existing bona fide individual investigation” means an active and good faith investigation of an identified prescriber, dispenser, or patient for possible violations falling under the jurisdiction of the requesting governmental unit or agency.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(6)">(6)</span> “Existing bona fide investigation” means an active and good faith investigation of identified prescribers, dispensers, or patients for possible violations falling under the jurisdiction of the requesting governmental unit or agency.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(7)">(7)</span> “Licensed health care practitioner” means an individual who is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(7)(a)">(a)</span> Licensed, certified, or registered under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Annotated Code of Maryland</a>, or the laws of the practitioner’s respective state, as appropriate, to provide health care services; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(7)(b)">(b)</span> Authorized by a prescriber or pharmacist to access prescription monitoring data in connection with the medical care of a patient to whom the prescriber prescribes or the pharmacist dispenses a monitored prescription drug.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(8)">(8)</span> “Licensing entity” means an entity authorized under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Annotated Code of Maryland</a>, to license, regulate, or discipline a prescriber or pharmacist.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(9)">(9)</span> “Medical director” means an individual who is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(9)(a)">(a)</span> A prescriber; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(9)(b)">(b)</span> Employed by or under contract with a health care facility and serves as that facility’s chief medical officer or in an equivalent role.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(10)">(10)</span> Monitored Prescription Drug.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(10)(a)">(a)</span> “Monitored prescription drug” means a prescription drug that contains a Schedule II, Schedule III, Schedule IV, or Schedule V controlled dangerous substance designated under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gcr/gcr.pdf" title="">Criminal Law Article, Title 5, Subtitle 4, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(10)(b)">(b)</span> “Monitored prescription drug” does not include naloxone medication.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(11)">(11)</span> “Naloxone medication” means an opioid antagonist approved by the federal Food and Drug Administration for the reversal of an opioid overdose.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(12)">(12)</span> “Naloxone medication data” means the information required to be submitted to the Program when dispensing naloxone medication</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(13)">(13)</span> “Office” means the Office of Controlled Substances Administration in the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(14)">(14)</span> “Opioid treatment services program” means a program that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(14)(a)">(a)</span> Is certified by the State under Health-General Article, §8-401, Annotated Code of Maryland or licensed by the State under Health-General Article, §7.5-401, Annotated Code of Maryland;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(14)(b)">(b)</span> Is authorized to treat patients with opioid dependence with a medication approved by the federal Food and Drug Administration for opioid dependence;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(14)(c)">(c)</span> Complies with:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(14)(c)(i)">(i)</span> The Code of Federal Regulations 42, Part 8;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(14)(c)(ii)">(ii)</span> <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.02.11" title=".11 Opioid Maintenance Therapy.">COMAR 10.47.02.11</a>; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(14)(c)(iii)">(iii)</span> Requirements for the secure storage and accounting of opioid medication imposed by the federal Drug Enforcement Administration and the State Division of Drug Control; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(14)(d)">(d)</span> Has been granted a certification for operation by the Department, the federal Substance Abuse and Mental Health Services Administration, and the Federal Center for Substance Abuse Treatment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(15)">(15)</span> “Patient” means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(15)(a)">(a)</span> An individual for whom a prescriber has prescribed or is considering prescribing a monitored prescription drug; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(15)(b)">(b)</span> An individual for whom a pharmacist has dispensed or is considering dispensing a monitored prescription drug.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(16)">(16)</span> “Pharmacist” means an individual who is licensed under Health-Occupations Article, Title 12, Annotated Code of Maryland, to dispense a monitored prescription drug.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(17)">(17)</span> “Pharmacist delegate” means an individual who is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(17)(a)">(a)</span> Authorized by a registered pharmacist to request or access prescription monitoring data; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(17)(b)">(b)</span> Employed by or under contract with the same professional practice as the registered pharmacist.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(18)">(18)</span> “Prescriber” means a practitioner:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(18)(a)">(a)</span> Lawfully authorized to prescribe a monitored prescription drug; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(18)(b)">(b)</span> Legally authorized to prescribe a monitored prescription drug under an institutional DEA registration;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(19)">(19)</span> “Prescriber delegate” means an individual who is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(19)(a)">(a)</span> Authorized by a registered prescriber to request or access prescription monitoring data; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(19)(b)">(b)</span> Employed by or under contract with the same professional practice as the registered prescriber.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(20)">(20)</span> “Prescription drug” has the meaning stated in Health-General Article, §21-201, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(21)">(21)</span> “Prescription monitoring data” means the information submitted to the program for a monitored prescription drug.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(22)">(22)</span> “Program” means the Prescription Drug Monitoring Program established under Health-General Article, Title 21, Subtitle 2A, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(23)">(23)</span> “Registered” means a person registered with the Program to request or access prescription monitoring data for clinical use.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(24)">(24)</span> “Rehabilitation program under a health occupations board” means a group, committee, or program recognized by a licensing entity that provides assistance to a licensed health care practitioner in need of treatment and rehabilitation for alcoholism, drug abuse, chemical dependency, or other physical, emotional, or mental condition.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(25)">(25)</span> “Technical Advisory Committee” means the Technical Advisory Committee established by Health-General Article, §21-2A-07, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.02#B(26)">(26)</span> “Zero report” means an electronic report submitted by a dispenser to the Program to confirm that no monitored prescription drugs were dispensed during the reporting time frame.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.07.03" data-order="|10|47|07|.03|" data-ref-path="10|47|07|.03" class="h__section">.03 Dispenser Reporting.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A">A.</span> For each monitored prescription drug and naloxone medication dispensed, the dispenser shall report data elements required by American Society for Automation in Pharmacy (ASAP) standards in addition to the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(1)">(1)</span> Identifying information for the prescription issued and drug dispensed, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(1)(a)">(a)</span> Prescription number;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(1)(b)">(b)</span> Date prescription was issued;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(1)(c)">(c)</span> Date prescription was filled;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(1)(d)">(d)</span> Whether the prescription was new or a refill;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(1)(e)">(e)</span> Number of refills ordered;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(1)(f)">(f)</span> Sources of payment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(1)(g)">(g)</span> National Drug Code for dispensed drug;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(1)(h)">(h)</span> Metric quantity of drug dispensed and units;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(1)(i)">(i)</span> Days’ supply of drug dispensed; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(1)(j)">(j)</span> Date prescription was sold;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(2)">(2)</span> Identifying information for the patient or animal owner or handler, as appropriate, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(2)(a)">(a)</span> Last name;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(2)(b)">(b)</span> First name;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(2)(c)">(c)</span> Date of birth;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(2)(d)">(d)</span> Gender;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(2)(e)">(e)</span> (text unchanged)</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(2)(f)">(f)</span> Address, including residential house or building number, apartment number, street name, state, and zip code;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(2)(g)">(g)</span> A patient identification number, which may include:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(2)(g)(i)">(i)</span> A state-issued driver’s license or identification card number;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(2)(g)(ii)">(ii)</span> An insurance or third-party payer identification number;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(2)(g)(iii)">(iii)</span> A passport identification number;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(2)(g)(iv)">(iv)</span> An employer-issued identification card number;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(2)(g)(v)">(v)</span> A student identification card number;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(2)(g)(vi)">(vi)</span> A United States Permanent Resident Card identification number; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(2)(g)(vii)">(vii)</span> A patient or customer identification number generated by the dispenser’s record management system;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(2)(h)">(h)</span> ID qualifier; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(2)(i)">(i)</span> Species indication;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(3)">(3)</span> First and Last name for the prescriber, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(3)(a)">(a)</span> For prescription monitoring data, a valid Drug Enforcement Administration registration number; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(3)(b)">(b)</span> For naloxone medication data, a valid National Provider Identifier;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(4)">(4)</span> Identifying information for the dispenser, including a valid Drug Enforcement Administration registration number; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#A(5)">(5)</span> Additional data elements consistent with the standards established by the ASAP.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#B">B.</span> Reporting Deadline.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#B(1)">(1)</span> A dispenser shall report prescription monitoring data and naloxone medication data to the Department to include zero reports at least once every 24 hours and in accordance with procedures developed by the Department and approved by the Advisory Board on Prescription Drug Monitoring.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#B(2)">(2)</span> A dispenser that suffers a mechanical, electrical, or other technical failure that, as a direct consequence, precludes the dispenser’s ability to report prescription monitoring data or naloxone medication data electronically shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#B(2)(a)">(a)</span> Notify the Department, by a communications method approved by the Department, within 24 hours of discovery of the technical failure; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#B(2)(b)">(b)</span> Submit a report for each monitored prescription drug and naloxone medication dispensed during the period of technical failure as soon as possible, but no later than 24 hours following reestablishment of the means of electronic reporting.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#C">C.</span> Waiver from Reporting Deadline.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#C(1)">(1)</span> At the Secretary’s discretion, a dispenser may be granted a waiver from <a class="internal-link " href="/us/md/exec/comar/10.47.07.03#B" title="">§B of this regulation</a>, provided that the dispenser’s waiver request:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#C(1)(a)">(a)</span> Is submitted on a form or in a method approved by the Department;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#C(1)(b)">(b)</span> Is particular to a unique problem, incident or other issue that prevents the dispenser from meeting the reporting deadline; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#C(1)(c)">(c)</span> Describes in detail and includes any available documentation of the specific circumstances that prevent the dispenser from meeting the reporting deadline.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#C(2)">(2)</span> A dispenser that receives a waiver shall comply with all the terms and conditions enumerated therein, including any new reporting deadline required.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#D">D.</span> Means of Data Submission and Data Format. Prescription monitoring data shall be transmitted to the Department or its agent:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#D(1)">(1)</span> In accordance with any procedures and guidelines established or approved by the Department, including by use of an encrypted electronic transmission method or a secure electronic reporting form; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#D(2)">(2)</span> In a format or utilizing a data standard approved by the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#E">E.</span> Reporting of Incomplete or Inaccurate Data. Data not accepted by the Department or its agent due to inaccuracy or incompleteness shall be corrected and resubmitted to the Department no later than 3 business days after receiving notification from the Department of receipt of incomplete or inaccurate data.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#F">F.</span> Reporting Exemptions. The following shall be exempt from reporting prescription monitoring data to the Program:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#F(1)">(1)</span> A licensed hospital pharmacy that only dispenses a monitored prescription drug for direct administration to an inpatient of the hospital;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#F(2)">(2)</span> An opioid treatment service program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#F(3)">(3)</span> A veterinarian licensed under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gag/gag.pdf" title="">Agriculture Article, Title 2, Subtitle 3, Annotated Code of Maryland</a>, when prescribing controlled substances for animals in the usual course of providing professional services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#F(4)">(4)</span> A pharmacy issued a waiver permit under COMAR 10.34.17.03 that provides pharmaceutical specialty services exclusively to persons living in assisted living facilities, comprehensive care facilities, and developmental disabilities facilities; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#F(5)">(5)</span> Dispensing to hospice inpatients, provided that the dispensing pharmacy has applied for and been granted a waiver by the Department pursuant to <a class="internal-link " href="/us/md/exec/comar/10.47.07.03#G" title="">§G of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#G">G.</span> Waiver for Dispensing to Hospice Inpatients.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#G(1)">(1)</span> On a form or in a manner approved by the Department, a pharmacy may apply to the Department to be granted a waiver from reporting prescription monitoring data or naloxone medication data for dispensing of monitored prescription drugs to hospice inpatients, provided that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#G(1)(a)">(a)</span> The pharmacy demonstrates, through written application, live demonstration, or any other method required by the Department, how it will distinguish dispensing to hospice inpatients from all other dispensing of monitored prescription drugs required to be reported to the Program; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#G(1)(b)">(b)</span> The pharmacy agrees that it will be subject to unannounced, on-site inspections by the Department to verify its reporting of prescription monitoring data and naloxone medication data on customers that are not hospice inpatients.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.03#G(2)">(2)</span> A waiver granted to a pharmacy under this regulation shall remain in effect for 2 years.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.07.04" data-order="|10|47|07|.04|" data-ref-path="10|47|07|.04" class="h__section">.04 Review of Prescription Monitoring Data.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.04#A">A.</span> The Program shall review prescription monitoring data and naloxone medication data for indications of possible:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.04#A(1)">(1)</span> Misuse or abuse of a monitored prescription drug; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.04#A(2)">(2)</span> Violations of law or possible breaches of professional standards by a prescriber or a dispenser.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.04#B">B.</span> In determining whether its review indicates a possible violation of law or possible breach of professional standards by a prescriber or dispenser, the Program shall take into account to the extent practicable the particular specialty, circumstances, patient type, and location of the prescriber or dispenser.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.07.05" data-order="|10|47|07|.05|" data-ref-path="10|47|07|.05" class="h__section">.05 Disclosure of Prescription Monitoring Data.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#A">A.</span> Registration of a Prescriber, a Prescriber Delegate, a Pharmacist, a Pharmacist Delegate, or a Licensed Health Care Practitioner to Request Prescription Monitoring Data.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#A(1)">(1)</span> A prescriber, a prescriber delegate, a pharmacist, a pharmacist delegate, or a licensed health care practitioner shall register with the Department or its agent, in a manner specified by the Department, in order to request disclosure of or otherwise access prescription monitoring data.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#A(2)">(2)</span> The Department or its agent shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#A(2)(a)">(a)</span> Establish procedures to authenticate a prescriber, a dispenser, or an authorized licensed health care practitioner in accordance with Health-General Article, §21-2A-06(b)(1)—(2), Annotated Code of Maryland; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#A(2)(b)">(b)</span> Issue credentials to a prescriber, a prescriber delegate, a pharmacist, or a pharmacist delegate that can be used to request disclosure of or otherwise access prescription monitoring data electronically.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#A(3)">(3)</span> If the credentials issued to a registrant are lost, stolen, or otherwise compromised, the registrant shall notify the Department or its agent, by a method approved by the Department, as soon as reasonably possible.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#A(4)">(4)</span> A prescriber or pharmacist who authorizes the registration of a licensed health care practitioner, prescriber delegate, or pharmacist delegate to request disclosure of or otherwise access prescription monitoring data shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#A(4)(a)">(a)</span> Make every reasonable effort, including regularly reviewing and auditing any available logs of system access and use, to ensure the prescriber delegate or pharmacist delegate is requesting disclosure of, redisclosing, or otherwise accessing prescription monitoring data in clear compliance with Health-General Article, Title 21, Subtitle 2A, Annotated Code of Maryland, and all other State and federal laws and regulations governing the security and confidentiality of protected health information and personal medical records;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#A(4)(b)">(b)</span> Immediately notify the Department or its agent, by a method approved by the Department, as well as the licensing entity responsible for licensing, certifying, or registering the prescriber delegate, or pharmacist delegate, if applicable, if the prescriber or pharmacist believes that the confidentiality of prescription monitoring data or the security of the Program has been compromised by that individual; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#A(4)(c)">(c)</span> Immediately notify the Department or its agent, by a method approved by the Department, of any requested change in the registration status of a licensed health care practitioner, prescriber delegate, or pharmacist delegate, including if that individual is no longer employed by or practicing under the authority of the prescriber or pharmacist.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#B">B.</span> Disclosure of Prescription Monitoring Data to a Prescriber, a Prescriber Delegate, a Pharmacist, or a Pharmacist Delegate.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#B(1)">(1)</span> Upon request from a prescriber or a licensed health care practitioner or a prescriber delegate authorized by a prescriber, the Program shall disclose patient-specific prescription monitoring data provided that the request is made solely for the purpose of the medical care or treatment of the patient about whom prescription monitoring data is being requested.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#B(2)">(2)</span> Upon request from a prescriber, the Program may provide a report containing prescription monitoring data on all monitored prescription drugs dispensed pursuant to the prescriber’s prescriptions, provided that the request is submitted on a form or in a manner approved by the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#B(3)">(3)</span> Upon request from a pharmacist or a licensed health care practitioner or pharmacist delegate authorized by a pharmacist, the Program shall disclose patient-specific prescription monitoring data provided that the request is made pursuant to a pharmacist’s responsibility to perform due diligence and exercise professional judgment when presented with a prescription to dispense a monitored prescription drug for use by the patient about whom prescription monitoring data is being requested.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#B(4)">(4)</span> The Department or its agent shall make available the electronic means by which a prescriber, a pharmacist, a prescriber delegate, or a pharmacist delegate may request disclosure of or otherwise access patient-specific prescription monitoring data.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#B(5)">(5)</span> If the Program’s review of prescription monitoring data under <a class="internal-link " href="/us/md/exec/comar/10.47.07.04" title=".04 Review of Prescription Monitoring Data.">Regulation .04 of this chapter</a> indicates possible misuse or abuse of a monitored prescription drug, possible violation of law, or possible breach of professional standards by a prescriber or dispenser, the Program shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#B(5)(a)">(a)</span> Report the possible misuse or abuse, possible violation of law, or possible breach of professional standards to the prescriber or dispenser of the monitored prescription drug in a manner and form determined by the Program; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#B(5)(b)">(b)</span> Provide education to the prescriber or dispenser.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#C">C.</span> Disclosure of Prescription Monitoring Data to a Federal, State, or Local Law Enforcement Agency. The Program shall disclose prescription monitoring data to a federal, State, or local law enforcement agency, for the purpose of furthering an existing bona fide individual investigation, on receipt of a subpoena that:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#C(1)">(1)</span> Includes information sufficient to identify the unique prescriber, dispenser, or patient about whom prescription monitoring data is requested;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#C(2)">(2)</span> Specifies the time frame for which prescription monitoring data is requested, including the day, month, and year the report is to begin and end;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#C(3)">(3)</span> Includes an agency case number or other identifier sufficient to identify an existing bona fide individual investigation; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#C(4)">(4)</span> Bears the name, title, and signature of the official under whose authority the subpoena is issued.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#D">D.</span> Disclosure of Prescription Monitoring Data to a Licensing Entity.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#D(1)">(1)</span> The Program shall disclose prescription monitoring data to a licensing entity upon receipt of an administrative subpoena.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#D(2)">(2)</span> The licensing entity shall include in the administrative subpoena:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#D(2)(a)">(a)</span> Information sufficient to identify the unique prescriber<em>,</em> dispenser<em>, </em>or patient about whom prescription monitoring data is requested;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#D(2)(b)">(b)</span> The time frame for which prescription monitoring data is requested, including the day, month, and year the report is to begin and end;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#D(2)(c)">(c)</span> A case number or other identifier sufficient to identify an existing bona fide individual investigation; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#D(2)(d)">(d)</span> The name, title, and original signature of the official under whose authority the subpoena is issued.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#E">E.</span> Disclosure of Prescription Monitoring Data to a Rehabilitation Program under a Health Occupations Board. The Program shall disclose prescription monitoring data to a rehabilitation program under a health occupations board upon receipt of an administrative subpoena that:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#E(1)">(1)</span> Includes information sufficient to identify the unique licensed health care practitioner about whom prescription monitoring data is requested;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#E(2)">(2)</span> Specifies the time frame for which prescription monitoring data is requested, including the day, month, and year the report is to begin and end; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#E(3)">(3)</span> Bears the name, title and original signature of the official under whose authority the subpoena is issued.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#F">F.</span> Disclosure of Prescription Monitoring Data to a Patient or a Patient’s Authorized Representative.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#F(1)">(1)</span> Upon request, the Program shall disclose to a patient 18 years old or older prescription monitoring data about the patient provided that the request is submitted to the Program:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#F(1)(a)">(a)</span> On a completed form approved by the Department that contains a notarized signature of the requester; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#F(1)(b)">(b)</span> In any other manner approved by the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#F(2)">(2)</span> Upon request, the Program shall disclose patient-specific prescription monitoring data to a patient’s authorized representative who is 18 years old or older, including the parent or legal guardian of a minor, an individual with power of attorney, the personal representative of a decedent’s estate, or any other person duly authorized by State law to request or otherwise access medical records on behalf of a patient, provided that the request shall be submitted to the Program:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#F(2)(a)">(a)</span> In person and accompanied by:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#F(2)(a)(i)">(i)</span> A completed form approved by the Department;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#F(2)(a)(ii)">(ii)</span> Valid photo identification issued by a government agency of any jurisdiction of the United States verifying that the patient’s authorized representative is 18 years old or older; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#F(2)(a)(iii)">(iii)</span> An original copy of any form or documentation required by State law or regulation to verify the authority of the representative to request or otherwise access the medical records of a patient on their behalf; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#F(2)(b)">(b)</span> In any other manner approved by the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#F(3)">(3)</span> If a patient, a patient’s authorized representative, or a patient’s prescriber believes that prescription monitoring data relating to the patient’s prescription history is incorrect, the patient, authorized representative, or prescriber may request that the Program correct the data provided that the request:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#F(3)(a)">(a)</span> Is submitted to the Program in writing and on a form or in a manner approved by the Department; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#F(3)(b)">(b)</span> Includes documentation, which may include but not be limited to, a copy of the original prescription and a signed, notarized statement from the prescriber or dispenser that demonstrates which of the specific data elements reported to the Program under <a class="internal-link " href="/us/md/exec/comar/10.47.07.03#A" title="">Regulation .03A of this chapter</a> are incorrect.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#F(4)">(4)</span> Upon determination by the Secretary that prescription monitoring data specific to a patient’s prescription history is incorrect, the Program shall issue a corrected prescription history report to the patient or the patient’s authorized representative.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#G">G.</span> Disclosure of Prescription Monitoring Data to the Office of the Attorney General. The Program shall disclose prescription monitoring data to the Office of the Attorney General, for the purpose of furthering an existing bona fide investigation, on receipt of a subpoena that:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#G(1)">(1)</span> Includes information sufficient to identify the prescribers, dispensers, or patients about whom prescription monitoring data is requested;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#G(2)">(2)</span> Specifies the time frame for which prescription monitoring data is requested, including the day, month, and year the report is to begin and end;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#G(3)">(3)</span> Includes an agency case number or other identifier sufficient to identify an existing bona fide investigation; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#G(4)">(4)</span> Bears the name, title, and signature of the official under whose authority the subpoena is issued.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#H">H.</span> Disclosure of Prescription Monitoring Data to an Authorized User of Another State’s Prescription Drug Monitoring Program or of any Other Authorized Agency.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#H(1)">(1)</span> Upon request, the Program shall disclose prescription monitoring data to an authorized user of another state’s prescription drug monitoring program or an authorized user with any other authorized local, state, territorial, or federal agency in connection with the provision of medical care, provided that the request:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#H(1)(a)">(a)</span> Is submitted in a manner approved by the Department;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#H(1)(b)">(b)</span> Is under the authority of the authorized administrator of that state’s program or authorized agency;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#H(1)(c)">(c)</span> Includes an attestation that prescription monitoring data will only be used or redisclosed in a manner consistent with the provisions of Health-General Article, §21-2A-06, Annotated Code of Maryland, and Regulation .08D of this chapter; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#H(1)(d)">(d)</span> Relates to a patient to whom the authorized user anticipates providing, is providing, or has provided medical care.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#H(2)">(2)</span> The Program may develop and implement interoperability with another state’s prescription drug monitoring program or authorized agency to facilitate the automated exchange of prescription monitoring data provided that a written agreement has been established with the other state’s program or authorized agency specifying that the information technology employed will:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#H(2)(a)">(a)</span> Only disclose prescription monitoring data to authorized users in a manner consistent with the provisions of Health-General Article, §21-2A-06, Annotated Code of Maryland, and this regulation; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#H(2)(b)">(b)</span> Operate in accordance with all other State and federal laws and regulations governing the security and confidentiality of protected health information and personal medical records.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#I">I.</span> Disclosure of Prescription Monitoring Data to Units of the Department. Upon request, the Program may disclose prescription monitoring data to the Maryland Medical Assistance Program, the Office of the Inspector General of the Department, the Office of Health Care Quality, and the Office, provided that the request:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#I(1)">(1)</span> Includes information sufficient to identify the unique individual about whom prescription monitoring data is requested;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#I(2)">(2)</span> Specifies the time frame for which prescription monitoring data is requested, including the day, month and year the report is to begin and end;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#I(3)">(3)</span> Includes a case number or other identifier sufficient to identify an existing bona fide individual investigation; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#I(4)">(4)</span> Is approved by the Secretary.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#J">J.</span> Disclosure of Prescription Monitoring Data to a Medical Director of a Health Care Facility. The Program may disclose prescription monitoring data to the medical director of a health care facility, as defined in Health-General Article, §19-114, Annotated Code of Maryland, or the medical director’s designee for the purpose of providing health care practitioners employed or contractually employed at the health care facility access to the prescription monitoring data in connection with the provision of medical care or the dispensing of a monitored prescription drug to an individual who receives health care at the health care facility and on whom a medical record is maintained at the health care facility, provided that the health care facility:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#J(1)">(1)</span> Is licensed by the Department of Health or is operated by the federal government or a federally recognized Indian tribe;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#J(2)">(2)</span> Has an active participation agreement with the State’s Health Information Exchange;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#J(3)">(3)</span> Operates in accordance with all other State and federal laws and regulations governing the security and confidentiality of protected health information and personal medical records; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#J(4)">(4)</span> Can provide an audit trail of the facility’s staff access to the prescription monitoring data to the Department upon request.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#K">K.</span> Disclosure of Prescription Monitoring Data to the Office of the Chief Medical Examiner.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#K(1)">(1)</span> Upon request from the Office of Chief Medical Examiner, the Program shall disclose decedent-specific prescription monitoring data, provided that the request is made solely for the purpose of carrying out duties authorized under Health-General Article, §5-309, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#K(2)">(2)</span> The Program shall determine the electronic means by which the Office of the Chief Medical Examiner may request disclosure of or otherwise access decedent-specific prescription monitoring data.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#L">L.</span> Disclosure of Prescription Monitoring Data to Case Review Entities.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#L(1)">(1)</span> Upon request, the Program may disclose prescription monitoring data to the following case review entities for the purposes of furthering an existing bona fide individual case review:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#L(1)(a)">(a)</span> The State Child Fatality Review Team or a local child fatality review team as defined in Health-General Article, §5-701, Annotated Code of Maryland, upon request from the chair of the State or local team;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#L(1)(b)">(b)</span> A local drug overdose fatality review team as described in Health-General Article, §5-902, Annotated Code of Maryland, upon request from the chair of the local team;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#L(1)(c)">(c)</span> The Maternal Mortality Review Program, as defined in Health-General Article, §13-1203, Annotated Code of Maryland, on request from the Program; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#L(1)(d)">(d)</span> A medical review committee described in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=1-401" title="">Health Occupations Article, §1-401(b)(3), Annotated Code of Maryland</a>, upon request from the committee.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#L(2)">(2)</span> The request shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#L(2)(a)">(a)</span> Include information sufficient to identify the unique individual about whom prescription monitoring data is requested;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#L(2)(b)">(b)</span> Specify the time frame for which prescription monitoring data is requested, including the day, month, and year the report is to begin and end;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#L(2)(c)">(c)</span> Include a case number or other identifier sufficient to identify an existing bona fide individual case review; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#L(2)(d)">(d)</span> Be approved by the Secretary.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#M">M.</span> Disclosure of Prescription Monitoring Data for Research, Analysis, Education, and Public Reporting.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#M(1)">(1)</span> The Program may disclose prescription monitoring data for research, analysis, education, and public reporting:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#M(1)(a)">(a)</span> In response to requests determined by the Department to be consistent with institutional review board protocols and human subjects research protections;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#M(1)(b)">(b)</span> Upon approval by the Department of a written proposal or abstract explaining the purpose and scope of the research, analysis, education, and public reporting; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#M(1)(c)">(c)</span> After redaction of all information that could identify a patient, prescriber, dispenser, or any other individual.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#M(2)">(2)</span> The Secretary may waive the requirement of <a class="internal-link " href="/us/md/exec/comar/10.47.07.05#M(1)(b)" title="">§M(1)(b) of this regulation</a> for requests from units of the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#N">N.</span> Technical Advisory Committee Review.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#N(1)">(1)</span> Before the Program discloses prescription monitoring data under §§C—E, H, and I of this regulation, the Technical Advisory Committee may:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#N(1)(a)">(a)</span> Review the request for disclosure; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#N(1)(b)">(b)</span> Within 10 business days of submission of the request to the Technical Advisory Committee for review, submit to the Program, in written form, clinical guidance and interpretation of the prescription monitoring data requested to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#N(1)(b)(i)">(i)</span> Assist the Secretary’s decision on how to respond to a judicial subpoena, administrative subpoena, or other request; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#N(1)(b)(ii)">(ii)</span> Be made available for use by the recipient of prescription monitoring data should the request for disclosure be authorized.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#N(2)">(2)</span> Notwithstanding <a class="internal-link " href="/us/md/exec/comar/10.47.07.05#N(1)" title="">§N(1) of this regulation</a>, the Program may disclose prescription monitoring data to the authorized administrator of another state’s prescription drug monitoring program or authorized agency for disclosure to an authorized user in a manner consistent with <a class="internal-link " href="/us/md/exec/comar/10.47.07.05#H" title="">§H of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#N(3)">(3)</span> Before the Program discloses prescription monitoring data to a prescriber or dispenser under <a class="internal-link " href="/us/md/exec/comar/10.47.07.05#B(5)" title="">§B(5) of this regulation</a>, the Technical Advisory Committee:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#N(3)(a)">(a)</span> For indications of possible misuse or abuse, may provide clinical guidance and interpretation of the prescription monitoring data that indicates possible misuse or abuse; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#N(3)(b)">(b)</span> For indications of possible violations of law or breach of professional standards, shall provide clinical guidance regarding the method used and advise whether the method identifies possible violations of law or breach of professional standards.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#N(4)">(4)</span> If the Technical Advisory Committee has not provided clinical guidance and interpretation in accordance with §N(1) or (3) of this regulation within 10 business days of submission of the request or data to the Technical Advisory Committee for review, the Program may proceed as if the Technical Advisory Committee does not have clinical guidance or interpretation to provide regarding the request, data, or method at issue.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#N(5)">(5)</span> Before making a referral to the Office in accordance with <a class="internal-link " href="/us/md/exec/comar/10.47.07.05#O" title="">Regulation .05O of this chapter</a>, the Program shall provide to the Technical Advisory Committee notice and an opportunity to make recommendations within 10 business days on the referral.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#N(6)">(6)</span> If the Technical Advisory Committee has not provided recommendations within 10 business days under <a class="internal-link " href="/us/md/exec/comar/10.47.07.05#N(5)" title="">§N(5) of this regulation</a>, the Program may proceed as if the Technical Advisory Committee does not have clinical guidance or interpretation to provide.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#N(7)">(7)</span> The Department shall establish procedures, which may include but not be limited to secure electronic messaging, for the timely disclosure of prescription monitoring data to the Technical Advisory Committee and the receipt of responses from the Technical Advisory Committee to ensure that the review process is conducted with all possible expediency.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#N(8)">(8)</span> For all purposes, including but not limited to confidentiality, security, redisclosure, and admissibility as evidence, Program reports based on evaluation of prescription monitoring data and that contain individual identifying information shall be considered as one and the same with the prescription monitoring data.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#O">O.</span> Disclosure of Prescription Monitoring Data to the Office. The Program may disclose prescription monitoring data and make a referral to the Office about a possible violation of law or possible breach of professional standards by a prescriber or dispenser as identified under <a class="internal-link " href="/us/md/exec/comar/10.47.07.04" title=".04 Review of Prescription Monitoring Data.">Regulation .04 of this chapter</a>, if the Program:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#O(1)">(1)</span> Determines the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#O(1)(a)">(a)</span> Outreach and education provided was inadequate to address the possible breach or violation; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#O(1)(b)">(b)</span> Outreach and education would be inadequate to address the possible violations of law or a possible breach of professional standards;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#O(2)">(2)</span> Provides notice and an opportunity to the Technical Advisory Committee to make recommendations within 10 business days regarding interpretation of the prescription monitoring data;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#O(3)">(3)</span> Provides the recommendations, if any, of the Technical Advisory Committee to the Office; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05#O(4)">(4)</span> Notifies the prescriber or the dispenser that the prescription monitoring data will be provided to the Office for further investigation.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.07.05-1" data-order="|10|47|07|.05-1|" data-ref-path="10|47|07|.05-1" class="h__section">.05-1 Disclosure of Naloxone Medication Data.</h3>
                <p>Disclosure of Naloxone Medication Data for Public Health Surveillance, Research, Analysis, Education, and Public Reporting.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05-1#A">A.</span> The Program shall disclose naloxone medication data for research, analysis, education, and public reporting:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05-1#A(1)">(1)</span> Upon approval by the Department of a written proposal or abstract explaining the purpose and scope of the research, analysis, education, and public reporting; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05-1#A(2)">(2)</span> After redaction of all information that could identify a patient, prescriber, dispenser, or any other individual.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05-1#B">B.</span> The Secretary may waive the requirement of <a class="internal-link " href="/us/md/exec/comar/10.47.07.05-1#A(1)" title="">§A(1) of this regulation</a> for requests from units of the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05-1#C">C.</span> The Program may disclose de-identified naloxone medication data for public health surveillance purposes.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.05-1#D">D.</span> The Program may not disclose identifiable naloxone medication data to any entity, including but not limited to prescribers or dispensers.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.07.06" data-order="|10|47|07|.06|" data-ref-path="10|47|07|.06" class="h__section">.06 Notice to Patients.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.06#A">A.</span> Pharmacists.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.06#A(1)">(1)</span> Any pharmacist who intends to request prescription monitoring data from the Program may post a sign that can be easily viewed by the public at the place where the prescription is delivered to the pharmacist.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.06#A(2)">(2)</span> The sign shall disclose to the public that the pharmacist may access prescription monitoring data on a patient for whom a prescription for a monitored prescription drug is presented.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.06#A(3)">(3)</span> In lieu of posting a sign, the pharmacist may provide such notice in written material provided to the patient.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.06#B">B.</span> Prescriber.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.06#B(1)">(1)</span> Any prescriber who intends to request prescription monitoring data from the Program may post a sign that can be easily viewed by the public that discloses to the public that the prescriber may access prescription monitoring data on a patient.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.06#B(2)">(2)</span> In lieu of posting a sign, the prescriber may provide such notice in written material provided to the patient.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.07.07" data-order="|10|47|07|.07|" data-ref-path="10|47|07|.07" class="h__section">.07 Confidentiality.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.07#A">A.</span> Prescription monitoring data and naloxone medication data are confidential, privileged, not subject to discovery, subpoena, or other means of legal compulsion in civil litigation, and are not public records.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.07#B">B.</span> The Program shall ensure that confidential or privileged patient information be kept confidential and that records or information protected by a privilege between a health care provider and a patient, or otherwise required by law to be held confidential, be filed in a manner that, except as otherwise provided in Health-General Article, §21-2A-06, Annotated Code of Maryland, and <a class="internal-link " href="/us/md/exec/comar/10.47.07.04" title=".04 Review of Prescription Monitoring Data.">Regulation .04 of this chapter</a>, does not disclose the identity of the person protected.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.07#C">C.</span> The Program shall periodically conduct an audit review of prescription monitoring data and naloxone medication data and disclosure requests to ensure compliance with <a class="internal-link " href="/us/md/exec/comar/10.47.07.07#B" title="">§B of this regulation</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.07.08" data-order="|10|47|07|.08|" data-ref-path="10|47|07|.08" class="h__section">.08 Penalties and Sanctions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.08#A">A.</span> Civil Penalties. A dispenser who knowingly fails to submit prescription monitoring data or naloxone medication data to the Program as required by <a class="internal-link " href="/us/md/exec/comar/10.47.07.03" title=".03 Dispenser Reporting.">Regulation .03 of this chapter</a> shall be subject to a civil penalty not exceeding $500 for each failure to submit required information.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.08#B">B.</span> Criminal Penalties. A person who knowingly discloses, uses, obtains, or attempts to obtain by fraud or deceit prescription monitoring data or naloxone medication data in violation of in Health-General Article, §21-2A, Annotated Code of Maryland, shall be guilty of a misdemeanor and on conviction is subject to imprisonment not exceeding 1 year or a fine not exceeding $10,000 or both.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.08#C">C.</span> Administrative Sanctions. A prescriber or pharmacist who knowingly discloses or uses prescription monitoring data or naloxone medication data in violation of Health-General Article, §21-2A, Annotated Code of Maryland shall be subject to disciplinary action by the appropriate licensing entity.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.07.09" data-order="|10|47|07|.09|" data-ref-path="10|47|07|.09" class="h__section">.09 General Provisions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.09#A">A.</span> The Program shall make available the information technology necessary for dispensers to report prescription monitoring data and naloxone medication data to the Program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.09#B">B.</span> The Program may not impose any fees or other assessments on prescribers or dispensers to support the operation of the Program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.09#C">C.</span> A prescriber or pharmacist, when acting in good faith, is not subject to liability or disciplinary action arising solely from:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.09#C(1)">(1)</span> Requesting or receiving prescription monitoring data from the Program; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.09#C(2)">(2)</span> Acting, or failing to act, on the basis of prescription monitoring data provided by the Program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.09#D">D.</span> Redisclosure of Prescription Monitoring Data.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.09#D(1)">(1)</span> Prescription monitoring data received under Health-General Article, §21-2A-06, Annotated Code of Maryland, and <a class="internal-link " href="/us/md/exec/comar/10.47.07.05" title=".05 Disclosure of Prescription Monitoring Data.">Regulation .05 of this chapter</a> may be redisclosed only:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.09#D(1)(a)">(a)</span> In a manner consistent with the Health Insurance Portability and Accountability Act of 1996 (HIPAA), 42 U.S.C. §1320d et seq., as amended, and all other State and federal laws and regulations governing the security and confidentiality of protected health information and personal medical records; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.07.09#D(1)(b)">(b)</span> For entities to which the Program has disclosed data, in furtherance of an existing, bona fide, individual investigation to another agency cooperating with or providing support to the original data.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.09#D(2)">(2)</span> The release of prescription monitoring data by a prescriber or pharmacist to a licensed health care professional solely for treatment purposes in a manner otherwise consistent with State and federal law is not a violation of Health-General Article, Title 21, Subtitle 2A, Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.09#E">E.</span> Redisclosure of Naloxone Medication Data. Naloxone medication data received under Health-General Article, §21-2A-6.1, Annotated Code of Maryland, and Regulation .05-1 of this chapter may be redisclosed only in a manner consistent with the Health Insurance Portability and Accountability Act of 1996 (HIPAA), 42 U.S.C. §1320d et seq., as amended, and all other State and federal laws and regulations governing the security and confidentiality of protected health information and personal medical records.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.09#F">F.</span> The Program shall retain prescription monitoring data and naloxone medication data for 5 years from the date of receipt.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.07.09#G">G.</span> A member of the Technical Advisory Committee:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.09#G(1)">(1)</span> Shall serve for a term of 3 years from the date of appointment; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.07.09#G(2)">(2)</span> May be reappointed at the discretion of the Secretary.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.47.08" data-order="|10|47|08|" data-ref-path="10|47|08" class="h__chapter">Chapter 08 Overdose Response Program</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: March 3, 2014 (41:4 Md. R. 301)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.08.02#B" title="">Regulation .02B</a> amended effective April 13, 2015 (42:7 Md. R. 570)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.08.03#A" title="">Regulation .03A</a>, D amended effective April 13, 2015 (42:7 Md. R. 570)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.08.04#A" title="">Regulation .04A</a> amended effective April 13, 2015 (42:7 Md. R. 570)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.08.05" title=".05 Naloxone Use.">Regulation .05</a> amended effective April 13, 2015 (42:7 Md. R. 570)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.08.08#C" title="">Regulation .08C</a> amended effective April 13, 2015 (42:7 Md. R. 570)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.08.10#B" title="">Regulation .10B</a>, C amended effective April 13, 2015 (42:7 Md. R. 570)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.08.10#D" title="">Regulation .10D</a>  adopted effective April 13, 2015 (42:7 Md. R. 570)</p>
                  <p>——————</p>
                  <p>——————</p>
                  <p>Chapter revised effective September 12, 2016 (43:18 Md. R. 1017)</p>
                  <p>Chapter revised effective October 7, 2019 (46:20 Md. R. 845)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, Title 13, Subtitle 31, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.47.08.01" data-order="|10|47|08|.01|" data-ref-path="10|47|08|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter sets forth the requirements for the Overdose Response Program administered by the Department for the purpose of providing a means of training individuals to administer naloxone to an individual experiencing, or believed to be experiencing, opioid overdose to help prevent a fatality when medical services are not immediately available.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.08.02" data-order="|10|47|08|.02|" data-ref-path="10|47|08|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.02#B(1)">(1)</span> “Department” means the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.02#B(2)">(2)</span> “Education and training program” means educational instruction in opioid overdose recognition and response and the administration of naloxone.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.02#B(3)">(3)</span> “Emergency medical services” means the Statewide comprehensive system of emergency medical care.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.02#B(4)">(4)</span> “Health care provider” means an individual licensed or certified under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Annotated Code of Maryland</a>, or <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=ged&amp;section=13-516" title="">Education Article, §13-516, Annotated Code of Maryland</a>, to provide health care services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.02#B(5)">(5)</span> “Naloxone” means an opioid antagonist medication used to counter the effects of an opioid overdose.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.02#B(6)">(6)</span> “Pharmacist” means an individual licensed to practice pharmacy in Maryland under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 12, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.02#B(7)">(7)</span> “Private or Public Entity” means a health care provider, local health department, community-based organization, substance use disorder treatment organization, or other person that addresses medical or social issues related to drug addiction.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.02#B(8)">(8)</span> “Standing order” means a written instruction for the prescribing and dispensing of naloxone in accordance with Health-General Article, Title 13, Subtitle 31, Annotated Code of Maryland.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.08.03" data-order="|10|47|08|.03|" data-ref-path="10|47|08|.03" class="h__section">.03 Authorization of a Private or Public Entity.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#A">A.</span> Application for Authorization. A private or public entity that seeks to conduct education and training programs under Health-General Article, Title 13, Subtitle 31, Annotated Code of Maryland, shall submit to the Department:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#A(1)">(1)</span> A completed application form containing all identifying information for the private or public entity that is required by the Department, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#A(1)(a)">(a)</span> Entity name;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#A(1)(b)">(b)</span> Type of entity based on categories supplied by the Department;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#A(1)(c)">(c)</span> Entity address;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#A(1)(d)">(d)</span> Entity telephone number;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#A(1)(e)">(e)</span> Entity email address;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#A(1)(f)">(f)</span> Name of Entity Director;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#A(1)(g)">(g)</span> Name of Training Program Director; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#A(1)(h)">(h)</span> Any additional information as requested by the Department;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#A(2)">(2)</span> For a public or private entity intending to provide naloxone:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#A(2)(a)">(a)</span> A copy of a written agreement between a health care provider with prescribing authority and the private or public entity for the prescribing and dispensing of naloxone;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#A(2)(b)">(b)</span> Identifying information for the health care provider with prescribing authority including:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#A(2)(b)(i)">(i)</span> Name;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#A(2)(b)(ii)">(ii)</span> Title;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#A(2)(b)(iii)">(iii)</span> Address;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#A(2)(b)(iv)">(iv)</span> Phone number;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#A(2)(b)(v)">(v)</span> Email address; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#A(2)(b)(vi)">(vi)</span> State license number; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#A(2)(c)">(c)</span> If applicable, a copy of the entity’s dispensing protocols for naloxone;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#A(3)">(3)</span> A description of ancillary topics to be covered in addition to the core educational training curriculum provided by the Department pursuant to <a class="internal-link " href="/us/md/exec/comar/10.47.08.04#A(2)" title="">Regulation .04A(2) of this chapter</a>, and copies of any training materials to be used during instruction;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#A(4)">(4)</span> Any other information required by the Department; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#A(5)">(5)</span> Any fee required by the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#B">B.</span> Approval of Applications. Upon approval of an application for authorization, the Department shall issue to the private or public entity a form that includes:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#B(1)">(1)</span> The name of the private or public entity and its director;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#B(2)">(2)</span> A statement that the private or public entity is authorized by the Department to conduct education and training programs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#B(3)">(3)</span> A serial number;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#B(4)">(4)</span> The date of the approval of the authorization; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#B(5)">(5)</span> The date of the expiration of the authorization.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#C">C.</span> Term of Authorization. An authorization under this chapter shall be valid for 2 years.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#D">D.</span> Notification of Significant Change of Information. An authorized private or public entity shall notify the Department in writing of any significant change in the information that was submitted in the application for authorization under §A(1)—(5) of this chapter within 30 days of such change.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#E">E.</span> Authorization Renewal.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#E(1)">(1)</span> An authorized private or public entity may apply to the Department for renewal of its authorization to conduct education and training programs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#E(2)">(2)</span> An authorized private or public entity shall submit to the Department a completed renewal application form, along with any fee required by the Department, on a schedule set by the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#E(3)">(3)</span> The Department may request additional information from the private or public entity as necessary to render a decision on the renewal application.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#E(4)">(4)</span> If the Department finds, after review of the application for authorization renewal, that the private or public entity is in compliance with the requirements for initial authorization set forth in this chapter, the Department shall issue a renewal authorization form to the private or public entity that includes the information set forth in <a class="internal-link " href="/us/md/exec/comar/10.47.08.03#B" title="">§B of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#E(5)">(5)</span> An authorization renewal under this chapter shall be valid for 2 years.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#F">F.</span> Expiration without Renewal. The Department may require a private or public entity whose authorization has expired without renewal to reapply for initial authorization as required under <a class="internal-link " href="/us/md/exec/comar/10.47.08.03#A" title="">§A of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.03#G">G.</span> Maintenance of Records. The Department shall maintain a record of each authorized private or public entity, including all information submitted by the private or public entity in the initial application for authorization and any additional information provided in an application for authorization renewal.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.08.04" data-order="|10|47|08|.04|" data-ref-path="10|47|08|.04" class="h__section">.04 Education and Training Programs.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.04#A">A.</span> A private or public entity authorized by the Department:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.04#A(1)">(1)</span> Shall offer an education and training program on opioid overdose recognition and response; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.04#A(2)">(2)</span> May provide access to naloxone.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.04#B">B.</span> Education and training shall include a core curriculum provided by the Department. The core curriculum shall include:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.04#B(1)">(1)</span> Education on recognizing the symptoms and signs of an opioid overdose;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.04#B(2)">(2)</span> Training on responding to an opioid overdose;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.04#B(3)">(3)</span> The proper use and administration of naloxone;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.04#B(4)">(4)</span> Proper rescue breathing technique;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.04#B(5)">(5)</span> The importance of contacting emergency medical services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.04#B(6)">(6)</span> The care of an individual after the administration of naloxone; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.04#B(7)">(7)</span> Any other topic required by the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.04#C">C.</span> The Department may approve multiple core curricula:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.04#C(1)">(1)</span> For use in training specific populations;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.04#C(2)">(2)</span> For delivery in specific settings; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.04#C(3)">(3)</span> Based on other relevant factors.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.04#D">D.</span> Education and training may include any other relevant topic at the discretion of the authorized private or public entity conducting the education and training.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.04#E">E.</span> A private or public entity authorized by the Department under this chapter may offer a training program online.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.08.05" data-order="|10|47|08|.05|" data-ref-path="10|47|08|.05" class="h__section">.05 Naloxone Use.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.05#A">A.</span> An individual of any age may receive from any health care provider with prescribing authority a prescription for naloxone and the necessary supplies for the administration of naloxone.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.05#B">B.</span> An individual for whom naloxone is prescribed and dispensed in accordance with this chapter may:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.05#B(1)">(1)</span> Possess prescribed naloxone and the necessary supplies for the administration of naloxone; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.05#B(2)">(2)</span> In an emergency situation when medical services are not immediately available, administer naloxone to an individual experiencing or believed by the individual to be experiencing an opioid overdose.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.05#C">C.</span> An individual who, in accordance with Health-General Article, Title 13, Subtitle 31, Annotated Code of Maryland, and this regulation, is administering naloxone to an individual experiencing, or believed by the individual to be experiencing an opioid overdose, may not be considered to be practicing:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.05#C(1)">(1)</span> Medicine for the purposes of <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 14, Annotated Code of Maryland</a>; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.05#C(2)">(2)</span> Registered nursing for the purposes of <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 8, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.05#D">D.</span> An individual may report information on the administration of naloxone by the individual, overdose reversals, and other program outcomes to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.05#D(1)">(1)</span> The private and public entity that provided training;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.05#D(2)">(2)</span> The Maryland Poison Center;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.05#D(3)">(3)</span> The Department; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.05#D(4)">(4)</span> Any other entity identified by the Department.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.08.06" data-order="|10|47|08|.06|" data-ref-path="10|47|08|.06" class="h__section">.06 Naloxone Prescribing and Dispensing.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.06#A">A.</span> A healthcare provider with prescribing authority may prescribe and dispense naloxone to an individual of any age who:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.06#A(1)">(1)</span> Is believed by the health care provider to be at risk of experiencing an opioid overdose; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.06#A(2)">(2)</span> Is in a position to assist an individual at risk of experiencing an opioid overdose.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.06#B">B.</span> A health care provider with prescribing authority may prescribe and dispense naloxone by issuing a standing order if the health care provider:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.06#B(1)">(1)</span> Is employed by the department or a local health department; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.06#B(2)">(2)</span> Has a written agreement with an authorized private or public entity under Health-General Article, §13-3104, Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.06#C">C.</span> A health care provider with prescribing authority who issues a standing order may delegate the dispensing of naloxone to an employee or a volunteer of an authorized private or public entity in accordance with a written agreement under Health-General Article, §13-3104, Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.06#D">D.</span> A health care provider who has dispensing authority also may dispense naloxone to any individual of any age in accordance with a standing order issued by a health care provider in accordance with Health-General Article, §13-3106, Annotated Code of Maryland.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.08.07" data-order="|10|47|08|.07|" data-ref-path="10|47|08|.07" class="h__section">.07 Denial, Suspension, and Revocation of Authorization of a Private or Public Entity.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.07#A">A.</span> If the Department determines that a private or public entity has failed to comply with the requirements of this chapter, the Department may initiate one or more of the following actions against the private or public entity:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.07#A(1)">(1)</span> Denial of an initial application for authorization;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.07#A(2)">(2)</span> Denial of an application for authorization renewal;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.07#A(3)">(3)</span> Suspension of the authorization of the private or public entity; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.07#A(4)">(4)</span> Revocation of authorization of the private or public entity.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.07#B">B.</span> Notification to Applicant or Private or Public Entity.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.07#B(1)">(1)</span> The Department shall notify an applicant or private or public entity in writing of the denial of initial application for authorization, denial of application for authorization renewal, suspension of authorization, or revocation of authorization.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.07#B(2)">(2)</span> The written notice shall include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.07#B(2)(a)">(a)</span> The reason for the action taken;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.07#B(2)(b)">(b)</span> The effective date of the action;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.07#B(2)(c)">(c)</span> The procedure for appeal of the decision to deny an initial application for, or to suspend, revoke, or not renew the authorization of, a private or public entity; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.07#B(2)(d)">(d)</span> Notification that the private or public entity may file an appeal of the Department’s decision and that any such appeal shall be filed within 10 days of receipt of the notice.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.07#C">C.</span> Summary Suspension.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.07#C(1)">(1)</span> Under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-226" title="">State Government Article, §10-226(c), Annotated Code of Maryland</a>, the Department may summarily suspend the authorization of a private or public entity if the Department finds that the public health, safety, or welfare imperatively requires emergency action.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.07#C(2)">(2)</span> From the time of receipt of the notice of summary suspension, the private or public entity may not:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.07#C(2)(a)">(a)</span> Conduct an education and training program; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.07#C(2)(b)">(b)</span> Provide access to naloxone.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.07#D">D.</span> Reinstatement of Authorization after Suspension. The Department may lift the suspension and reinstate authorization of a private or public entity if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.07#D(1)">(1)</span> The private or public entity submits in writing to the Department a request for the reinstatement that documents how the conditions leading to the suspension have been remedied or corrected; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.07#D(2)">(2)</span> The Department verifies that the conditions leading to the suspension have been remedied or corrected.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.07#E">E.</span> Application after Revocation. After authorization of a private or public entity has been revoked for a period of 12 months, the former authorized entity may reapply for authorization approval pursuant to the process set forth in <a class="internal-link " href="/us/md/exec/comar/10.47.08.03" title=".03 Authorization of a Private or Public Entity.">Regulation .03 of this chapter</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.08.08" data-order="|10|47|08|.08|" data-ref-path="10|47|08|.08" class="h__section">.08 Appeals.</h3>
                <p>A private or public entity may request a hearing on an action taken by the Department pursuant to <a class="internal-link " href="/us/md/exec/comar/10.47.08.07" title=".07 Denial, Suspension, and Revocation of Authorization of a Private or Public Entity.">Regulation .07 of this chapter</a> as allowed by:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.08#A">A.</span> <a class="internal-link no-wrap" href="/us/md/exec/comar/10.01.03" title="Chapter 03 Procedures for Hearings Before the Secretary of Health">COMAR 10.01.03</a>;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.08#B">B.</span> <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gsg/gsg.pdf" title="">State Government Article, Title 10, Subtitle 2, Annotated Code of Maryland</a>; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.08#C">C.</span> Health-General Article, Title 2, Subtitle 2, Annotated Code of Maryland.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.08.09" data-order="|10|47|08|.09|" data-ref-path="10|47|08|.09" class="h__section">.09 Record Maintenance and Reporting.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#A">A.</span> The Department shall maintain the following records:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#A(1)">(1)</span> Information on private or public entities authorized by the Department, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#A(1)(a)">(a)</span> Names of entities and directors;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#A(1)(b)">(b)</span> Addresses of entities;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#A(1)(c)">(c)</span> Serial numbers of the initial authorizations;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#A(1)(d)">(d)</span> Initial authorization dates; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#A(1)(e)">(e)</span> Dates of authorization renewals; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#A(2)">(2)</span> Information on private or public entities whose authorization has been suspended or revoked, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#A(2)(a)">(a)</span> Names of entities and directors;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#A(2)(b)">(b)</span> Addresses of entities;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#A(2)(c)">(c)</span> Serial numbers of the initial authorizations;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#A(2)(d)">(d)</span> Effective dates of suspensions or revocations;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#A(2)(e)">(e)</span> Reasons for suspensions or revocations; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#A(2)(f)">(f)</span> If applicable, dates on which the approvals for authorization were reinstated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#B">B.</span> If providing naloxone, a private or public entity authorized by the Department shall maintain records for each individual who has been provided naloxone, including:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#B(1)">(1)</span> Full name of individual;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#B(2)">(2)</span> Name of prescriber;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#B(3)">(3)</span> Name and address of dispenser;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#B(4)">(4)</span> Date of dispensing; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#B(5)">(5)</span> Type and dosage of naloxone dispensed.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#C">C.</span> Reporting Information to the Department. A private or public entity authorized by the Department shall report to the Department:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#C(1)">(1)</span> Information on program operations, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#C(1)(a)">(a)</span> Number of individuals who have completed education and training programs;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#C(1)(b)">(b)</span> For private or public entities authorized by the Department that provide naloxone directly or by means of a voucher for redemption at a pharmacy:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#C(1)(b)(i)">(i)</span> Form of naloxone dispensed;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#C(1)(b)(ii)">(ii)</span> Number of initial doses of naloxone dispensed; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#C(1)(b)(iii)">(iii)</span> Number of naloxone refills dispensed; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#C(1)(c)">(c)</span> Number and location of naloxone administrations and overdose reversals to the extent this information is reported to the private or public entity authorized by the Department;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#C(2)">(2)</span> Demographic information on individuals who participated in an education and training program, including aggregate number of individuals by:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#C(2)(a)">(a)</span> Sex;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#C(2)(b)">(b)</span> Ethnicity;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#C(2)(c)">(c)</span> Race;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#C(2)(d)">(d)</span> Age; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#C(2)(e)">(e)</span> The specific reason to receive education and training; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#C(3)">(3)</span> Any other information required by the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.09#D">D.</span> Information under <a class="internal-link " href="/us/md/exec/comar/10.47.08.09#C" title="">§C of this regulation</a> shall be reported by the private or public entity authorized by the Department on a monthly basis in a format specified by the Department.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.47.08.10" data-order="|10|47|08|.10|" data-ref-path="10|47|08|.10" class="h__section">.10 General Provisions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.10#A">A.</span> Waiver of Fees. The Department may waive any fee required under this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.10#B">B.</span> Discipline of a Health Care Provider. A health care provider who prescribes or dispenses naloxone to an individual in good faith, may not be subject to any disciplinary action under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Annotated Code of Maryland</a>, solely for the act of prescribing or dispensing naloxone to the individual.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.10#C">C.</span> A cause of action may not arise against any health care provider with prescribing authority, or pharmacist for any act or omission when prescribing or dispensing naloxone and the necessary paraphernalia for the administration of naloxone to an individual in good faith under Health General Article, §13-3108, Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.47.08.10#D">D.</span> An individual who administers naloxone to an individual who is or in good faith is believed to be experiencing an opioid overdose shall have immunity from liability under Courts and Judicial Proceedings Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcj&amp;section=5" title="">5</a>–<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcj&amp;section=603" title="">603</a> and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcj&amp;section=5" title="">5</a>–<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcj&amp;section=629" title="">629</a>, Annotated Code of Maryland.</p>
                <hr class="section-separator" aria-hidden="true"/>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__maryland-dsd" aria-label="Previous and next article links">
            <section>
              <a href="/us/md/exec/comar/10.46" aria-label="Subtitle 46 BOARD OF OCCUPATIONAL THERAPY PRACTICE">
                <div class="h__ui">Previous</div>
                <span>Subtitle 46 BOARD OF OCCUPATIONAL THERAPY PRACTICE</span>
              </a>
            </section>
            <section>
              <a href="/us/md/exec/comar/10.48" aria-label="Subtitle 48 CHILD ABUSE AND NEGLECT MEDICAL REIMBURSEMENT PROGRAM">
                <div class="h__ui">Next</div>
                <span>Subtitle 48 CHILD ABUSE AND NEGLECT MEDICAL REIMBURSEMENT PROGRAM</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__maryland-dsd">
        <div id="section__footer__inner" class="ns__document__maryland-dsd">
          <div id="area__footer__content" class="ns__document__maryland-dsd">
            <p>The codes and laws on this website are in the public domain.</p>
            <p>
      Please do not scrape. Instead, bulk download the <a href="https://github.com/maryland-dsd/law-html">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml">XML</a>.
    </p>
            <p>Powered by the non-profit <a href="https://www.openlawlib.org/">Open Law Library</a>.</p>
          </div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
